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Quantum dots have been used as alternatives to organic dyes for fluorescence 
imaging because they are resistant to photobleaching, exhibit strong response to two-
photon excitation, and can be conjugated to a wide variety of targeting molecules. Silicon 
(Si) nanocrystal quantum dots in particular exhibit bright, size-dependent emission with 
visible to near infrared wavelengths and are biocompatible, making them potentially 
interesting for in vitro and in vivo bioimaging. Here, Si nanocrystals are studied for 
imaging applications. 
The stability of Si nanocrystal dispersibility and photoluminescence (PL) in 
aqueous solutions was studied. Hydrophobic Si nanocrystals were dispersed with 
surfactants to produce colloidally stable and brightly fluorescent dispersions, with PL 
quantum yields in the range of 3.2% - 6.6%. Hydrophilic Si nanocrystals capped with a 
ligand containing a terminal carboxylic acid group could be directly dispersed in aqueous 
environments with quantum yields of up to 9.1% in water. The nanocrystal PL was stable 
in water for at least one week, however there was a significant loss of PL when the 
particles were dispersed in biological solutions. The drop in PL was accompanied by 
surface oxidation and degradation of the nanocrystals. Si nanocrystals incubated with 
mouse macrophage cells were actively taken up by endocytosis. Cell viability assays 
indicated that the nanocrystals were not toxic to the macrophages. The Si nanocrystals 
 viii 
were bright enough to be imaged within the cells by one-photon and two-photon 
microscopy. Hydrophilic Si nanocrystals that emit in the near infrared (900-1000 nm) 
could also be dispersed directly into water, however the emission quantum yields were 
prohibitively low for imaging applications. Time gated imaging of cells labeled with Si 
nanocrystals enabled multiplex imaging using optical probes with spectral overlap by 
separating the PL of organic dyes with short nanosecond lifetimes and Si nanocrystals 
with long microsecond lifetimes. Finally, biotin bioconjugation was accomplished to Si 
nanocrystal surfaces, though the conjugation reaction efficiencies were relatively low. 
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Chapter 1:  Introduction 
1.1 NANOPARTICLES FOR MEDICAL APPLICATIONS 
Nanotechnology advances over the past few decades have led to improved 
precision in the synthesis of nanoparticles with well characterized size, surface, and 
physical properties. These improvements have led to the successful application of 
nanotechnology in a variety of fields, including photovoltaics, light emitting diodes, 
catalysis, and medicine.
1
 At the nanoscale, material physical properties are dominated by 
features such as high surface area to volume ratios as well as quantum size effects.
2
 There 
has been considerable interest in the use of biocompatible nanotechnology for biomedical 
applications since the particles are on the same size scale as biomolecules and cells, and 
unique nanoscale properties can be exploited for use in medical imaging, sensing, and 
therapy.
3–8
 Nanoparticles constructed of various materials have been synthesized 
extensively over the past few decades for medical applications. For example, the plasmon 
resonance observed in gold nanoparticles can be useful for photothermal therapy,
9
 while 
iron oxide nanoparticles have been developed for use in magnetic resonance imaging.
4
 
Fluorescent particles hold particular interest for medical imaging applications 
where organic dyes are currently used.
3,6,8,10–12
 Compared to dyes, fluorescent 
nanoparticles typically exhibit favorable properties including improved photostability, 
broader absorption spectra, narrower emission spectra, and longer fluorescence 
lifetimes.
11
 However, not all fluorescent particles are compatible for use in medical 
applications. Throughout the process of nanoparticle design, consideration must be given 
to the intended use of the products: for example, stability and toxicity of nanostructures 
in biological environments are critical considerations. Nanoparticles ranging from 
 2 
inorganic nanocrystals to surfactant assemblies have thus been developed and studied for 
both in vitro and in vivo applications, including silicon based materials. 
 
1.2 SEMICONDUCTOR NANOPARTICLES 
1.2.1 Quantum Dots 
Nanoscale semiconductor particles, known as quantum dots, were first reported in 
the early 1980’s.
13,14
 When semiconductor materials are scaled down to several 
nanometers, the electron wavefunctions become constrained, resulting in the energy 
levels in the conduction and valence bands becoming discrete and the bandgap widening 
(Figure 1.1).
2,3,14
 The effective mass approximation can predict the bandgap for nanoscale 
materials. The result is composition and size-dependent photoluminescence (PL) 
emission which spans from the visible to infrared wavelengths for quantum dots 
constructed of materials including CdSe, CdS, CdTe, InP, InAs, GaAs, ZnSe, ZnS, PbSe, 
PbS, Si, and Ge.
3,14,15
 Extensive research has been conducted to improve size-specific 
synthesis methods, resulting in particles with wide absorption spectra but narrow 
emission spectra, thereby making quantum dots ideal for multi-color imaging 
applications.
10,16–18
 Further, the surface chemistries of quantum dots have been 
engineered with shells and ligands to enhance and stabilize PL emission while also 






Figure 1.1 Illustration of the bandgap (Eg) in bulk semiconductor materials and 
nanoscale materials. 
Although there has been a tremendous amount of research done on semiconductor 
quantum dots, much of that research has been based on heavy-metal containing particles, 
such as CdSe and CdS quantum dots. Because of the necessity for biocompatible and 
non-toxic materials, there has been a growing interest in silicon nanoparticles. 
 
1.2.2 Silicon Nanocrystals 
At the same time that heavy-metal quantum dots were first synthesized, 
photoluminescence was also observed in silicon (Si) based nanostructures.
14,20,21
 Bulk 
silicon is an indirect bandgap semiconductor, such that the valence band maximum and 
conduction band minimum do not align in k-space and a phonon is necessary for electron 
hole recombination (Figure 1.2). While bulk silicon has a bandgap of 1.12 eV, quantum 
confinement effects at the nanoscale result in size-dependent photoluminescence 
emission ranging from visible to infrared wavelengths for nanocrystals on the scale of 2-
10 nm.
14,22–24
 The absorption spectra for Si nanocrystals exhibit no exciton peaks, and a 




Figure 1.2 Illustration comparing electron-hole recombination and light emission in 
direct and indirect bandgap semiconductors. 
 
 
Figure 1.3 Absorbance and PL spectra (excited at 320 nm) for 2.8 nm diameter Si 
nanocrystals passivated with 1-octene and dispersed in chloroform. 
A number of synthesis methods have been developed for Si nanocrystals. Early 
efforts focused on the formation of Si–rich films by various methods such as ion 
implantation and co-sputtering which could then be etched with hydrofluoric acid to 
result in colloidal Si nanocrystals.
25,26
 Si nanocrystals have also been formed by the 
reductive thermolysis of (HSiO1.5)n sol-gel glasses,
27
 by solution based methods such as 
precursor reduction or zintl salt based reactions,
28–31




 and by decomposition of silanes by plasma or heat.
34–36
 It should be noted that 
some of these methods produce blue emitting Si nanocrystals instead of the red emitting 
particles predicted by the effective mass approximation. These blue emitting nanocrystals 
tend to display size independent emission. An analysis of the methods that produce blue 
emitting particles suggests that the introduction of nitrogen or oxygen impurities during 
synthesis can contribute to the blue emission.
37,38
 Ideally, Si nanocrystal emission should 




A method proposed by Hessel, et al. was developed which addresses challenges 
encountered with other synthesis methods such as low production yield and poor size 
control, and reproducibly produces pure nanocrystals which emit in visible to infrared 
wavelengths (Figure 1.4).
23,42,43
 The synthesis starts with a silicon rich flowable oxide 
(hydrogen silsesquioxane) which is heat in a tube furnace under a reducing atmosphere 
(forming gas 7% H2 and 93% N). The result of the annealing is an SiO2 matrix with 
embedded Si nanocrystals. The annealing step conditions determine the particle size; for 
example, annealing at 1100 °C for 1 hour results in Si nanocrystals with diameters of 
approximately 2.8 nm. After annealing the material can be ground into a fine powder first 
using a mortar and pestle and then by shaking with borosilicate beads in a wrist action 
shaker for 9 hours. Etching with HF and HCl in the dark results in liberation of the Si 
nanocrystals from the SiO2 matrix, and is typically accomplished over 3-6 hours. The 
result of the etching is hydrogen terminated Si nanocrystals. This process not only 
produces size-controlled nanocrystals, but produces them in high quantities (for example, 






Figure 1.4 Illustration of the process for forming Si nanocrystals by the thermal 
annealing of hydrogen silsesquioxane. 
For all Si nanocrystal synthesis methods, surface chemistry is of critical 
importance to ensure that the nanocrystals are photoluminescent and stable. Because 
nanocrystals can contain just a few hundred atoms, a large percentage of the atoms are at 
the surface. It has been commonly observed that oxidizing Si nanoparticle surfaces 
results in a PL blue shift, while the introduction of certain functional groups (such as 
alkyls or amines) can also change emission color.
34,44–46
 Hydrogen terminated Si 
nanocrystals tend to oxidize quickly and surfaces must be protected to maintain 
photoluminescence. Unlike other quantum dots, adding a semiconductor shell on the Si 
nanocrystal core is challenging because of the lack of lattice-matched materials that are 
compatible with crystalline Si. Thus, most preparation methods for colloidal Si 
nanocrystals use surface passivation through hydrosylilation, resulting in stable Si-C 
bonds linking ligands to the nanocrystals. Hydrosylilation can be accomplished by 
thermal processing, UV irradiation, or with the assistance of a platinum catalyst.
23,44,47–49
 
Si nanocrystals have been passivated with hydrophobic and hydrophilic ligands 
including, but not limited to, 1-dodecene, 1-octadecence, 10-undecenoic acid, 3-butenoic 
acid, 1-dodecanethiol, styrene, and diphenylamine.
23,45,50–54
 Si nanocrystals passivated 
with these ligands tend to maintain stable emission for long periods of time (sometimes 
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on the scale of years). Depending on the ligand, Si nanocrystals may be dispersed in polar 
or non-polar solvents. 
 Compared to heavy-metal containing quantum dots, Si nanocrystals developed 
thus far have slightly lower reported quantum yields (up to 60% vs around 80%), longer 
PL decay lifetimes (10’s of µs vs 10’s of ns), wider emission spectra (full width at half 
maximum on the order of 150-200 nm, Figure 1.3), and, as discussed above, challenges 
with surface oxidation.
11,23,24,51
 However, the biocompatibility of Si, along with emission 
in the visible to infrared wavelengths, continues to drive the development of these 
materials for biomedical applications. Silicon is found in trace amounts in the human 
body, which suggests that if the particles degrade in vivo the silicic acid products would 
not be adverse to patient health.
55,56
 Previous work has demonstrated promising results 
for using Si nanocrystals in in vitro and in vivo applications,
50,51,56–59
 and therefore there 
is an opportunity to continue investigating their use for bioimaging. 
 
1.3 DISPERSING NANOPARTICLES IN AQUEOUS SOLUTIONS 
In order for materials to be useful for biological applications, the particles should 
remain colloidally dispersed without aggregation in aqueous solutions. Nanoparticle 
stability in biological solutions can generally be achieved in one of two ways depending 
on the particle’s surface chemistry: (i) hydrophobic nanoparticles can be dispersed with 
the assistance of amphiphilic molecules, or (ii) hydrophilic nanoparticles can be directly 
dispersed into water. 
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1.3.1 Surfactants and Polymers 
Amphiphilic molecules have been used to coat the surfaces of individual 
nanoparticles to allow dispersion in aqueous environments. Molecules used to coat 
nanoparticles have included polymers such as polyethylene glycol or poly(maleic 
anhydride), and has included direct conjugation of the polymer to the nanoparticle or 
surface adsorption.
51,60–63
 The use of molecules such as polyethylene glycol can also 
impact nanoparticle interactions with cells: the layer can provide “stealth” characteristics 




Surfactant molecules can also be used to disperse nanoparticles with hydrophobic 
surfaces. Micelles and liposomes have been used for decades as delivery vehicles for 
hydrophobic and hydrophilic drugs, with many formulations in clinical use (Figure 
1.5).
65,66
 Liposomes have been extensively characterized and thus there is considerable 
knowledge available for lipids that can, for example, target specific types of cells, or that 
are responsive to heat.
66,67
 Nanoparticles incorporated with surfactants have been shown 
to be stable and easily dispersible in aqueous solutions.
50,51,68–71
 Techniques such as 
cryogenic transmission electron microscopy can aid in the study of these assemblies since 







Figure 1.5 Illustration of liposome showing assembly of hydrophobic particles inside of 
the lipid bilayer and hydrophilic particles inside the aqueous core. 
 
1.3.2 Hydrophilic Ligands 
 Nanoparticle surfaces have been engineered with shells or surface-conjugated 
ligands to allow direct dispersion of the particles in water without the need for additional 
polymers or surfactants. Hydrophilic capping ligands include molecules that can be 
directly bound to the silicon surface and contain distal polar groups that can interact with 
an aqueous environment.
49,73,74
 Si nanocrystals have been capped with 10-undecenoic 
acid, which results in distal polar carboxylic acid groups that can enable the nanocrystals 
to be dispersed in polar solvents such as ethanol or water.
52,75
 In aqueous solutions at 
neutral pH, the carboxylic acids deprotonate, leaving the nanoparticles with negatively 
charged surfaces that contribute to electrostatic repulsive forces between the 
nanoparticles to achieve colloidal stability.
76
 This stabilization is very sensitive, however, 
to conditions including the solution pH and ionic content, and thus particles that may be 
stable in water can aggregate when exposed to biological solutions. In contrast to the 
methods using polymers and surfactants, ligand-dispersible nanoparticles tend to be much 
smaller. For example, a Si nanocrystal with 2.8 nm diameter core has a diameter of 
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around 5 nm when capped with 10-undecenoic acid ligands. This puts the nanocrystals on 
the same size scale as large proteins or antibodies. 
 
1.4 BIOIMAGING 
Fluorescence imaging techniques have been extensively developed and used in 
applications ranging from the study of in vitro biological processes to labeling in vivo 
structures for medical diagnostics.
12,77,78
 These techniques can often be performed using 
simple equipment (such as an ultraviolet lamp) and the results can be evaluated by direct 
observation or by capturing and processing images, making fluorescence imaging a 
quick, yet accurate technique to obtain valuable biological information.
12
 Imaging relies 
on the ability for fluorescent probes such as organic dyes to accumulate at the sites of 
certain biomolecules or tissue. Nanoparticles continue to be explored as fluorescent 
probes due to favorable attributes such as resistance to photobleaching and adaptable 
surface chemistries that can enable cell targeting.
11,79
 
Fluorescent silicon nanoparticles have been demonstrated for use in bioimaging at 
the cellular, tissue, and animal scales, with no toxicity observed.
50,51,56–59,74,80–82
 The 
ability to reproducibly synthesize Si nanocrystals with specific emission wavelengths that 
span the near-infrared imaging window make them potential candidates for spectrally 
multiplexed imaging, where one excitation wavelength can be used to excite probes that 
emit at different wavelengths, and which has been demonstrated with quantum dots.
16–18
 
Unfortunately, spectral multiplexing with Si nanocrystals has been difficult to achieve 
due to the broad emission spectra, with full width at half maximum in the range of 150-
200 nm. Beyond spectral multiplexing, temporal multiplexing has also been investigated 
for imaging with multiple fluorescent probes. Time-correlated single photon counting 
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(TCSPC) allows for the measurement of fluorescence decay in biological samples, and 
thus can discern between probes that have different fluorescent lifetimes (Figure 1.6a).
83
 
Because of the unique time scales typically observed for organic dyes (< 10 ns), quantum 
dots (10-100 ns, depending on the material), and Si nanocrystals (10-100 µs), lifetime 




Multi-photon imaging has also been explored with quantum dots since they 
efficiently undergo two-photon absorption (Figure 1.6b).
87
 Because the two photons have 
lower energy than photons used for single photon excitation, pulsed infrared lasers are 
typically used, which enables imaging deep into tissue samples.
39,87,88
 Additionally, 
because two-photon absorption depends on the simultaneous presence of two photons the 
excitation probability is localized to a small focal volume and thus allows for three-
dimensional resolution.
77,87






Figure 1.6 (a) Illustration of lifetime gating using a short lived (3 ns) probe and a long 
lived (60 µs) probe. By gating the emission at short times (region R1) versus 
long times (region R2), it is possible to separate the contributions from the 
two probes. (b) Illustration of one-photon and two-photon excitation. 
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In the development of new probes for bioimaging, it is necessary to consider the 
interactions between nanoparticles and biomolecules or cells. Previous work has 
identified that nanoparticle characteristics such as their size, shape, and surface chemistry 
can impact how particles are taken up by cells, as well as how nanoparticles are cleared 
from the body.
56,90–94
 If the intent is to use a probe for imaging inside of cells it is 
necessary to study the uptake mechanism used by the cells to ensure the probe can reach 
its target.
93
 The fate of the material after imaging is another important factor in the design 
of new fluorescent probes. Since silicon is found in the human body in trace amounts and 
the body is able to process and clear silicic acids,
55,95
 it is expected that silicon based 
probes can degrade over time and be removed from patients without the accumulation of 
toxic materials. 
Additionally, the fluorescence stability of probes is a critical consideration for in 
vivo and in vitro imaging. Probes must be able to retain their fluorescence when exposed 
to the biological environment, and should maintain their fluorescence for a sufficiently 
long enough period for the particles to accumulate in the target cell or tissue. Considering 
that nanoparticles may accumulate in tissues or organelles with low pH or high 
concentrations of biomolecules, characterization of the particle fluorescence stability in 
those environments will guide the use of Si nanocrystals for in vivo and in vitro imaging 
applications. 
 
1.5 DISSERTATION OVERVIEW 
The need for biocompatible and non-toxic particles has continued to be of primary 
interest for the development of new fluorescent probes for bioimaging. Si nanocrystals 
synthesis methods have been greatly improved to produce passivated particles with size-
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dependent photoluminescence, and thus the goal of this work is to move Si nanocrystals 
toward practical use in fluorescence imaging. Chapter 2 presents the results of using 
liposomal assemblies to disperse hydrophobic Si nanocrystals, and also examines the 
uptake of the fluorescent Si nanocrystal-liposome assemblies by macrophage cells. 
Chapter 3 studies the incorporation of Si nanocrystals into “quatsomes,” which are stable 
surfactant assemblies composed of cetyl trimethylammonium bromide and cholesterol. 
Chapter 4 explores the stability of 10-undecenoic acid capped Si nanocrystals in aqueous 
biological solutions and characterizes the uptake of the Si nanocrystals in cells using flow 
cytometry and confocal microscopy, as well as assesses the toxicity of the nanoparticles. 
Chapter 5 presents data for water dispersible Si nanocrystals that emit in the near 
infrared. Chapter 6 demonstrates the use of 10-undecenoic acid capped Si nanocrystals 
for two-photon and lifetime gated in vitro imaging. Chapter 7 presents data on the 
bioconjugation of biotin to 10-undecenoinc acid capped Si nanocrystals. Chapter 8 
provides final conclusions and proposed future research. 
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Chapter 2:  Assembly of Fluorescent Silicon Nanocrystals with 
Liposomes and Uptake by Macrophage Cells 
2.1 INTRODUCTION 
The ability to use nanoparticles in place of traditional fluorescent molecules for 
biomedical imaging has led to the development of contrast agents with broad excitation 
and emission spectra, long fluorescence lifetimes, high quantum yields, and high stability 
against photobleaching.
1–3
 Silicon (Si) based nanoparticles in particular are attractive 
probes for bioimaging because the material is considered non-toxic and biocompatible, 
and methods to synthesize Si nanocrystals can produce alkene capped particles with 
narrow size distributions.
4–9
 Various methods have been proposed for stabilizing 
hydrophobic Si nanocrystals in aqueous environments, including the use of surfactants or 
polymer coatings.
3,5,7,10,11
 The optimization of bright photoluminescence from Si 
nanocrystal-surfactant assemblies is important for the use of these assemblies in vitro and 
in vivo, and depends on both the capacity for nanocrystals to load into the surfactant 
dispersion as well as the photoluminescence stability. 
Liposomes have hydrophobic and hydrophilic regions that can be loaded with 
particles and have found use as targeted and non-targeted carriers for drugs, molecules, 
genes, SiRNA, and nanoparticles.
12–16
 The lipids in liposome assemblies can vary in their 
net charge, headgroup composition, hydrocarbon chain length, and hydrocarbon 
saturation, and these factors can affect how particles incorporate into the liposomes as 
well as how the assemblies interact with cells.
13,16–18
 Additionally, preparation procedures 
for nanoparticle-liposome assemblies such as chloroform annealing can affect loading 
capacity.
19
 Here, we examined the assembly of 2.8 nm hydrophobic Si nanocrystals into 
liposomes (“Lip-NC assemblies”) constructed from various lipids to maximize dispersion 
emission. The ability for Si nanocrystals to incorporate into liposomes was examined 
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using cryogenic transmission electron microscopy (cryoTEM). The nanocrystals 
incorporated as aggregates into the assemblies, with the highest loading in anionic 
liposome formulations with quantum yields of 3.2%. 
The Lip-NC dispersions assemblies were also evaluated for bioimaging with live 
cells. It was possible to capture Si nanocrystal emission in the interior of macrophage 
cells using confocal microscopy after incubating Lip-NC assemblies with the cells. One-
photon and two-photon imaging of Si nanocrystals could be achieved. Additionally, the 
assemblies did not show any toxicity towards the cells, demonstrating the potential for 
using the Lip-NC assemblies as bioimaging probes. 
 
2.2 EXPERIMENTAL METHODS 
2.2.1 Materials 
 Hydrogen silsesquioxane (HSQ) was obtained from Dow Corning. Hydrochloric 
acid (HCl, 37%), hexanes (≥98.5%), chloroform (≥99.8%), toluene (≥99.5%), and 
sodium chloride were purchased from Fisher. 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) (HEPES), sodium hydroxide, hydrofluoric acid (HF, 
48%), 1-octene (98%), 1-dodecene (95%), and 1-hexene (97%) were purchased from 
Sigma. Ethanol was purchased from Pharmco-Aaper. Cholesterol was obtained from 
Anatrace. All lipids were purchased from Avanti Polar Lipids. DAPI-Fluoromount-G was 
purchased from SouthernBiotech, while sodium pyruvate was purchased from Hyclone. 
Dulbecco's Modified Eagle Medium (DMEM) and phosphate buffered saline (PBS) were 
purchased from Gibco. Fetal bovine serum (FBS) and penicillin/streptomycin were 
purchased from Life Technologies. Non-essential amino acids were purchased from 
Lonza. The CytoTox 96® Non-Radioactive Cytotoxicity Assay and CellTiter 96® 
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AQueous Non-Radioactive Cell Proliferation Assay kits were purchased from Promega. 
Ultrapure water was obtained from a Millipore Synergy Ultrapure water system operating 
at 18.2 MΩ/cm. 
 
2.2.2 Si Nanocrystal Synthesis 
Silicon nanocrystals capped with alkenes were synthesized from HSQ as 
previously reported.
7
 Solvent was removed from HSQ and the material was placed in a 
tube furnace for 1 hour at 1100 °C under forming gas (93% nitrogen and 7% hydrogen) 
flow. A mortar and pestle were used to grind the resulting material. The particle size was 
further reduced using 9 hours of mechanical shaking in a wrist action shaker with 
borosilicate beads. From the resulting material, 300 mg of the powder was etched with 1 
ml HCl and 10 ml HF for 3.5 hours in the dark. The hydrogen terminated silicon 
nanocrystals were then washed by centrifugation: first the solution was centrifuged and 
the precipitated material was retained, then two washes with ethanol and one wash with 
chloroform were used to remove any trace acids. The nanocrystals were then dispersed in 
15 ml of 1-octene and injected into a 3-neck flask under vacuum. Three freeze-thaw 
cycles were performed to remove residual oxygen with the freeze being done under 
vacuum and the thaw under nitrogen gas. The flask was then left stirring at 120 °C for 12 
hours. The solution was then transferred to a centrifuge tube and centrifuged for 5 min at 
8000 rpm and the precipitate containing poorly passivated nanocrystals was discarded. 
Ethanol (antisolvent) was added until the solution became turbid and the sample was 
centrifuged. The supernatant was removed and the nanocrystals were redispersed in 
hexanes. Three additional cycles of solvent-antisolvent washing were used before finally 
dispersing the nanocrystals in chloroform for storage. 
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 For the nanocrystal size experiments, size selective precipitation was used to 
separate a sample of 1-octene capped Si nanocrystals into subsets of smaller and larger 
particles. By adding a small amount of anti-solvent (ethanol) to a solution of Si 
nanocrystals dispersed in hexane, the largest nanocrystals were precipitated out by 
centrifuging at 8000 rpm for 5 minutes. The supernatant containing smaller nanocrystals 
was then transferred to a new centrifuge tube and a small amount of ethanol was added 
before centrifuging, causing the next largest nanocrystals to precipitate out. This process 
was repeated until five size fractions were produced, of which the largest (3.0 ± 0.6 nm) 
and smallest (2.7 ± 0.6 nm) were used for experiments with liposomes. 
 
2.2.3 Incorporation of Si Nanocrystals with Liposomes 
In a typical preparation, a total of 15 µmol of lipid and 0.75 mg of silicon 
nanocrystals were dispersed in 1 ml of chloroform in a 50 ml round bottom glass flask. 
The solution was then dried into a film using a rotary evaporator (Rotavapor R-3000 
connected to a Welch dry vacuum system, model 2025) for 15 minutes at 25 °C, followed 
by 3 hours under vacuum in a vacuum oven (Isotemp Vacuum Oven Model 281A) set to 
25° C at -760 mmHg vacuum. Where chloroform annealing was used, the dried film was 
inverted and placed over a glass bottle filled with chloroform for 1 hour, as previously 
reported.
19
 The film was then hydrated using 1 ml of either water (for neutral liposomes) 
or a solution of 10 mM HEPES and 10 mM NaCl (for charged liposomes) adjusted to pH 
7.2 using NaOH. The flask was bath sonicated for 5 minutes to disperse the lipids and 
nanoparticles into solution before transferring the solution to a 20 ml glass vial for 
another 30 minutes of bath sonication (Bransonic M1800 bath sonicator, 40kHz, half 
gallon tank). The dispersion was then transferred to a 1.5 ml centrifuge tube and 
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centrifuged for 5 minutes at 600 G to separate any silicon nanocrystals that were not 
incorporated into liposomes. The supernatant was removed and transferred to a new 1.5 
ml centrifuge tube and centrifuged for 5 minutes at 900 G. The supernatant containing the 
Lip-NC assemblies was transferred to a new vial and stored at 25 °C. 
 
2.2.4 Si Nanocrystal and Liposome Characterization 
Silicon nanoparticles were characterized with Transmission Electron Microscopy 
(TEM) using an FEI Tecnai Biotwin TEM operated at 80 kV accelerating voltage. 
Samples were prepared by drop casting silicon nanocrystals onto 200 mesh carbon-coated 
copper grids (Electron Microscopy Science) and images were acquired digitally. Si 
nanocrystal diameters were estimated from TEM issues by measuring 100 particles. 
X-ray diffraction (XRD) data was acquired on a Rigaku R-Axis Spider 
diffractometer using Cu Kα radiation (λ = 0.15418 nm) and an image plate detector. 
Dried nanocrystals were positioned onto a nylon loop using mineral oil (a background 
scan was complete without nanocrystals added). The sample was then rotated at 10° per 
second for 20 minutes. The two dimensional diffraction data was then integrated using 
2DP Spider software (version 1.0, Rigaku). 
Fourier transform infrared spectroscopy (FTIR) data was acquired on a Thermo 
Mattson Infinity Gold FTIR spectrometer with a Spectra-Tech Thermal ARK attenuated 
total reflectance module. The chamber was purged with nitrogen gas for 15 minutes 
before the background signal was collected. The nanocrystal sample was then drop cast 
onto the ARK crystal plate and allowed to dry under a nitrogen gas purge for 15 minutes. 
Measurements were taken by acquiring 512 scans at a resolution of 4 cm
-1
 and 
background was subtracted. 
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Cryogenic TEM (cryoTEM) samples were prepared on lacey carbon coated 
copper 200 mesh grids (Electron Microscopy Science) using a Leica EM GP. The 
environmentally controlled chamber was set to 25 °C and 90% humidity, and the sample 
was blotted for 3 seconds on one side and 1 second on the other side before being 
plunged into liquid ethane at -182 °C. The grid was then transferred under liquid nitrogen 
into a Gatan 626 Cryo-Transfer Holder, which was then inserted into an FEI Tecnai 
Biotwin TEM. The TEM was operated at 80 kV accelerating voltage with FEI low dose 
software used for imaging. 
Dynamic Light Scattering (DLS) data were acquired with a Zetasizer Nano ZS 
(Malvern Instruments) at an angle of 173° and temperature of 25 °C. Sample sizes were 
measured in triplicate in 40 µl disposable cuvettes. Zeta potential data were captured in 
triplicate with the same instrument using disposable folded capillary zeta cells. Zetasizer 
software (Malvern Instruments) was used to analyze sample average size (z-average), 
polydispersity index (PDI), and zeta potential. 
Spectroscopy data was collected for samples after 20 times dilution into water 
using glass cuvettes. Absorbance spectra were acquired on a Varian Cary 50 Bio 
ultraviolet-visible spectrophotometer. Photoluminescence emission (PL) and 
photoluminescence excitation (PLE) spectra were captured on a Varian Cary Eclipse 
fluorescence spectrophotometer. All PL spectra were captured using an excitation 
wavelength of 320 nm while PLE spectra were captured using an emission wavelength of 
665 nm. PL peak wavelength position was calculated by determining the average 
emission wavelength. Rhodamine B was used as a standard for quantum yield 
measurements (quantum yield of 0.49 in ethanol).
20
 Quantum yield was calculated 
according to the relation: QYSi=(QYref) (Aref/ASi)(Isi/Iref)(ηSi/ηref)
2
, where QY is the 
quantum yield, A is the absorbance at 350 nm, I is the PL intensity upon excitation at 350 
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nm, η is the solvent refractive index, and the subscripts Si and ref refer to the Si 
nanocrystal samples and Rhodamine B reference, respectively. 
 
2.2.5 Liposome-Si Nanocrystal Incubation with Cells 
J774A.1 macrophage cells were grown in DMEM supplemented with 10% fetal 
bovine serum, 100 U/mL penicillin-streptomycin, and 1 mM sodium pyruvate. Caco-2 
epithelial cells were grown in the same medium with the addition of 0.1 mM non-
essential amino acids. All cells were maintained in a humidified 37 °C incubator with an 
atmosphere of 5% CO2, unless otherwise indicated. 
For confocal microscopy experiments cells were seeded on glass coverslips in 6-




 two days before the assay. Culture medium was 
replaced with Lip-NC dispersions diluted 5-fold in growth medium, and incubated for 3 
hours at 37 °C unless otherwise indicated. At the end of the incubation the coverslips 
were washed 4 times with PBS to remove Lip-NC assemblies not taken up by the cells. 
The cells were then fixed with 4% formaldehyde for 10 minutes at 37 °C. The coverslips 
were then washed three times with PBS, mounted on glass slides with DAPI 
Fluoromount-G. For experiments performed at 4 °C the cell culture plate was maintained 
on ice for 30 minutes before and during the assay. 
For flow cytometry experiments cells were seeded in 6-well or 24-well plates at a 




 two days before the assay. Culture medium was replaced with 
Lip-NC dispersions diluted 5-fold in growth medium, and incubated for 3 hours at 37 °C 
unless otherwise indicated. At the end of the incubation the cells were washed 4 times 
with PBS to remove Lip-NC assemblies not taken up by the cells. The cells were then 
mechanically scraped from the wells for flow cytometry. 
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2.2.6 Cell Uptake Characterization 
Confocal imaging was conducted on a Zeiss LSM 710 confocal microscope. 
DAPI was excited at a wavelength of 405 nm and emission was captured at 417-566 nm. 
Silicon nanocrystals were excited at a wavelength of 405 nm and emission was captured 
at 670-740 nm. Images were taken at the center plane of the cells using the DAPI stained 
nucleus as a guide. Zeiss confocal software was used to overlay images with the DAPI 
channel in blue and the silicon nanocrystal channel in red. 
Two-photon microscopy was conducted on a commercial two-photon/confocal 
microscopy system (Prairie Technologies, Ultima Intravital). The microscope objective 
used was an Olympus XLUMPLFLN 20x 1.0 NA, water immersion lens. The two-photon 
excitation source was a Ti:sapphire laser (Spectra-Physics Tsunami) with 150 fs pulses 
while the single photon excitation source was a diode laser. Both Si nanocrystals and 
DAPI were excited at either 405 nm (for one photon images) or 800 nm (for two photon 
images). Si nanocrystal fluorescence was captured using a 690 ± 30 nm filter, while 
DAPI fluorescence was captured using a 460 ± 25 nm filter. Images were false colored 
red for Si nanocrystals and blue for DAPI. 
Flow cytometry was conducted on a BD Biosciences LSR Fortessa Flow 
Cytometer. Silicon nanocrystals were excited at 405 nm and emission was captured using 
a 670 nm long pass filter for 10,000 live cells. FlowJo software was used for data 
analysis. 
Two assays were used to test the effect of Lip-NC assemblies on cell viability: the 
lactate dehydrogenase (LDH) assay using CytoTox 96® Non-Radioactive Cytotoxicity 
Assay kit and 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium (MTS) assay using CellTiter 96® AQueous Non-
Radioactive Cell Proliferation Assay kit. Both assays were performed according to the 
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manufacturer’s instructions. Briefly, cells were seeded and grown as for the flow 
cytometry experiments. Lip-NC assemblies were incubated with the cells at 37 °C for 1, 
3, or 6 hours. Next, the culture supernatants were transferred to microcentrifuge tubes and 
centrifuged at 13,000 g for 10 minutes. 50 µl of each clarified supernatant was transferred 
to a flat-bottom 96-well plate and mixed with 50 µl of LDH substrate using a 
multichannel pipette. After 30 minutes of incubation at room temperature in the dark, the 
absorbance was read at 490 nm. The viability % is calculated as follows: [1-(Sample 
A490 - Cells without treatment A490)/(100% lysis A490 - Cells without treatment 
A490)] X 100%. 100% lysis was from cells lysed with 0.9% Triton X-100.  
The remaining cells in the plate were immediately washed three times with PBS 
to remove residual Lip-NC assemblies, and medium containing 6-fold dilution of MTS 
and phenazine methosulfate (PMS) solution was added into each well and incubated in 37 
°C incubator with 5% CO2 for 1 hour. Then the supernatants were transferred to a flat-
bottom 96-well plate to be read at 490 nm. The viability % was calculated as follows: 
(Sample A490 – No cell A490)/(Cells without treatment A490– No cell A490) X 100%. 
Wells without cells were used as the blank to account for automatic coloration. 
 
2.3 RESULTS AND DISCUSSION 
2.3.1 Liposome-Si Nanocrystal Assembly 
Figure 2.1 shows the 1-octene passivated Si nanocrystals used in the liposome 
assembly experiments. Nanocrystals were synthesized by thermal decomposition of 
hydrogen silsesquioxane (HSQ) as previously reported by Hessel et al.
7
 using an 
annealing temperature of 1100 °C to produce nanocrystals with diameters of 2.8 ± 0.5 
nm. Figure 2.1b shows the x-ray diffraction pattern confirming a diamond cubic lattice 
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structure. The nanocrystals were passivated with 1-octene to prevent surface oxidation 
and confer dispersibility in non-polar solvents such as chloroform. Figure 2.1c shows 
FTIR data indicating peaks associated with hydrosylilation of an alkene to the Si surface, 
including C-H stretching (2800-3000 cm
-1





), and Si-O-Si stretching (~1100 cm
-1
). The absence of C=C 
stretching (~1640 cm
-1
) indicates that all 1-octene was either bound to the silicon 
nanocrystal surface or washed away. 
 
 
Figure 2.1 (a) TEM image of 2.8 nm octene capped Si nanocrystals. Inset shows vial of 
Si nanocrystals under ambient light and on a 365 nm ultraviolet lamp. (b) 
XRD pattern confirmed the diamond cubic silicon structure with 
a=b=c=0.543 nm (PDF # 027-1402). (c) FTIR data for Si nanocrystals 
passivated with 1-octene confirmed surface passivation with an alkene. 
 Figure 2.2 illustrates the process used to incorporate Si nanocrystals into 
liposomes, which was similar to the methods previously reported for loading hydrophobic 
drugs and particles into liposomes.
17,21,22
 0.75 mg of octene coated Si nanocrystals were 
dispersed with 15 µmol of lipid in 1 ml of chloroform and then dried into a thin film. In 
some preparations, the thin film underwent a chloroform annealing step, which has 
previously been identified as improving the incorporation of nanoparticles into liposomes 
by allowing rearrangement of the particles in the film.
19
 The film was then hydrated to a 
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final volume of 1 ml and bath sonicated to form liposomes. The samples were centrifuged 
to precipitate nanocrystals not incorporated into liposomes. 
 
 
Figure 2.2 Illustration of the process used to incorporate Si nanocrystals into 
liposomes. The chloroform annealing step was performed on some samples. 
Liposomes assembled with Si nanocrystals were composed of the following lipids 
and molecules: 
(i) Zwitterionic, unsaturated lipids. 1,2-dioleoyl-sn-glycero-3-phosophocholine 
(DOPC), an 18:1(Δ9-cis) unsaturated lipid was used. Unsaturated lipids have 
higher membrane fluidity than saturated lipids,
17
 and DOPC liposomes have a 
bilayer thickness of 4.6 nm
23
 that should be able to accommodate the 2.8 nm Si 
nanocrystals. DOPC has previously been shown to incorporate gold nanocrystals 
into the lipid bilayer.
19
 DOPC is considered a helper lipid in many liposome 
formulations as it can be used to control surface charge density.
15
  
(ii) Zwitterionic, saturated lipids. 1,2-dilauroyl-sn-glycero-3-phosphocholine (DLPC), 
an 12:0 saturated lipid was used. While saturated lipids have less membrane 
fluidity, DLPC has a shorter hydrocarbon chain than DOPC and is in the 
disordered liquid crystalline phase at room temperature. 
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(iii) Anionic lipids. 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DOPG), an 
18:1(Δ9-cis) unsaturated lipid was used. 
(iv) Cationic lipids. 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP), an 
18:1(Δ9-cis) unsaturated lipid was used. 
(v) Zwitterionic, unsaturated lipids with conical structure. 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine (DOPE), an 18:1(Δ9-cis) unsaturated lipid that can form an 
inverted hexagonal phase was used. DOPE is frequently used as the zwitterionic 
lipid in formulations for drug release applications.
13,15,24
 
(vi) Polyethylene glycol (PEG) conjugated lipids. DOPE-PEG2000 was used, which 
has a 2,000 molecular weight PEG molecule conjugated to DOPE. Adding PEG to 
liposome surfaces can improve liposome stability, increase in vivo circulation 
time, and alter how liposomes are taken up by cells.
12,16,25
 





Figure 2.3 shows cryoTEM images, vial photographs, and photoluminescence 
data for the Lip-NC formulations prepared with the chloroform annealing step. In all 
samples the Si nanocrystals appeared as aggregates that exhibited different shapes and 
sizes depending on the formulation. Formulations containing only DOPC or DOPC with 
DOPG had Si nanocrystal aggregates that were approximately the same size and shape as 
empty liposomes (green arrows). In other dispersions the aggregates appeared at similar 
sizes as the empty liposomes, however they had non-spherical shapes (yellow arrows). 
Finally, some dispersions appeared to contain irregularly shaped, large aggregates (red 
arrows). The photoluminescence data indicates either no blue shift or a very small blue 
shift in the emission wavelengths (<10 nm) compared to the Si nanocrystals dispersed in 
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chloroform, which may correspond to either slight surface oxidation of the Si 





Figure 2.3 CryoTEM images of Lip-NC assemblies synthesized with the chloroform 
annealing step. Nanocrystal aggregates were observed with sizes and shapes 
similar to empty liposomes (green arrows), non-spherical shapes (yellow 
arrows), and large irregular shapes (red arrows). Pictures of the dispersions 
under ambient light and on a 365 nm ultraviolet lamp. Normalized PL and 
PLE spectra for each of the dispersions, with black dotted lines indicating 
peak PL wavelength for Si nanocrystals in chloroform (718 nm). 
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Table 2.1 presents the dynamic light scattering and zeta potential data for the 
chloroform annealed samples. The assembly sizes ranged from 128-322 nm, which are 
typical sizes for small unilamellar liposomes and on the same scale as liposomal 
formulations used for drug delivery.
15
 The polydispersity index (PDI) values for Lip-NC 
assemblies were in the range (0.1-0.5) expected for samples that have a low level of 
polydispersity.
27
 A comparison of the sizes for liposomes constructed in the absence of Si 
nanocrystals but using the same preparation process (including the chloroform annealing 
step) found that the formulations with Si nanocrystals had slightly larger sizes. 
 
Liposome – Si nanocrystal assemblies 





Liposome – Si nanocrystal assemblies 
DOPC 205.3 ± 6.2 0.304 ± 0.002 -23.9 ± 0.6 
DLPC 165.7 ± 1.4 0.236 ± 0.015 -1.2 ± 0.3 
1:1 DOPC:DOPG 184.7 ± 4 0.227 ± 0.019 -49.5 ± 0.8 
3:1 DOPC:DOPG 159.1 ± 2.8 0.238 ± 0.009 -54.0 ± 2.8 
10:1 DOPC:DOPG 128.4 ± 3.2 0.256 ± 0.006 -30.5 ± 0.6 
1:1 DOPC:DOTAP 135.5 ± 4 0.265 ± 0.007 58.6 ± 3.4 
3:1 DOPC:DOTAP 314.7 ± 27.2 0.242 ± 0.129 49.5 ± 1.0 
10:1 DOPC:DOTAP 236.1 ± 21 0.439 ± 0.065 37.6 ± 0.8 
1:1 DOPE:DOPG 192.7 ± 2.6 0.252 ± 0.018 -63.6 ± 0.5 
1:1 DOPE:DOTAP 147.5 ± 4.5 0.299 ± 0.005 56.5 ± 0.6 
98:2 DOPC:DOPE-PEG 154.4 ± 2.3 0.261 ± 0.012 -47.8 ± 2.3 
95:5 DOPC:DOPE-PEG 160.4 ± 2.2 0.256 ± 0.003 -29.9 ± 0.5 
1:1:0.1 
DOPC:DOPG:Cholesterol 156.9 ± 3.4 0.246 ± 0.012 -67.0 ± 0.4 
1:1:1 DOPC:DOPG:Cholesterol 322.4 ± 3.3 0.347 ± 0.052 -69.1 ± 1.4 
Liposomes prepared without Si nanocrystals 
DOPC 149.4 ± 2.2 0.195 ± 0.011 -13.6 ± 1.1 
1:1 DOPC:DOPG 98.1 ± 1.8 0.219 ± 0.008 -86.4 ± 3.0 
1:1 DOPC:DOTAP 182.7 ± 3.3 0.294 ± 0.006 82.5 ± 0.5 
Table 2.1 DLS and zeta potential measurements for Si nanocrystal and liposome 
dispersions, measured in triplicate at 25 °C. 
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The shapes and sizes attained by the various lipid constructs indicate that lipid 
chemistry plays a role in how the nanocrystals assemble, likely through differences in 
membrane fluidity. Liposomes constructed with saturated lipids (DLPC) or cholesterol 
have less membrane fluidity, and the Si nanocrystal assemblies appeared non-spherical. 
Samples containing DOPE, which can attain inverted hexagonal phases, displayed 
irregular shapes as well. It also appears that headgroup charge can affect Si nanocrystal 
incorporation: within the series of charged liposomes with the same hydrocarbon chain 
configurations (DOPC with either DOPG or DOTAP) the Si nanocrystals assembled 
either as round aggregates or with irregular shapes. Charged headgroups interact with the 
surrounding aqueous solution, and examinations of charged lipid bilayers have identified 
that local solvent ionic content can impact membrane fluidity.
28
 The interaction between 
DOPC, DOPG, and DOTAP with the HEPES buffer solution can result in membrane 
fluidity changes that result in differences in aggregate shape, such as the irregular shapes 
observed with the DOTAP formulations. 
Figure 2.4 illustrates the likely assembly process for the Si nanocrystal 
aggregates. Hydrophobic nanoparticles in aqueous environments are known to cluster to 
minimize free energy in the system, as well as to associate with the hydrophobic 
hydrocarbon chains on lipids.
29
 In order for nanocrystals to enter into a liposome bilayer, 
there must be sufficient energy to cause the lipid bilayer to unzip and make space for the 
particles.
22
 The hydrophobic pocket inside the bilayer then has void space surrounding it, 
and adding new nanoparticles to the cluster causes a further decrease in the system free 
energy. Thus, once one bilayer accommodates some nanoparticles, it is likely that the 
cluster will grow. This can explain why the cryoTEM images show either completely 
empty liposomes or clusters of nanoparticles. A recent study analyzing the effect of 
hydrophobic nanoparticle size on the ability to incorporate into lipid bilayers found that 
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there is a threshold in lipid behavior for nanoparticles with diameters above 6 nm.
30
 
Below this threshold, small nanoparticles can incorporate into the bilayer. However, 
larger particles disrupt the bilayer structure and a lipid monolayer wraps around the 
particle surface. While the Si nanocrystals used here are small (2.8 nm), if they become 
aggregated into clusters > 6nm, there will be a driving force for the lipids to form 
monolayers over the clusters. The fact that the Lip-NC assemblies remain dispersed for at 
least several days (see stability testing below) supports the scenario of a lipid monolayer 
coating the Si nanocrystals. 
 
 
Figure 2.4 Illustration of the formation of Si nanocrystal aggregates. The thin film 
containing lipids and octene capped Si nanocrystals is hydrated and bath 
sonication is used to form liposomes. After one Si nanocrystal associates 
with the hydrophobic core in the bilayer, there is a driving force for 
nanoparticles to cluster. The cluster may then act as a single large particle 
and becomes coated with a lipid monolayer. 
 From a visual inspection of the Lip-NC assemblies presented in Figure 2.3, the 
brightest dispersion appeared to be 1:1 DOPC:DOPG. The quantum yield for a 1:1 
DOPC:DOPG Lip-NC dispersion was 3.2%. While this is lower than the quantum yield 
calculated for the 1-octene capped Si nanocrystals in chloroform (14.6%), it is 
comparable to fluorophores currently used in bioimaging.
31 
The loading capacity of Si nanocrystals into the liposome dispersions was 
quantitatively assessed using a variation of a calculation used for pharmaceutical 
liposomes. The encapsulation efficiency measures the percentage of drug encapsulated in 
liposomes for drugs delivered using liposomal assemblies (as opposed to drug material 
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that is lost during the assembly procedure and thus is not available for delivery to the 
patient).
17
 Here, the loading capacity for Si nanocrystals in liposomes was estimated as 







 100   Equation 2.1 
where ILip-NC is the measured emission intensity from a Lip-NC dispersion and ISiNC is the 
measured emission intensity from Si nanocrystals dispersed in chloroform at the 
maximum concentration possible according to the synthesis methods (0.75 mg Si 
nanocrystals in 1 ml chloroform). This relation uses PL emission as a measure of 
nanocrystal loading and thus takes into consideration not only the amount of Si 
nanocrystals incorporated, but also any loss of PL that results from dispersing the 
nanocrystals with liposomes. Figure 2.5 shows the DEF for samples prepared with or 
without the chloroform annealing step. The measured DEF values agreed with the visual 
appearance of the nanocrystal samples: the samples with the highest DEF values 
displayed visibly brighter fluorescence when excited by ultraviolet light. 
The highest DEF values were close to 50%, indicating that half of the Si 
nanocrystals introduced into the Lip-NC assembly synthesis were incorporated into the 
dispersions. The results show that while the chloroform annealing step had some effect 
on the loading (often to increase the emission), the difference between annealed and non-
annealed samples is not significant in most formulations. CryoTEM images of assemblies 
prepared without the chloroform annealing step showed that in all cases the nanocrystals 
assembled as aggregates, and thus it appears that the annealing step does not have an 
impact on Lip-NC assembly formation. 
 40 
 
Figure 2.5 Calculated dispersion emission fractions (DEF) for Lip-NC assemblies. 
Samples were prepared either with (blue bars) or without (yellow bars) the 
chloroform annealing step. All samples were prepared in triplicate, and error 
bars represent standard deviation. * DEF for PEG samples were not 
measured in the absence of the annealing step. 
 The charged liposomes displayed a trend between surface charge and DEF: 
compared to the neutral DOPC Lip-NC assemblies, as the proportion of anionic lipid 
(DOPG) was increased the DEF increased; while conversely as the proportion of cationic 
lipid (DOTAP) was increased the DEF decreased. These results suggest that although the 
octene coated Si nanocrystals are lipophilic and interact with the lipid hydrocarbon 
chains, the headgroup charge and/or composition impact the ability of the lipids to 
assemble with the silicon nanocrystals, as previously discussed. 
The data indicated that for the liposomes with PEG, increasing the fraction of 
PEG correlated with a higher DEF. Although from cryo-TEM images (Figure 2.3) the 
PEGylated liposomes associated with nanoparticles appeared in non-spherical shapes, it 
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is possible that the dispersions still held more nanocrystals due to the increased steric 
stabilization between liposomes that PEG provides. For samples containing cholesterol, it 
was found that a ratio of 1:1:0.1 DOPC:DOPG:cholesterol did not affect the ability for Si 
nanocrystals to incorporate with the lipids (as compared to 1:1 DOPC:DOPG Lip-NC 
assemblies). However, when the amount of cholesterol was increased to a ratio of 1:1:1 
DOPC:DOPG:Cholesterol the DEF decreased significantly. This formulation was also 
seen to have irregular shapes (Figure 2.3) and large size as measured by DLS, suggesting 
that the Si nanocrystals disrupted the formation of stable liposomes. The positioning of 
cholesterol within the lipid bilayer may compete with the ability for silicon nanocrystals 
to associate with the hydrophobic regions of the lipids, or the membrane may become 
less fluid, both of which can result in lower levels of Si nanocrystal incorporation. 
The effect of Si nanocrystal size on loading into liposomes was evaluated by size 
selecting the octene capped nanocrystals into smaller and larger subsets before 
incorporating them into 1:1 DOPC:DOPG liposomes. Although the particles were still 
very close in size (3.0 ± 0.6 nm and 2.7 ± 0.6 nm for the larger and smaller nanocrystal 
subsets, respectively), measurement of their loading into 1:1 DOPC:DOPG liposomes 
found that the larger nanocrystals resulted in a DEF of 24.2%, while the smaller 
nanocrystals resulted in a DEF of 70.6%, demonstrating a considerable increase in Si 
nanocrystal loading with decreasing particle size. These results can also explain the slight 
blue shift observed after incorporating Si nanocrystals into liposome assemblies, since the 
smallest particles are more likely to be included in the dispersion. CryoTEM images 
taken of the samples prepared with the size-selected Si nanocrystals (data not shown) 
confirmed that the assemblies appeared similar to the 1:1 DOPC:DOPG Lip-NC 
assemblies prepared without size selection. 
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 The loading capacity was also investigated by increasing the total amount of lipid 
used to disperse the Si nanocrystals, from 15 µmol up to 60 µmol. The DEF only 
increased by 7% with the additional lipids. 
 
2.3.2 Liposome-Si Nanocrystal Photoluminescence Stability 
Lip-NC dispersions were assessed for photoluminescence stability by monitoring 
the PL emission intensity and wavelength over three weeks. Figure 2.6 shows the 
stability for Lip-NC assemblies prepared with DOPC, 1:1 DOPC:DOPG, 1:1 
DOPC:DOTAP, and 98:2 DOPC:DOPE-PEG. The emission of DOPC, 1:1 
DOPC:DOPG, and 98:2 DOPC:DOPE-PEG appeared to drop off after the first week to 
around 70% of the original dispersion emission intensity, and then leveled off close to 
60% after three weeks. In contrast, the sample constructed with 1:1 DOPC:DOTAP had a 
sharp decrease in PL intensity after 1 week and only maintained 20% of the original 
emission intensity after three weeks. Additionally, the 1:1 DOPC:DOTAP sample was 
the only sample to see a significant blue shift in the PL wavelength (drop of 
approximately 50 nm), suggesting that the cationic formulation did provide as much 
stability as the other formulations. 
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Figure 2.6 (a) Normalized emission intensity and (b) PL emission wavelength for 
samples constructed of DOPC, 1:1 DOPC:DOPG, 1:1 DOPC:DOTAP, and 
98:2 DOPC:DOPE-PEG, showing the change in Lip-NC dispersion PL over 
three weeks. 
 
2.3.3 Uptake of Liposome-Si Nanocrystal Assemblies 
The uptake of anionic 1:1 DOPC:DOPG Lip-NC assemblies was studied in 
J77A.1 mouse macrophage cells. We selected this combination because the 1:1 
DOPC:DOPG Lip-NC assemblies exhibited bright PL (close to 50% DEF) and anionic 
liposomes have been found to be readily taken up by mouse macrophage cells.
18,32,33
 
After incubating the Lip-NC assemblies with the cells for 3 hours at 37 °C, the cells were 
rinsed to remove any Lip-NC assemblies not taken up. Confocal microscopy was used to 
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image Si nanocrystals with an excitation wavelength of 405 nm and emission was 
captured at 670-740 nm. Figure 2.7a shows the confocal microscopy images of the cells, 
with Si nanocrystals false colored red and DAPI nucleus dye false colored blue. The Si 
nanocrystals appear to spread through the cell interior. Figure 2.7b shows that incubation 
at 4 °C resulted in considerably less nanocrystal signal observed. Endocytosis is an 
energy dependent process, and since macrophage cells are not metabolically active at 4 
°C, the attenuated signal may be attributed to adsorption of Lip-NC assemblies to the cell 
surfaces rather than active take up of the Lip-NC assemblies.
33,34
 
Figure 2.7d shows flow cytometry data for Si nanocrystal emission from the 
macrophage cells. Flow cytometry can measure the emission intensity for a sample of 
cells, and higher emission intensities are expected when nanocrystals have been taken up 
by cells.
35
 After incubating the cells with Lip-NC assemblies, the cells were rinsed and 
then mechanically scraped from the wells. A 405 nm excitation wavelength and 670 nm 
longpass filter were used to capture emission from the Si nanocrystals. Flow cytometry 
confirmed higher emission intensity at 37 °C (4605 ± 14, mean emission intensity ± 
standard deviation with n=2) as compared to 4 °C (1347 ± 15), indicating that more 
nanocrystals were taken up at the higher temperature. The background fluorescence 
signals for cells without any liposomes (382 ± 1) or with liposomes that didn’t have any 
nanocrystals (402 ± 2) were significantly lower. Thus, the flow cytometry data confirms 
the increased signal from silicon nanocrystals that was observed under confocal 
microscopy. 
Figure 2.7e plots the relationship between Lip-NC concentration and the amount 
of emission observed from cells. A series of dilutions were made to 1:1 DOPC:DOPG 
Lip-NC assemblies and the relative emissions were measured. Flow cytometry was then 
used to measure the emission of Si nanocrystals from cells incubated with the dilutions. 
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The data fits a linear regression and suggests that in the concentration range tested the 
point of saturation was not reached, which is consistent with macrophage uptake by non-








Figure 2.7 Confocal images showing emission captured from Si nanocrystals (false 
colored red) and DAPI nucleus dye (false colored blue) after incubation of 
1:1 DOPC:DOPG Lip-NC assemblies with J774 cells for 3 hours. (a) At 37 
°C Lip-NC assemblies incubated with the cells resulted in a visible uptake 
of Si nanocrystals. Inset shows two cells with brightfield overlay (scale bar 
10 µm). (b) At 4 °C the Si nanocrystal signal is significantly lower as active 
uptake is limited. (c) Cells incubated without Lip-NC assemblies did not 
show any signal in the silicon nanocrystal emission range. (d) Flow 
cytometry confirmed higher emission intensity for cells incubated with Lip-
NC assemblies at 37 °C as compared to 4 °C. (e) Concentration dependent 
uptake was measured for Lip-NC assemblies. A linear fit was made to the 
data (R
2
 = 0.9997). Error bars are standard deviation (n=2). 
 Figure 2.8 shows confocal images and flow cytometry data for 1:1 DOPC:DOPG 
Lip-NC assemblies incubated with J774 cells for 1, 3, or 6 hours. At longer incubation 
times there was more Si nanocrystal emission visible in the confocal images. Flow 
cytometry of the cells (Figure 2.8d) confirmed that over time the mean fluorescence 
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emission intensity increased from 1 hour (4,694 ± 5, mean emission intensity ± standard 
deviation, n=2), to 3 hours (10,107 ± 730), to 6 hours (12,545 ± 774), with a minimal 
signal from cells incubated without Lip-NC assemblies for 3 hours as a control (744 ± 7). 
 
 
Figure 2.8 Confocal images of cells showing signal from silicon nanocrystals (false 
colored red) and DAPI nucleus dye (false colored blue) after incubation with 
J774 cells at 37 °C for (a) 1 hour, (b) 3 hours, or (c) 6 hours with 1:1 
DOPC:DOPG Lip-NC assemblies. (d) Flow cytometry of the cells 
confirmed the time dependent uptake. 
 Figure 2.9 presents the flow cytometry results for nanocrystal uptake measured 
for different liposome compositions and with different cell types. Lip-NC assemblies 
were prepared with either neutral (DOPC), anionic (1:1 DOPC:DOPG), or cationic (1:1 
DOPC:DOTAP) lipids, and the dispersions were diluted to have identical emission 
intensities. The fluorescent dispersions were then incubated for 3 hours at 4 °C or 37 °C 
with either J774 mouse macrophage cells or Caco2 epithelial cells. For the J774 cells all 
formulations resulted in more silicon nanocrystal emission at 37 °C as compared to the 
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emission observed at 4 °C, suggesting that the Lip-NC assemblies were actively taken up 
by the cells. The most significant uptake at 37 °C was observed with the anionic Lip-NC 
formulation and is consistent with previous reports for macrophage cells.
18,32
 For the 
Caco2 cells, the emission was nearly constant regardless of liposome formulation or 
incubation temperature, and was at the same intensity of the sample incubated without 
any Si nanocrystals. Confocal microscopy performed on the Caco2 cells also was not able 
to identify any Si nanocrystal emission from the cells. The failure of Caco2 cells to take 
up silicon nanocrystals is likely related to the non-specific surface chemistry on the Lip-
NC assemblies. Caco2 cells exhibit low levels of non-specific particle uptake and 
preferentially take up particles displaying specific recognition groups such as folic acid or 




Figure 2.9 Flow cytometry results showing Si nanocrystal emission from (a) J774 cells 
and (b) Caco2 cells incubated with neutral (DOPC), anionic (1:1 
DOPC:DOPG), or cationic (1:1 DOPC:DOTAP) Lip-NC assemblies at 
either 37 °C or 4 °C. Error bars are standard deviation (n=2). * Data was not 
collected for samples without Lip-NC assemblies at 4 °C. 
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2.3.4 Cytotoxicity of Liposome-Si Nanocrystal Assemblies 
Figure 2.10 shows the results of cytotoxicity assays performed for 1:1 
DOPC:DOPG Lip-NC assemblies incubated with J774 cells for 1, 3, or 6 hours. Two 
different assays were selected to assess viability: (i) a lactate dehydrogenase (LDH) 
enzyme assay to measure the release of the LDH enzyme upon damage to the cellular 
plasma membrane which accompanies cell death and (ii) an 3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay to measure 
the metabolic activity of the cells. Neither toxicity assay showed significant cellular 
toxicity over the 6 hour incubation with the Lip-NC assemblies (Figure 10). For 
comparison, cells were also incubated with liposome-gold nanocrystal assemblies (since 
gold is considered biocompatible)
39
 and liposomes that did not contain any nanoparticles, 
and all three samples resulted in similar cytotoxicity results. It should be noted that the 
>100% viability rates measured for the MTS assay may have been the result of increased 
metabolic activity from Lip-NC uptake through the energy-dependent endocytosis 
pathway. Overall, the low toxicity observed with J774 cells over a 6 hour period suggest 




Figure 2.10 Cell viability was measured by (a) LDH assay and (b) MTS assay for J774 
cells incubated at 37 °C with 1:1 DOPC:DOPG liposomes assembled with 
Si nanocrystals, gold nanocrystals, or no nanocrystals. Error bars are 
standard deviation (n=3).  
 
2.3.5 Two-Photon Imaging of Macrophage Cells 
Figure 2.11 shows the results of imaging macrophage cells with 1:1 DOPC:DOPG 
Lip-NC assemblies and DAPI using either one-photon or two-photon microscopy. A 
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pinhole is typically used to exclude out of focus light in one-photon microscopy.
31
 Here a 
large pinhole (2000 µm) was used, resulting in images that appear blurry. In contrast, 
two-photon microscopy requires the simultaneous absorption of two photons from a 
pulsed laser source, such that the probability of excitation is localized to a small focal 
volume.
44
 Thus, the two-photon images in Figure 2.11 appear to have better spatial 
resolution without the use of a pinhole. 
 
 
Figure 2.11 Images of macrophages with Si nanocrystals (in 1:1 DOPC:DOPG Lip-NC 
assemblies) and DAPI taken using one-photon (405 nm) and two-photon 
(800 nm) excitation. 
 
2.4 CONCLUSION 
 The experiments presented here demonstrate the assembly of hydrophobic Si 
nanocrystals with lipids, and the subsequent use of the Lip-NC assemblies to traffic 
fluorescent nanoparticles into cells for confocal imaging. In all Lip-NC formulations we 
observed that the nanocrystals appeared as aggregates rather than loading into liposome 
bilayers (Figure 2.3). Previous studies on the incorporation of nanoparticles into 
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liposomes often observed small inclusions of <5 nanoparticles per liposome, which 
would limit the efficacy of using liposomes as nanoparticle delivery vehicles.
40–43
 We 
have demonstrated high loading (up to 50% dispersion emission fraction) for Lip-NC 
assemblies and have confirmed that the dispersions are bright enough to be imaged using 
confocal microscopy. Lip-NC assembly uptake was consistent with previous reports of 
charged liposome uptake by macrophages, where liposomes interact with cell surfaces 
before being taken up by endocytosis.
18,33,34
 Liposomal carriers can be tagged with 
specific biomolecules that allow targeted interactions with cells,
16
 and future work may 
investigate the uptake of tagged Lip-NC assemblies by cells. 
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Chapter 3:  Highly Fluorescent Silicon Nanocrystals Stabilized in Water 
using Quatsomes 
3.1 INTRODUCTION 
Semiconductor nanocrystals, or quantum dots, have been used extensively to 
study biological systems due to their fluorescence properties and photostability.
1–5
 Silicon 
nanoparticles offer biocompatibility and photoluminescence that is well-suited for 
medical imaging using near-infrared (NIR) or long-wavelength visible light.
3,6–8
 For these 
applications, Si nanocrystals must be dispersed in aqueous media and retain their 
fluorescence. This has been accomplished by capping Si nanocrystals with organic 
ligands bearing polar functional groups or by coating hydrophobic nanocrystals with 
surfactant or amphiphilic polymer.
3,7–10
 By incorporating nanocrystals into surfactant 
assemblies, such as micelles or vesicles, additional functionality might be achieved.
1,7,10–
17
  For example, liposomal vesicles are especially interesting since they are medically-
accepted pharmaceutical carriers and could provide a therapeutic delivery vehicle 
combined with the imaging capabilities of the nanocrystals.
18–20
 However, liposomes can 
suffer from aggregation and non-uniformity, which can negatively impact 
pharmacological properties and pharmaceutical properties.  
Here, we show that non-liposomal vesicular structures, called quatsomes, can be 
highly effective dispersing agents and carriers for Si nanocrystals, with long-term 
dispersion stability and fluorescence. Quatsomes are composed of sterols and quaternary 
ammonium surfactants that self-assemble into vesicular bilayers.
21
 Quatsomes are 
extremely stable and have been shown to remain dispersed for several years with high 
uniformity in size and lamellarity.
22–24
 Quatsomes have antibacterial and anti-biofilm 
properties, and have been used successfully to prepare stable multifunctional vesicle-
biomolecule conjugates, to incorporate water insoluble fluorene-based probes, and to 
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protect excited state intramolecular proton transfer (ESIPT) fluorophores in aqueous 
media.
23,25–27
 Furthermore, quatsomes are largely unaffected by changes in temperature or 
dilution, making them ideal candidates for use in vivo.
21,24
 Here, we demonstrate that the 
integration of Si nanocrystals with orange fluorescence (2.8 nm diameter, 
photoluminescence quantum yields of about 15%) into quatsomes composed of 
cholesterol (chol) and cetyl trimethyl ammonium bromide (CTAB) provides stable 
nanocrystal dispersions in aqueous media with quantum yields of 6.6%. 
 
3.2 EXPERIMENTAL METHODS 
3.2.1 Materials 
 Hydrogen silsesquioxane (HSQ) was purchased from Dow Corning. Hydrofluoric 
acid (HF, 48%) was purchased from Macron Fine Chemicals. Ethanol was purchased 
from Pharmco-Aaper. CTAB (high purity grade) was purchased from Amresco. Chol was 
purchased from Anatrace. 1-Dodecanethiol (98%) was purchased from Acros Organics. 
1-octene (98%), gold(III) chloride trihydrate (≥99.9%), tetraoctylammonium bromide 
(TOAB, 98%), and sodium borohydride (≥98.0%) were purchased from Sigma-Aldrich. 
Hydrochloric Acid (HCl), hexanes (≥98.5%), chloroform (≥99.8%), and toluene 
(≥99.5%) were purchased from Fisher. 1,2-dioleoyl-sn-glycero-3-phosophocholine 
(DOPC) and 1,2-dioleoyl-sn-glycero-3-(1’-rac-glycerol) (DOPG) in chloroform were 
purchased from Avanti Polar Lipids. Carbon dioxide was obtained from Matheson and 
nitrogen was obtained from the University of Texas Department of Physics Cryolab. 
Water used in all experiments was high purity water (18.2 MΩ/cm) and was obtained 
from a Millipore Synergy Ultrapure water system. 
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3.2.2 Si Nanocrystal Synthesis and Assembly with Quatsomes 
Silicon nanocrystals were synthesized following procedures reported in Hessel, et 
al.
8
 40 ml of HSQ was degassed and then heated to 1100 °C for 60 min in a tube furnace 
under forming gas (90% N2/10% H2) flow. The resulting brown reaction product was 
then ground with a mortar and pestle, followed by further size reduction by mechanical 
shaking in a wrist action shaker with borosilicate beads for 9 hr. The final brown powder 
consists of Si nanocrystals embedded in an SiO2 matrix. To liberate the nanocrystals from 
the matrix, 0.6 g of powder was etched in the dark with 2 ml HCl and 20 ml HF for 3.5 
hr. After etching, the material was precipitated by centrifugation for 5 min at 8000 rpm. 
The supernatant containing HF was removed with a pipette, and the precipitate was 
redispersed in 20 ml of ethanol and then centrifuged again. This washing process was 
repeated again with 20 ml of ethanol and once more with 20 ml of chloroform. The 
resulting H-terminated nanocrystals were redispersed in 20 ml of 1-octene and then 
injected with a syringe into a 3-neck flask connected to a Schlenk line under vacuum. 
Liquid nitrogen was used to immediately cool the flask contents under vacuum, and then 
the dispersion was thawed to room temperature under nitrogen flow. The freeze-thaw 
process was repeated three more times. The dispersion was stirred under nitrogen flow at 
120°C for 12 hr. The unpassivated nanocrystals were precipitated by centrifugation at 
8000 rpm for 5 min. The passivated nanocrystals in octene were placed on a rotary 
evaporator under vacuum at 60°C to evaporate the octene. The nanocrystals were then 
redispersed in 3 ml of hexanes. The Si nanocrystals were then purified by four washing 
steps using hexanes/ethanol as the solvent/antisolvent pair. The nanocrystals were 
redispersed in chloroform at a concentration of 6.75 mg/ml for use. 
 Gold nanocrystals were synthesized using the procedures described in Rasch, et 
al.
13
 33 mg of gold (III) chloride trihydrate was dissolved in 20 ml of deionized water. A 
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separate solution of 6 g of TOAB dissolved in 80 ml toluene was prepared. The aqueous 
and toluene solutions were mixed and stirred for 1 hr. The aqueous phase was discarded. 
0.6 ml of 1-dodecanethiol was added to the toluene solution and stirred for 15 min. An 
aqueous solution of 378 mg of sodium borohydride in 20 ml of water at 0°C was 
prepared and added to the toluene solution. After stirring overnight, the aqueous phase 
was discarded. The nanocrystals were precipitated by adding 5 ml of the gold nanocrystal 
dispersion to a glass centrifuge tube and 20 ml of ethanol and centrifuging for 5 min at 
8000 rpm. The supernatant was discarded and the precipitate was redispersed in toluene. 
This washing procedure was repeated until the entire gold solution had been washed with 
ethanol. Finally, the nanocrystals were redispersed and stored in toluene. Prior to use, the 
nanocrystals were dried and redispersed in chloroform at a concentration of 3 mg/ml. 
 Quatsomes were made by DELOS-SUSP (depressurization of an expanded liquid 
organic solution-suspension) as previously described.
23
 CO2-expanded ethanol was used 
to dissolve cholesterol (chol). A 7.5 ml high-pressure vessel was loaded with a solution of 
76 mg of chol in 2.88 ml of ethanol at atmospheric pressure and 35°C. CO2 was then 
added by syringe pump until reaching a working pressure of 10 MPa and a CO2 molar 
fraction of XCO2= 0.62. The system was kept at 35°C and 10 MPa for approximately 1 
hr. Finally, the CO2-expanded chol solution was removed from the reactor through a 
depressurization valve and collected in 24 ml of water with 72 mg of dissolved CTAB to 
produce the chol-CTAB quatsomes. In this final step, a flow of N2 is used as a plunger to 
push down the CO2-expanded solution from the vessel and to maintain a constant 
pressure inside the vessel during depressurization. The molar ratio between the CTAB 
and the chol in the final formulation was 1 to 1, which has been shown to be the correct 
proportion in order to have a pure vesicular phase.
21
 The final quatsome dispersions were 
composed of 7 mM each of chol and CTAB in water containing 10% ethanol. This 
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quatsome formulation is referred to throughout as “7 mM quatsomes.” A more diluted 
quatsome formulation composed of 0.7 mM chol and CTAB was prepared by dilution of 
7 mM quatsomes with water with 10% ethanol. These are referred to as “0.7 mM 
quatsomes.” 
 Nanocrystals were incorporated into quatsomes by adding 750 μL of 7 mM or 0.7 
mM quatsomes to a 2 ml glass vial. 20 μl of a dispersion of Si nanocrystals in chloroform 
with a concentration of 6.75 mg/ml were added (corresponding to 0.135 mg Si 
nanocrystals). The vial was bath-sonicated for 5 min at room temperature (Misonix 
1510R-MT or Bransonic M1800 bath sonicator, 40kHz, 1/2 gallon tank). In experiments 
performed with only CTAB in place of the quatsomes, 7 mM CTAB in water was bath 
sonicated with the same quantity of Si nanocrystals as above. 
DOPC (neutral) liposomes were prepared using the DELOS-susp process.
22,23
 35 
mg of DOPC were dissolved in 1.9 ml of ethanol and loaded into a 7.5 ml high-pressure 
vessel at atmospheric pressure and 35 °C. The solution was then expanded with 
compressed CO2 until reaching a molar fraction of CO2 of XCO2= 0.76 at a working 
pressure of 10 MPa. The system was kept at 35 °C and 10 MPa for 1 hr. Finally, the CO2-
expanded DOPC solution was removed from the reactor through a depressurization valve 
and collected in 9 ml of an aqueous solution to create the liposomes. The final 
concentration of DOPC in the liposomal system was 3.6 mM in high purity water 
containing 17% ethanol. 
DOPG (anionic) liposomes were prepared by thin film hydration and extrusion. 7 
µmol DOPG in chloroform were dried into a film on a rotary evaporator for 15 min. 
Residual solvent was removed by placing the film in a vacuum oven for 2 hr. The lipid 
film was then hydrated with 1 ml of 10 mM HEPES, 10 mM NaCl and bath sonicated for 
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30 min. Finally, the suspension was extruded 21 times through a polycarbonate filter (100 
nm pore size) on an Avanti MiniExtruder (Avanti Polar Lipids). 
Dialysis was performed using SnakeSkin Dialysis Tubing with 10 kDa molecular 
weight cutoff (Life Technologies). Six rounds of dialysis into water, each lasting 24 
hours, were performed. 
 
3.2.3 Characterization 
Transmission electron microscopy (TEM) and cryogenic transmission electron 
microscopy (cryoTEM) images were acquired digitally using an FEI Tecnai Biotwin 
TEM operated at 80 kV accelerating voltage. For imaging, Si nanocrystals were drop cast 
from chloroform onto 200 mesh carbon-coated copper grids (Electron Microscopy 
Science). CryoTEM samples were prepared using a Leica EM GP by dropping 3 μL of 
sample onto Quantifoil R1.2/1.3 holey carbon on 300 mesh copper grids (Electron 
Microscopy Science) inside the environmental control chamber set to 25°C and 90% 
humidity. After a blotting time of 3.5 sec, the grid was plunged into liquid ethane to 
vitrify the sample. The grid was transferred to a Gatan 626 Cryo-Transfer Holder under 
liquid nitrogen. FEI low dose software was used to obtain images of cryoTEM samples 
using a reduced electron beam dose.   
Optical absorbance spectra were acquired on a Varian Cary 50 Bio UV-vis 
spectrophotometer or a Varian Cary 500 ultraviolet-visible-near infrared 
spectrophotometer. Photoluminescence (PL) emission and excitation (PLE) spectra were 
acquired on a Varian Cary Eclipse fluorescence spectrophotometer. Samples were diluted 
1/20 prior to measurement. PL quantum yields were determined using Rhodamine B as a 
PL dye standard, which has a quantum yield of 49% in ethanol.
28
 Quantum yield was 
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calculated according to the equation: QYsample=(QYref)(Aref/Asample)(Isample/Iref)(ηsample/ηref)
2
, 
where QY is the quantum yield, A is the absorbance at 350 nm, I is the PL intensity 
(excited at 350 nm), η is the solvent refractive index, and the subscripts sample and ref 
refer to the Si nanocrystal samples and Rhodamine B reference, respectively. 
Dynamic light scattering (DLS) data were acquired on a Zetasizer Nano ZS 
(Malvern Instruments). Samples were measured in 40 µl disposable cuvettes at 173°, with 
temperature set to 25°C. All measurements were conducted in triplicate. Zetasizer 
software (Malvern Instruments) was used to analyze data and determine the average size 
(z-ave) and polydispersity index (PDI), with the dispersant set depending on the medium, 
as follows: 10% ethanol in water by volume had 8.06% by weight ethanol in water with 
viscosity of 1.28 cP and refractive index of 1.34, while 17% ethanol in water by volume 
had 13.9% by weight ethanol in water with a viscosity of 1.66 cP and refractive index of 
1.34. 
Thermal gravimetric analysis (TGA) was performed using a Mettler Toledo 
TGA/DSC 1. Nanocrystals dispersed in chloroform were dried in a 70 µl alumina 
crucible (Mettler Toledo). Sample were heated under 50 ml min
-1
 of air flow at a rate of 
10°C min
-1
 from 25°C to 800°C and then held at 800°C for 30 min. 
 
3.3 RESULTS AND DISCUSSION 
3.3.1 Incorporation of Si Nanocrystals with Quatsomes 
Figures 3.1a shows TEM images of the Si nanocrystals prepared with 1-octene as 
a ligand and used for the quatsomes experiment. Figure 3.1b shows a size histogram 
determined from TEM: the average diameter is 2.8±0.6 nm (n=150). TGA was conducted 
to determine the mass of ligand per Si nanocrystals (Figure 3.1c). At the beginning of the 
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TGA cycle, the sample consists of Si cores and octene ligand, while at the end of the 
cycle there was no remaining ligand and all the Si converts to SiO2. Based on the 
measured size of the Si core (2.8 nm) and the fractional mass loss, the sample is 
composed of 37% Si by mass and 63% ligand, corresponding to a ligand coverage 





Figure 3.1 (a) TEM images of octene-coated Si nanocrystals. (b) Histogram showing 
size distribution of Si nanocrystals. (c) TGA results for 1-octene coated Si 
nanocrystals. 
Silicon nanocrystals dispersed in chloroform were incorporated into pre-formed 
aqueous 7 mM quatsomes using a 5 minute bath sonication procedure, as outlined in 
Figure 3.2a. The quatsome dispersions initially have a cloudy blue/grey appearance and 
then become light yellow following the addition of the Si nanocrystals and bath 
sonication. There is no visible precipitation or phase separation after addition of the 
nanocrystals to the quatsomes. Figures 3.2b-3.2d show photographs of the quatsome and 
nanocrystal dispersions before and after they are combined, along with TEM images. The 
nanocrystal quatsome assemblies dispersed in water exhibit orange fluorescence 




Figure 3.2 (a) Schematic representation of the process for incorporating Si nanocrystals 
into quatsomes through bath sonication. (b-d) CryoTEM or TEM images of 
7 mM quatsomes, Si nanocrystals, and their assemblies along with 
photographs of the dispersions under ambient light (on the left) and a 365 
nm UV lamp (on the right), as well as illustrations of the structures. 
 Figure 3.3 shows additional cryoTEM images of the fluorescent Si nanocrystal-
quatsome assemblies. The Si nanocrystals appear as clusters of similar size as the 
quatsomes. The nanocrystals do not distribute in the surfactant bilayers of the quatsomes 
as dodecanethiol-capped gold nanocrystals have been observed in other liposomal 
vesicles.
13,17
 The Si nanocrystal clusters are attached to one (green arrow) or more 
quatsomes (blue arrow), or in some cases not attached to any quatsomes (red arrow). 
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Figure 3.3 CryoTEM images of fluorescent dispersions of Si nanocrystal-quatsome 
assemblies. The red arrows indicate Si nanocrystal clusters that are not 
associated with quatsomes; whereas, the green and blue arrows show 
clusters associated with one or more quatsomes, respectively.     
Figure 3.4a compares the optical absorbance, PLE and PL spectra collected from 
Si nanocrystals either dispersed in chloroform or associated with quatsomes in aqueous 
media, with constant Si nanocrystal concentration. PL was measured upon excitation at 
320 nm, while PLE was measured at an emission of 660 nm. The spectra are nearly 
identical, indicating that the optical properties of the nanocrystals are successfully 
transferred to aqueous media using quatsomes as a dispersing vehicle. The quatsome-Si 
nanocrystal preparations have slightly higher absorbance, which results from additional 
light scattering of the quatsomes (see, for example, the turbidity of the quatsome 
dispersions in Figure 3.4). The PL intensity of the quatsome-Si nanocrystal assemblies 
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was lower than the Si nanocrystals dispersed in chloroform, although the samples still 
exhibit relatively bright fluorescence when placed over a UV lamp. The decreased PL is 
partly due to the light scattering of the quatsomes. The PL peak positions of both samples 
were also nearly identical. Figure 3.4b shows the quantum yield data for the samples. The 
PL quantum yields of the Si nanocrystals in chloroform and in the quatsome assemblies 
in water were 16.1% and 6.6%, respectively. 
 
 
Figure 3.4 (a) Absorbance (solid lines), PL (dashed lines), and PLE (dotted lines) 
spectra for octene capped Si nanocrystals dispersed in chloroform and 
incorporated into quatsomes in aqueous media. Inset shows photographs of 
vials of (left) Si nanocrystals in chloroform and (right) quatsome-Si 
nanocrystal assemblies, each containing the same concentration of Si 
nanocrystals, under ambient light (top) or on a 365 nm ultraviolet lamp 
(bottom). (b) Data collected for quantum yield calculation. 
The ratio of Si nanocrystals per quatsome could be estimated based on the 
preparation conditions. The TGA results provide information on the number of Si 
nanocrystals per mg of material, and thus it could be deduced that when 135 µg of Si 
nanocrystals are used in a preparation with 5.25 μmol each of CTAB and chol (750 μl of 
7 mM solution), the molar ratio of CTAB : Cholesterol : Si nanocrystal is 1695 : 1695 : 1. 
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Furthermore, by estimating the diameter of a quatsome from DLS data as 79.3 nm, 
assuming a bilayer thickness of 4.4 nm,
21
 and assuming a CTAB head group area of 0.64 
nm
2
, it was possible to estimate that there are approximately 55,000 chol-CTAB pairs in 
each quatsome. In combination with the known amount of Si nanocrystals added to the 
preparation, it was determined that there are approximately 32 Si nanocrystals per 
quatsome. CryoTEM images show that not all quatsomes have Si nanocrystals associated 
with them, though when the Si nanocrystals do assemble into quatsomes they form 
aggregates with many nanoparticles, so this estimate appears to be reasonable. 
The sonication parameters were found to influence the Si nanocrystal-quatsome 
assembly size and polydispersity (Figure 3.5). Both cryoTEM images and DLS data 
indicated that while the quatsomes maintained similar size distributions after bath 
sonication for 1 or 5 minutes, sonication times of 15 or 30 minutes decreased the size of 
the quatsomes in solution (sizes measured by DLS (each measured in triplicate) were: 1 
min z-ave 82 ± 3 nm, PDI 0.248 ± 0.003; 5 min z-ave 69 ± 2 nm, PDI 0.232 ± 0.007; 15 
min z-ave 61 ± 2 nm, PDI 0.15 ± 0.02; 30 min z-ave 65 ± 3 nm, PDI 0.139 ± 0.008). 
Other approaches to loading Si nanocrystals into the quatsomes were also explored, but 
bath sonication of a mixture of Si nanocrystals dispersed in chloroform added to a 
quatsome dispersion was found to be the only way to obtain fluorescent assemblies in the 
same size range as quatsomes. For example, direct addition of Si nanocrystals into the 
DELOS-susp quatsome formation process did not yield fluorescent dispersions. Probe 
sonication and vortexing of Si nanocrystals added to quatsome dispersions also did not 
yield fluorescent dispersions. Probe sonication led to aggregation, while the vortexed 
sample lost fluorescence. 
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Figure 3.5 CryoTEM images of the Si nanocrystal-quatsome samples prepared by bath 
sonication for (a) 1 minute, (b) 5 minutes, (c) 15 minutes, and (d) 30 
minutes. (d) DLS data showing smaller size at 15 and 30 minutes of bath 
sonication. 
 
3.3.2 Colloidal and Fluorescence Stability of Si Nanocrystal-Quatsome Assemblies 
The colloidal and fluorescence stability of the quatsome-Si nanocrystal 
assemblies was tested. Table 3.1 summarizes the samples prepared for the stability 
testing. Figure 3.6 shows photographs of 7 mM quatsome-Si nanocrystal dispersions over 
the course of 12 weeks. The dispersions were visibly stable during this time period and 
retained their fluorescence. The optical absorbance did decrease during the first two 
weeks, but then appeared to stabilize. Perhaps the system is not completely at equilibrium 
initially, or perhaps there is some oxidation of poorly capped nanocrystals during this 
time period. Surface oxidation as a result of the aqueous environment may also contribute 
to the decrease in the average PL wavelength as the nanocrystal core size shrinks. For 
comparison, over 8 weeks the average PL wavelength blue shifted by 40 nm for the 
quatsome-Si nanocrystal assemblies but only by 3 nm for Si nanocrystals in chloroform, 
 69 
suggesting that the aqueous environment and/or CTAB and cholesterol molecules 
contribute to the observed blue shift. There is no observable change in the morphology of 
the assemblies imaged by CryoTEM (Figure 3.7). 
 
Sample Si nanocrystals Dispersant Molar ratio of 
components 
i – typical 
preparation 




750 µl of 7 mM chol-CTAB 
quatsomes (7 mM CTAB 
and 7 mM cholesterol) in 
10% ethanol in water 
1 Si nanocrystal : 
1695 CTAB : 
1695 cholesterol 
ii – low 
chol-CTAB 




750 µl of 0.7 mM chol-
CTAB quatsomes (0.7 mM 
CTAB and 0.7 mM 
cholesterol) in 10% ethanol 
in water 
1 Si nanocrystal : 
170 CTAB : 170 
cholesterol 
iii – CTAB 
only 




750 µl of 7 mM CTAB in 
10% ethanol in water 
1 Si nanocrystal : 
1695 CTAB 
iv – water 
only 




750 µl of 10% ethanol in 
water 
- 
v – no Si 
nanocrystals 
20 µl of 
chloroform 
750 µl of 7 mM chol-CTAB 
quatsomes (7 mM CTAB 
and 7 mM cholesterol) in 
10% ethanol in water 
- 




Figure 3.6 Fluorescence stability of Si nanocrystals (SiNCs) dispersed in aqueous 
solution with quatsomes or CTAB. The five samples shown in (a-e) are 
summarized in Table 3.1. Photographs of vials under ambient light (top) and 
on a 365 nm UV lamp (bottom) taken (a) immediately, (b) one day, (c) 2 
weeks, (d) 8 weeks, and (e) 12 weeks after preparation. (f) Absorbance 
measured at 320 nm and (g) average PL wavelength (excited at 320 nm) 
demonstrate the stability of the nanoparticle fluorescence in quatsomes. 
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Figure 3.7 CryoTEM images of 7 mM quatsome-Si nanocrystal assemblies taken (a)-
(c) on the day the sample was prepared and (d)-(f) 2 days, (g)-(i) 7 weeks, 
and (j)-(l) 12 weeks after the sample was prepared. 
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Figure 3.8 shows DLS data for 7 mM quatsome-Si nanocrystal assemblies 
monitored over 8 weeks (for quatsome-Si nanocrystal assemblies, sizes measured by DLS 
were: week 0 z-ave 54.3 ± 0.4 nm, PDI 0.262 ± 0.006; week 8 z-ave 65.2 ± 0.2 nm, PDI 
0.157 ± 0.008; for quatsomes alone sizes measured by DLS: week 0 z-ave 58.4 ± 0.7 nm, 
PDI 0.235 ± 0.008; week 8 z-ave 79.3 ± 0.3 nm, PDI 0.10 ± 0.02). There was no 
observable change in the mean size of the assemblies, but the size distribution became 
narrower, with the polydispersity index (PDI) decreasing from 0.262 ± 0.006 to 0.157 ± 
0.008 over 8 weeks. A similar narrowing of the size distribution was also observed for 
quatsomes that were bath-sonicated without any nanocrystals (sample v), indicating that 
this narrowing of the size distribution is inherent to the quatsomes and not related to the 
presence of the nanocrystals. A similar peak narrowing phenomena was observed in 
vesicle assemblies formed by cholesterol and zwitterionic surfactants.
29,30
 Over time the 
distribution narrows as the quatsomes return to a thermodynamically stable size range, as 




Figure 3.8 DLS data showing change in size distribution over 8 weeks for (a) 7mM 
quatsome-Si nanocrystal assemblies (sample (i) from stability trials) and (b) 
nanocrystal-free quatsomes (sample (v) from stability trials). 
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The stability of the quatsome-Si nanocrystal assemblies was also tested after 
dilution. As shown in Figure 3.6 sample ii, the assemblies were still stable after a 10X 
dilution, i.e., 0.7 mM quatsome-Si nanocrystals. This is an important result, as it indicates 
that there is no loss of integrity of the assemblies even when the CTAB concentration is 
below the CMC of free CTAB. Figure 3.9 shows cryoTEM images of the 0.7 mM 
quatsome-Si nanocrystal assemblies, which exhibit similar morphology as the 7 mM 
quatsome-nanocrystal assemblies. Indeed in many medical applications, dilution is 
required and it is important that the quatsome-nanocrystal assemblies retain their 
colloidal stability under these conditions. This is not the case when Si nanocrystals are 
dispersed only with CTAB. As shown in Figure 3.6 sample iii, CTAB could also be used 
to form stable dispersions of Si nanocrystals in aqueous media; however, with pure 
CTAB it is not possible to stabilize Si nanocrystals below the CMC. The CTAB-
dispersed Si nanocrystals also tended to produce very polydisperse aggregates of 
nanocrystals, as observed by CryoTEM (Figure 3.10). Again, for medical applications, 
consistent size and concentration of load delivery is important, and thus the wide size 
distribution observed with CTAB micelles would not be ideal for those applications. This 
is discussed in more detail below. 
 
 
Figure 3.9 CryoTEM images of 0.7 mM quatsome-Si nanocrystal assemblies.     
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Figure 3.10 CryoTEM images of Si nanocrystals dispersed with 7 mM CTAB. 
 
3.3.3 Comparison to Liposomal Structures 
For comparison to liposomal vesicles, Si nanocrystals were combined with 
charge-neutral DOPC and anionic DOPG lipids—systems that have been used in the past 
to disperse dodecanethiol-capped gold nanocrystals.
13,17
 The same bath sonication used to 
make the nanocrystal-quatsome assemblies was applied to Si nanocrystal incorporation 
into the DOPC and DOPG liposomes. Figure 3.11 shows cryoTEM images of these 
nanocrystal-liposome assemblies. The charge-neutral DOPC liposomes become 
multilamellar and mixed with large aggregates of Si nanocrystals (Figures 3.11a-3.11d). 
DLS of the DOPC liposomes showed that they had a z-average size of 58 ± 2 nm (PDI 
0.230 ± 0.008) before sonication and grew to a z-average of 464 ± 28 nm (PDI 0.135 ± 
0.143) after sonication in the presence of the Si nanocrystals. The vial containing the 
DOPC and Si nanocrystals also had a white precipitate of lipid at the bottom after 
sonication. The anionic DOPG liposomes retained their initial size, but no Si nanocrystals 
were observed to associate with the liposomes (Figures 3.11e-3.11h). The dispersion, 
however, was fluorescent and separate lipid-stabilized aggregates of Si nanocrystals were 
observed in the cryoTEM images. The fluorescence of these dispersions however was 
poor and the DOPG-dispersed nanocrystals no longer fluoresce after only 3 days. 
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Figure 3.11 Results from using the quatsome-Si nanocrystal assembly process with 
DOPC (neutral) and DOPG (anionic) liposomes. Photographs of vials of (a) 
DOPC and (e) DOPG were taken under ambient light and on a 365 nm UV 
lamp (i) before bath sonication, (ii) immediately after sonication, (iii) after 1 
day, and (iv) after 3 days. CryoTEM images of the liposomes before adding 
nanocrystals showed that the (b) DOPC and (f) DOPG liposomes formed 
small, unilamellar vesicles. CryoTEM images (c-d) of the DOPC liposomes 
after bath sonication showed that Si nanocrystals incorporated with the lipid, 
however formed large complexes. CryoTEM images (g-h) of the DOPG 
liposomes after bath sonication showed that the Si nanocrystals aggregated 
outside of empty liposomes with no incorporation into the liposomes. 
 
3.3.4 Dispersion Stability of Diluted Assemblies 
 Medical diagnostic or theranostic applications that use fluorescent nanocrystals as 
contrast agents usually require dilution. Si nanocrystals were dispersed in CTAB micelles 
with CTAB at the same concentration as in the 7 mM quatsome-Si nanocrystal 
dispersions. Both dispersions were then dialyzed to test their stability against dilution. 
Figure 3.12 compares the stability of the dispersions. Both dispersions are initially 
fluorescent, but only the quatsome dispersion remains fluorescent after dialysis. The 
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CTAB surfactant is only weakly associated with the Si nanocrystals in the micelles, and 
repeated dilutions lead to loss of dispersibility of the nanocrystals, which precipitate out 
of the solution. CryoTEM images (Figures 3.12e-3.12f) of the quatsome assemblies show 
that the dialysis has little effect on the structure of the assemblies. This shows the benefit 
of the quatsome assemblies compared to CTAB micellar dispersions of the nanocrystals: 
while both maintain fluorescence for 12 weeks (Figure 3.6), only the quatsome 
assemblies are stable under dilution.   
 
 
Figure 3.12 Dilution by dialysis of Si nanocrystals dispersed with (i) 7 mM CTAB and 
(ii) 7 mM quatsomes. (a) Photographs of vials containing (i) and (ii) prior to 
dialysis. Top row under ambient light and bottom row illuminated with a 
254 nm ultraviolet lamp. (b-c) Photographs of the nanocrystal dispersions 
after (b) 3 and (c) 6 rounds of dialysis. (d) Photographs of dispersions 
removed from the dialysis tubing after 6 rounds of dialysis. (e-f) CryoTEM 
images of the 7 mM quatsome-Si nanocrystals after 6 rounds of dialysis. 
 
3.3.5 Role of Chloroform in Si Nanocrystal-Quatsome Assemblies 
Figure 3.13 shows the results of changing the amount of chloroform used in the 
assembly of Si nanocrystals with quatsomes. Using the standard preparation conditions of 
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750 μl of quatsomes combined with 20 μl of 6.75 mg/ml Si nanocrystals in chloroform 
resulted in stable, fluorescent dispersions (Figure 3.13, sample ii). If a larger volume of 
chloroform was used in the preparation, a white precipitate formed (Figure 3.13, samples 
iii-v). The larger volume of chloroform destabilized the quatsomes. Conversely, if a 
smaller volume of chloroform was added, not all of the nanocrystals incorporated into the 
quatsomes and there was visible nanocrystal precipitation (Figure 3.13, sample i). A 
small amount of chloroform enhances the uptake of dodecanethiol-capped Au 
nanocrystals into the lipid bilayer of DOPC liposomes.
17
 A similar role for chloroform 





Figure 3.13 Results of changing chloroform volume to quatsome-Si nanocrystal 
assembly stability, under ambient light (top row) and on a 254 nm UV lamp 
(bottom row). In each sample 135 µg of Si nanocrystals was added, though 
in different concentrations, and thus volumes of chloroform. Samples from 
left to right are: (i) 10 μl of 13.5 mg/ml Si nanocrystals in chloroform, (ii) 
20 μl of 6.75 mg/ml Si nanocrystals in chloroform (typical conditions), (iii) 
40 μl of 3.375 mg/ml Si nanocrystals in chloroform, (iv) 80 μl of 1.6875 
mg/ml Si nanocrystals in chloroform, (v) 200 μl of 0.675 mg/ml Si 
nanocrystals in chloroform. (f) Within one day after preparation (vial (i) had 
orange-brown precipitate consistent with Si nanocrystals. 
 
3.3.6 Interaction between Dodecanethiol-Capped Gold Nanocrystals and 
Quatsomes 
To characterize the interaction of quatsomes with hydrophobic metal 
nanoparticles, gold nanocrystals were prepared. The Au nanocrystals were capped with 1-
dodecanethiol and could be dispersed in chloroform. Figure 3.14 shows TEM images of 
the gold nanocrystals used in the quatsome studies. The average Au nanocrystal size was 
1.8±0.4 nm (n=150), as measured by TEM (Figure 3.14b). TGA conducted on the Au 
nanocrystals determined that the sample was 28.5% ligand by mass and 71.5% Au by 






Figure 3.14 (a) TEM images of dodecanethiol-capped Au nanocrystals. (b) Histogram 
showing size distribution of Au nanocrystals. (c) TGA results for 
dodecanethiol-capped Au nanocrystals. 
It was not possible to make assemblies of dodecanethiol-capped Au nanocrystals 
and quatsomes. Dispersions of 1.8 nm diameter dodecanethiol-capped gold nanocrystals 
in 20 µl of chloroform (3 mg/ml Au nanocrystals) were combined with 750 µl of 7mM 
quatsomes and bath sonicated for 5 min. Immediately after sonication, the dispersion 
became cloudy with a grey hue, indicating that the nanocrystals were initially dispersed 
by the presence of quatsomes (Figures 3.15a). The nanocrystals appeared as aggregates 
(Figures 3.15d-3.15e), similar to what was observed for Si nanocrystals. In contrast, Au 
nanocrystals of this size have previously been shown to readily incorporate into the lipid 
bilayer of phosphatidylcholine liposomes.
13,17
 The dispersions of Au nanocrystals with 
quatsomes, however, were unstable and the color changed from grey to purple after a few 
days (Figure 3.15a). A plasmon peak at around 520 nm emerged in the absorbance 
spectra, indicating that nanocrystals had aggregated or coalesced.
17
 CryoTEM of the 
purple solution at one week showed that the Au nanocrystal aggregates had decreased in 
size, with some larger coalesced particles observed both inside the aggregates (Figure 
3.15f) and separate from empty quatsomes (Figure 3.15g). Additional cryoTEM (Figures 
3.15h-3.15i) of the purple dispersion after several weeks showed that the nanocrystals 
had coalesced to form large particles (6.7 ±3.0 nm (n=150) as measured by TEM, Figure 
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3.15c) that were not associated with quatsomes. It is possible that—similar to Si 
nanocrystals dispersed with CTAB (Figure 3.10)—the coalesced gold nanoparticles 
remain dispersed due to an interaction with CTAB micelles. CTAB is commonly used in 
the synthesis of gold nanocrystals in various sizes and shapes,
32–34
 and is known to 










Figure 3.15 Results of incorporating 1.8 nm dodecanethiol capped Au nanocrystals into 
quatsomes through 5 minutes of bath sonication. (a) Photographs of vial 
with Au nanocrystals and quatsomes over 8 weeks showed a gradual change 
in color from brown-grey to purple (i) before sonication, (ii) immediately 
after sonication, (iii) after 1 day, (iv) after 2 weeks, (v) after 4 weeks, and 
(vi) after 8 weeks. (b) UV-Vis data for samples over time showed increase 
in plasmon peak intensity. (c) Size distribution of Au nanocrystals as 
measured by TEM. CryoTEM images of quatsome-AuNC dispersions at (d-
e) 0 days, (f-g) 1 week, and (h-i) several weeks after preparation. 
 
3.3.7 Mechanism of Interaction between Nanocrystals and Quatsomes 
The difference in experimentally observed interactions between the quatsomes 
and the Si and Au nanocrystals may result from the qualitatively different structure of the 
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ligand shells on the nanocrystals. Figures 3.16b-3.16c illustrate a proposed mechanism 
for the interactions between nanocrystals and quatsomes. Both Au and Si nanocrystals 
aggregate in water due to their hydrophobic coating. As the nanocrystal aggregates or 
clusters form, they interact with other clusters of particles and with the quatsomes. In the 
case of Au nanocrystals (Figure 3.16b), the less dense capping ligands (6.9 ligands/nm
2
) 
can be repulsed from quatsomes due to entropic repulsive interactions from the “hairy” 
ligand layer, which play a substantial role in self-assembly processes of nanoparticles.
35
 
As a result, the Au particles aggregate into large clusters, without incorporation into the 
quatsomes. These Au aggregates may then become smaller as they stabilize in the 
aqueous solution, perhaps with a CTAB coating, which can contribute to the observed 
particle coalescence.
32,33
 In the case of Si particles (Figure 3.16c), the denser capping 
ligand coverage (9.9 ligands/nm
2
) may result in an interaction reminiscent of that 
between vesicles and hydrophobic solid surfaces. In this case, the layers of the quatsome 
vesicles spread over the surface of the clusters of Si particles. This spreading process 
requires first the breaking of vesicles and the input of energy. Vesicles are dynamic 
structures that can be reformed or reduced in size with the addition of sonication 
energy.
36,37
 It was observed that when chol-CTAB quatsomes with Si nanocrystals were 
sonicated for 15 or 30 min, they were smaller than those sonicated for 1 minute or 5 
minutes (Figure 3.5). Thus, it can be hypothesized that when quatsomes are sonicated 
they are broken down through a redistribution of membrane molecules. When the 
sonication is performed in the presence of hydrophobic Si nanocrystals with dense 
capping ligand coverage, this redistribution would allow small aggregates of Si 
nanocrystals to become stabilized by the hydrophobic part of cholesterol-CTAB 
monolayers (Figure 3.16c). The resulting self-assembled structure (clusters of Si particles 
covered by a quatsome monolayer) is now stable in water and acquires the radius 
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corresponding to the spontaneous curvature of the quatsome building blocks (the 
bimolecular entities made by the association between CTAB and cholesterol).
21
 The 
result of this process is the coexistence between quatsome vesicles and these self-
assembled clusters of Si covered by CTAB and cholesterol with a diameter similar to that 
of quatsome vesicles. Further, the lack of coalesced Si nanocrystals was likely due to the 
stable Si-C surface bonds formed upon passivating the surfaces with 1-octene, which 





Figure 3.16 Proposed mechanism for the formation of quatsome-nanocrystal assemblies. 
In the diagram, CTAB is the blue headed structure, cholesterol is the yellow 
structure. (a) Scheme of the ligand densities on the Si nanocrystals (SiNC) 
and Au nanocrystals (AuNC). (b) Illustration of the interactions of Au 
nanocrystals and quatsomes and CTAB molecules. (c) Scheme of the 
interactions of Si nanocrystals and quatsomes, and the formation of the 
stable Si nanocrystals covered with a monolayer of chol-CTAB pairs. 
Although the Si nanocrystals are aggregated in quatsomes, it is still apparent that 
the synergy between cholesterol and CTAB, observed before in plain quatsomes,
21
 leads 
to the stable interaction between quatsomes and Si nanocrystals. When CTAB micelles 
were sonicated with Si nanocrystals, the Si nanocrystals appeared as either very small or 
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very large, irregularly shaped clusters (Figure 3.10). Additionally, cryoTEM images of Si 
nanocrystals incorporated into quatsomes in Figure 3.3 show that the Si nanocrystal 
aggregates are approximately the same size as quatsomes without any Si nanocrystals. 
Since the size of quatsomes is influenced by the interaction between cholesterol and 
CTAB, the size of Si nanocrystals aggregated suggests that they are associated with the 
same chol-CTAB units. Further, as shown in the dilution experiment in Figure 3.12, only 
Si nanocrystals dispersed in quatsomes remain stable after several rounds of dilution, 
while Si nanocrystals dispersed in CTAB micelles result in precipitation of the Si 
nanocrystals after multiple dilutions. Thus, it is specifically the quatsomes where 
cholesterol and CTAB interact as bimolecular building blocks that contribute to 
stabilizing the Si nanocrystals. 
 
3.4 CONCLUSION 
A method to disperse fluorescent Si nanocrystals in aqueous media with long-
term stability was developed, utilizing chol-CTAB quatsomes, which are into non-
liposomal vesicular structures. The stable Si nanocrystal aqueous dispersions can be 
made with five minutes of bath sonication. The nanocrystals remain dispersed in water 
and maintain the fluorescence properties of the Si nanocrystals for several weeks and 
after dilution with additional water. The experimental data show that the association of Si 
nanocrystals with chol-CTAB quatsomes is unique to the nanocrystal type (as compared 
to Au nanocrystals) as well as the method of preparation. Quatsomes, which have been 
shown to have extremely long term stability of at least three years in aqueous solutions,
21
 
provide a vehicle for the dispersion of hydrophobic Si nanocrystals into in vitro or in vivo 
environments, even under dilute conditions. The biocompatibility of both quatsomes and 
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near infrared emitting Si nanocrystals make these structures excellent candidates for 
biomedical imaging applications. Furthermore, quatsomes have been shown to enhance 
protein activity and to protect proteins against premature degradation in topical 
pharmaceutical formulations, as well as to treat biofilms.
25,26
 Therefore, the incorporation 
of both biomolecules and Si nanocrystals into quatsome structures offers the possibility to 
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Chapter 4:  Stability of Hydrophilic Ligand Passivated Silicon 
Nanocrystals in Biological Solutions and Uptake by Cells 
4.1 INTRODUCTION 
Photoluminescent quantum dots have been investigated for use in medical 
imaging applications due to their small diameters, photostability, size-tunable emission, 
and well defined surface chemistries that can allow bioconjugation to various targeting 
molecules.
1–3
 Si based quantum dots have been researched as biocompatible alternatives 
to heavy metal quantum dots as they offer size-dependent photoluminescence (PL) in the 
biological optical window.
4–7
 While nanocrystals can be dispersed in aqueous solutions 
using polymers or surfactants, these assemblies are typically much larger than just the 
nanocrystals, and so there is interest in developing nanocrystals that can be directly 
dispersed into water.
1,3
 Si nanocrystals intended to be used for in vivo or in vitro 
applications must, however, also demonstrate photoluminescent stability in aqueous 
biological solutions, though this can be challenging due to the tendency for Si to oxidize. 
Recently, a method to passivate 2.8 nm diameter Si nanocrystals with 10-
undecenoic acid was demonstrated.
8
 Passivating Si nanocrystals slows surface oxidation, 
and using ligands with terminal carboxylic acid groups enables the particles to disperse in 
polar solvents such as ethanol or water. In an aqueous environment, the electric double 
layer repulsions imparted by a nanoparticle’s surface charge must exceed aggregating 
forces for the particles to remain colloidally dispersed.
9–11
 For carboxylic acid terminated 
nanoparticles the pH must be sufficiently high to deprotonate a large enough fraction of 
the ligands such that the surface charge can overcome aggregating forces. However, at 
high pH Si nanocrystal surfaces are subject to increased rates of oxidation from 
hydroxide ions, which can lead to decrease in Si core size as well as loss of PL.
6,12
 Thus, 
careful control of solvent pH and ionic content is required for Si nanocrystals to remain 
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photoluminescent and well dispersed in aqueous solutions. Biological solutions 
encountered in in vivo or in vitro environments contain a high concentration of 
biomolecules with a wide variety of ions,
13
 and thus it is important to characterize the 
stability of Si nanocrystal PL in response to biomolecules to understand how many hours, 
days, or weeks the particles can be used as fluorescent biological probes. 
The interactions between nanoparticles and cells have been found to vary 
significantly based on particle composition, surface curvature, net charge, and ligand 
density.
13–19
 The biomolecules in biological solutions also impact how nanoparticles can 
interact with cells, since typically a layer of molecules, called a protein corona, is 
adsorbed to the surfaces of charged particles.
13,17,14
  
Here, the photoluminescence stability of 2.8 nm diameter Si nanocrystals capped 
with 10-undecenoic acid transferred into aqueous solutions was studied and showed that 
depending on solution pH and content, PL emission was stable for at least one week. 
Further, we evaluated the uptake of the Si nanocrystals by macrophage cells. The 
nanocrystals were taken up by endocytosis and did not result in any cell toxicity or 
immune response, suggesting that the particles can be useful as bioimaging probes. 
 
4.2 EXPERIMENTAL METHODS 
4.2.1 Materials 
Hydrochloric acid (HCl), hexanes, chloroform, toluene, sodium chloride (NaCl), 
bovine serum albumin (BSA), acetic acid, amino acids, vitamins, and inorganic salts were 
purchased from Fisher. 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES), 
sodium hydroxide (NaOH), hydrofluoric acid (HF), ethanol (EtOH), Dulbecco’s 
Phosphate Buffered Saline (DPBS), 2-[(2-Hydroxy-1,1-bis(hydroxymethyl)ethyl)amino] 
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ethanesulfonic acid (TES), 2-Amino-2-(hydroxymethyl)-1,3-propanediol (TRIS), 3-(N-
Morpholino)propanesulfonic acid (MOPS), potassium phosphate monobasic, sodium 
acetate trihydrate, citric acid monohydrate, trisodium citrate dehydrate, Si standard for 
ICP, amino acids, vitamins, inorganic salts, Cytochalasin D (CytD), and Nocodazole 
(Noco) were purchased from Sigma. Hydrogen silsesquioxane (HSQ) was purchased 
from Dow Corning. 4',6-diamidino-2-phenylindole (DAPI)-Fluoromount-G was 
purchased from SouthernBiotech. Sodium pyruvate (100 mM) and Dulbecco’s Modified 
Eagle Medium (DMEM, containing 4.0 mM l-glutamine and 4500 mg/L glucose, no 
sodium pyruvate) were purchased from Hyclone. Phosphate buffered saline (PBS) was 
purchased from Gibco. Lysozyme was purchased from MP Biomedicals. Fetal bovine 
serum (FBS), penicillin/streptomycin, Modified Eagle Medium (MEM) non-essential 
amino acids (100x), and MEM vitamin solution (100x) were purchased from Life 
Technologies. Non-essential amino acids were purchased from Lonza. Deionized water 
was obtained from a Millipore Synergy Ultrapure water system operating at 18.2 MΩ/cm. 
 
4.2.2 Si Nanocrystal Synthesis 
Si nanocrystals were synthesize following a previously reported procedure.
8
 
Solvent was removed from hydrogen silsesquioxane, and the resulting material was 
placed in a quartz boat in a tube furnace heat to 1100 °C for 1 hour under forming gas 
flow. The brown material was then downsized by first grinding with a mortar and pestle 
and then shaking with borosilicate beads in a wrist action shaker for 9 hours. For a typical 
reaction, 0.3 g of the Si powder was stirred with 1 ml HCl and 10 ml HF for 4 hours in 
the dark. The acids were washed away by precipitating the material and redispersing in 
ethanol, and this rinse was repeated three times. Finally, the nanocrystals were dispersed 
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in chloroform, once again precipitated, and then redispersed in 15 ml of 10-undecenoic 
acid. The suspension was transferred to the three neck flask on a Schlenk line and three 
freeze-pump-thaw cycles were performed to remove oxygen. The dispersion was then 
stirred overnight at 35 °C. The next day, the dispersion was transferred to a vial and 10 
ml of EtOH was added. The vial was capped with a septum, and left to sit on the 
benchtop for 1 week, during which time the dispersion turned from cloudy to clear as the 
hydrosilylation reaction yield increased. The dispersion was washed by first precipitating 
and removing any unpassivated nanocrystals. Then, 5 ml of hexanes was added until the 
dispersion became turbid, and the sample was centrifuged. The precipitate (containing Si 
nanocrystals) was redispersed in 5 ml of EtOH, and 3 more hexane washes were 
performed. The final dispersion of 10-undecenoic acid capped Si nanocrystals was stored 
in ethanol until use. 
 
4.2.3 Transfer of Si Nanocrystals into Water and Incubation with Biological 
Solutions 
2 ml of Si nanocrystals in ethanol (5 mg/ml) was added to a vial with 8 ml ethanol 
and 5 ml pH 7.4 water (adjusted with NaOH). After mixing the Si nanocrystals into the 
ethanol-water mixture, they were transferred into an Amicon 15 30 kDa filter (Millipore) 
and centrifuged at 1100 g for 7 minutes. At this filter size, Si nanocrystals remain above 
the filter, and the ethanol-water mixture that passes through can be discarded. 5 more ml 
of water were then added to the Si nanocrystal solution and the centrifugation process 
was repeat. This process was repeat a total of 6 times until the Si nanocrystal were in 
water at a concentration of approximately 2 mg/ml (unless otherwise noted). 
For each of the tested biological solution, samples were prepared by adding 0.3 
mg of Si nanocrystals in water to 15 ml of the test solution. The samples were incubated 
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either at room temperature for 7 days or at 37 °C for 1 day. Samples were prepared in 
triplicate and the results were averaged. The buffers were prepared as follows: DPBS was 
diluted to a concentration of 10% in water. TES, TRIS, and MOPS buffers were prepared 
at 0.1 M and adjusted to pH 7 with NaOH or HCl. Phosphate buffer was prepared using 
0.1 M potassium phosphate monobasic and adjusted to pH 7 with NaOH. Acetate buffer 
was prepare with 0.1 M sodium acetate trihydrate, and adjusted to pH 6 with acetic acid. 
Citrate buffer was prepared at 0.1M with citric acid monohydrate and trisodium citrate 
dehydrate at pH 6. 
All cell culture medium biological solutions were prepared in a biosafety cabinet 
to reduce the chance of contamination. Cell culture medium was prepared with: 100 ml 
DMEM, 10 ml FBS, 1 ml penicillin/streptomycin, 1ml sodium pyruvate, and 1 ml non-
essential amino acids. For individual testing components: DMEM was not diluted, while 
FBS, sodium pyruvate, penicillin/streptomycin, and non-essential amino acids were each 
diluted in water to the appropriate concentration for use in cell culture. Essential amino 
acids mix was composed of all proteins listed in the DMEM formulation. MEM vitamin 
mix was dilute to 4% in water to match the DMEM formulation. Inorganic salts mix was 
prepared by mixing all inorganic salts at the concentrations listed in the DMEM 
formulation. Each individual component (for example, each amino acid or vitamin) was 




4.2.4 Si Nanocrystal Characterization 
Photoluminescence spectra were acquired for samples using glass or 
polymethacrylate cuvettes. Absorbance spectra were captured on a Varian Cary 50 Bio 
ultraviolet-visible spectrophotometer; a cuvette with water was background subtracted 
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from each spectrum. Photoluminescence emission (PL) spectra were captured for samples 
excited at 320 nm on a Varian Cary Eclipse fluorescence spectrometer. PL peak emission 
was estimated by integrating the PL spectra and calculating the average emission 
wavelength between 550-800 nm. The Si nanocrystal quantum yields were calculated 
relative to Rhodamine B (49% quantum yield in ethanol).
23
 
Transmission electron microscopy was used for Si nanocrystal samples dropcast 
on 200 mesh carbon-coated copper grids (Electron Microscopy Sciences). Images were 
digitally acquired on an FEI Tecnai Biotwin TEM operated at 80 V accelerating voltage. 
Si nanocrystal size was estimated by measuring 100 particles. 
A Mettler Toledo TGA/DSC 1 was used to capture thermal gravimetric analysis 
(TGA) data. Samples of Si nanocrystals were dried into 70 µl alumina crucibles. Samples 
were ramped from 25 °C to 800 °C at a rate of 10 °C per minute, and then held at 800 °C 
for an additional 30 minutes. Experiments were run under 50 ml per minute air flow, such 
that over time all ligands are removed from the surface and Si is converted to SiO2. 
A Thermo Mattson Infinity Gold Fourier Transform Infrared (FTIR) spectrometer 
was used to capture attenuated total reflectance (ATR) FTIR spectra. Si nanocrystal 
samples were drop cast onto a Spectra-Tech Thermal ARK ATR module, then purged 
with N2 for 20 minutes to remove residual CO2. Measurements were taken with 512 scans 
at a resolution of 4 cm
-1
, and background (ATR crystal with no sample) was subtracted. 
X-ray diffraction data was captured with a Rigaku R-Axis Spider diffractometer 
using Cu Kα radiation (λ=0.15418 nm) and an image plate detector operated at 40 kV and 
40 mA. Si nanocrystals were dried out of solution and then scraped with a needle. The 
sample was then loaded onto a nylon loop using mineral oil. Two-dimensional diffraction 
data were collected over 20 minutes while rotating the sample 10° per second. Data was 
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radially integrated using 2DP Spider software (version 1.0, Rigaku Americas Corp.), and 
background was removed (background was collected as mineral oil on a nylon loop). 
Inductively coupled plasma optical emission spectroscopy (ICP-OES) was 
conducted on a Varian 710 plasma emission spectrophotometer. Known concentrations of 
Si nanocrystals in various solutions were dilute 1:1 into 70 wt% nitric acid for digestion 
for 1 hour. The solutions were then dilute 1:10 into 3% nitric acid for analysis. Si 
standards were prepared at 6 known concentrations from 0 – 10.0 mg/L for calibration. 
Three Si analytical lines were measured for each sample and averaged. 
X-ray photoelectron spectroscopy (XPS) was performed using a Kratos Axis Ultra 
X-ray photoelectron spectrometer, utilizing a monochromatic Al Kα X-ray source 
(hν=1486.5 eV at 150 W, 12 mA and 10 kV), hybrid optics (employing a magnetic and 
electrostatic lens simultaneously), and a multi-channel plate coupled to a hemispherical 
photoelectron kinetic analyzer. The instrument work function is calibrated to give a 
binding energy (BE) of 368.3 eV for the Ag 3d5/2 line for metallic silver.  Spectra were 
charge-corrected by shifting the BE of the carbon 1s (graphite-like carbon) to 284.8 eV. 
To prepare a sample for XPS, nanocrystals were drop cast onto indium tin oxide coated 
glass slides, and secured on the experimental tray using double-sided Cu tape. High-
resolution spectra were collected with 20 eV pass energy at 0.1 eV intervals and 2000 ms 
integration time. Casa XPS analysis software (Version 2.3.18 PR 1.0) was used for peak 
deconvolution. 
A Zetasizer Nano ZS (Malvern Instruments) was used to acquire dynamic light 
scattering (DLS) and zeta potential data. DLS data was acquired for samples in 40 µl 
disposable cuvettes using an angle of 173°. Sizes were calculated by fitting each 
measurement to the correlation coefficient data.
24
 Zeta potential data was acquired using 
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folded capillary zeta cells. All measurements were taken in triplicate at 25 °C. Zetasizer 
software (Malvern Instruments) was used to obtain the correlation data and zeta potential.  
 
4.2.5 Si Nanocrystal Incubation with Cells and Characterization 
J774A.1 mouse macrophage cells (ATCC) were grown in DMEM supplemented 
with 10% fetal bovine serum, 100 U/ml penicillin-streptomycin, and 1 mM sodium 
pyruvate. CHO-K1 hamster ovary cells (ATCC) were grown in the same medium but 
without the added sodium pyruvate. Cells were maintained in a humidified 37 °C 
incubator with an atmosphere of 5% CO2, unless otherwise indicated. 
For confocal microscopy, cells were seeded on glass coverslips in 6-well plates at 




 three days before the assay. Culture medium was replaced with Si 
nanocrystals diluted 5-fold in growth medium (0.4 ml of 2 mg/ml Si nanocrystals in 
water with 1.6 ml of cell culture medium), and incubated for 3 hours at 37 °C, unless 
otherwise indicated. The coverslips were then washed 4-5 times with PBS to remove Si 
nanocrystals not taken up by the cells. Next, the cells were fixed with 4% formaldehyde 
for 10 min at 37 ˚C. The coverslips were washed three times with PBS and mounted on 
glass slides with DAPI Fluoromount-G. A Zeiss LSM 710 confocal microscope was used 
to obtain confocal images of cells stained with DAPI (excited at 405 nm, emission 
filtered to 417-566 nm) and Si nanocrystals (excited at 405 nm, emission filtered to 670-
740 nm). Zeiss confocal software was used to overlay the captured images. 





 three days before the assay. Culture medium was replaced with 2 ml (for the 
6-well plates) or 0.5 ml (for the 24-well plates) containing Si nanocrystals diluted 5-fold 
in growth medium. Experiments comparing the dilution of Si nanocrystals into cell 
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culture medium confirmed that the 5-fold dilution did not impact cell viability (data not 
shown). Cells were removed using ~250 μL 0.25% trypsin-EDTA solution (Sigma 
T4049) which was quenched with 250 μL of culture media. Cells were washed 3 times by 
spinning at 250 g for 5 min and resuspended in 1mL ice cold wash buffer (1% FBS in 
PBS). After the final wash, cells were resuspended in 0.5ml wash buffer and kept on ice. 
A BD Biosciences LSR Fortessa flow cytometer was used to measure emission from cells 
incubated with Si nanocrystals. Samples were excited using the violet laser (405 nm) and 
emission was captured using a 670 nm long pass filter for 10,000 live cells. FlowJo 
software was used for data analysis. 
To test the effect of Si nanocrystals on cell viability, two assays were employed: 
the lactate dehydrogenase (LDH) assay using CytoTox 96® Non-Radioactive 
Cytotoxicity Assay kit and MTS assay using CellTiter 96® AQueous Non-Radioactive 
Cell Proliferation Assay kit (Promega). The LDH assay measures the lactate 
dehydrogenase enzyme leaked into the culture supernatant upon cell death; while the 
MTS assay measures the metabolic activity of viable cells to convert MTS into a soluble 
color product. Both assays were performed according to the manufacturer’s instruction. 
Briefly, cells were seeded and incubated with 5-fold diluted Si nanocrystals or water in a 
24-well plate as above for the indicated time. Then, the culture supernatants were 
transferred to microfuge tubes and centrifuged at 13,000 g for 10 min. 50 µl of each 
clarified supernatant was transferred to a flat-bottom 96-well plate and mixed with 50 µl 
of LDH substrate using a multichannel pipette. After 30 min incubation at room 
temperature in the dark, the absorbance was read at 490 nm with a Spectramax M3 plate 
reader. The viability % is calculated as follows: [1-(Sample A490- Cells without 
treatment A490)/(100% lysis A490- Cells without treatment A490)] X 100%. 100% lysis 
was calculated as the absorbance for cells lysed with 0.9% Triton X-100. The remaining 
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cells in the plate were immediately washed three times with PBS to remove residual Si 
nanocrystals, and medium containing 6-fold diluted MTT/PTS solution was added into 
each well and incubated at 37 ˚C for 1 hour. The supernatants were then transferred to 
flat-bottom 96-well plate to be read at 490 nm. The viability% is calculated as follows: 
(Sample A490 – No cell A490)/(Cells without treatment A490– No cell A490) X 100%. 
Wells without cells were used as the blank to account for automatic coloration. 
Silicon nanocrystal uptake was inhibited by administering phagocytic inhibitors. 
J774 cells were seeded in 6 and 24-well plates as above and incubated with 5-fold diluted 
silicon nanocrystals with or without cytochalasin D (CytD) or nocodazole (Noco) at the 
concentrations indicated in the text. Confocal microscopy and flow cytometry were used 
to assess effects of inhibitors. 
Cell inflammatory response to Si nanocrystals was measured. Cells were seeded 
in 6-well plates as above and incubated with silicon nanocrystals diluted 5-fold in growth 
media for 3 hours. Control samples were treated with 100 ng/ml lipopolysaccharide 
(LPS) or water at the same dilution in growth media for 3 hours. Gene expression levels 
of the proinflammatory markers tumor necrosis factor-α (TNFα) and interleukin-1β (IL-
1β) were compared by analyzing total RNA by reverse transcriptase- polymerase chain 
reaction (RT-PCR).
21,22
 β-Actin was used as a reference gene. RNA was extracted using 
the PureLink ™ RNA mini kit (Ambion #12183020) per the manufacturer’s instructions. 
Isolated RNA was quantified using a NanoDrop 2000 and quality was assessed by the 
ratio of absorbance at 260 nm / 280 nm. First strand synthesis was carried out using the 
SuperScript IV first strand synthesis system (Invitrogen) with 1 μg of RNA in a 20 μl 
reaction using random hexamers per the manufacturer’s instructions. Quantitative PCR 
(qPCR) was performed on the target DNA using Power SYBR® green PCR master mix 
(Applied Biosystems) in a 20 μl reaction, per manufacturer’s instructions, using 1 μl of 
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the first strand synthesis product and the oligonucleotide primers: TNFα (forward: 5’-
GAACTGGCAGAAGAGGCACT-3’, reverse: 5’- AGGGTCTGGGCCATAGAACT-
3’), IL-1β (forward: 5’- GCCACCTTTTGACAGTGATGAGA-3’, reverse: 5’- 
ATCAGGACAGCCCAGGTCAA-3’), and β-Actin (forward: 5’- 
CACTGTCGAGTCGCGTCCA-3’, reverse: 5’- GCCCACGATGGAGGGGAATA-3’). 
Amplification was monitored using a Viia-7 Real-Time PCR System and the number of 
cycles required to reach a threshold level (CT) was determined using QuantStudio7 
software. The differences between CT values from LPS or Si nanocrystal treated cells and 
water treated cells for TNF-α and IL-1β (ΔCT,X) were compared using β-Actin as an 
internal reference (ΔCT,R). The fold expression relative to water was obtained from the 
software. Amplification was also visualized by separating the gene product on a 1% 
agarose gel with low molecular weight (NEB) ladder as a marker and observed using 
ethidium bromide. 
 
4.3 RESULTS AND DISCUSSION 
4.3.1 Si Nanocrystals in Biological Solutions 
Figure 4.1 shows the characterization of 10-undecenioc acid capped Si 
nanocrystals. The nanocrystals were prepared according to a previously reported 
method.
8
 The prepared Si nanocrystals were dispersed in ethanol and had a diameter of 
2.8 nm ± 0.5 nm. The nanocrystals were then transferred into pH 7.4 water by repeated 
filtration through a 30 kDa centrifugal filter, which allowed the controlled deprotonation 
of carboxylic acid groups. Figure 4.1a shows the absorbance and PL spectra for Si 
nanocrystals in ethanol and after transfer into water. The mean emission wavelength for 
Si nanocrystals in ethanol was 705 nm, while after transfer to water the emission was at 
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704 nm, indicating a minimal blue shift. The Si nanocrystal quantum yield was measured 
relative to a dye standard, and was 10.7% when dispersed in ethanol and 9.1% when 
dispersed in water. Transmission electron microscopy (TEM) images of the Si 
nanocrystals before and after transfer into water demonstrate that the particles maintained 
their integrity (Figure 4.1b and 4.1c). Figure 4.1d shows thermogravimetric analysis 
(TGA) data for 10-undecenoic acid capped Si nanocrystals, which had a ligand density of 
5.2 ligands/nm
2
. This corresponds to approximately 126 ligands per Si nanocrystal, 




Figure 4.1e shows FTIR results for Si nanocrystals before and after transfer into 
water. While characteristic stretches such as the CH2 asymmetric and symmetric stretches 
(2925 and 2850 cm
-1
), Si-H stretch (2100 cm
-1
), and Si-O stretch (1096 cm
-1
) were 
present in both spectra, only the Si nanocrystals in water showed COO
-
 asymmetric and 
symmetric stretches (1600 and 1400 cm
-1
). This corresponds with the deprotonation of 
the carboxylic acid groups upon transfer from ethanol to water. The Si-H and Si-O 
stretches indicate that the surface was not completely passivated by the ligands, which is 
anticipated due to steric hindrance between the ligands. X-ray diffraction (XRD) patterns 
collected for Si nanocrystals dried out of ethanol and water indicated that they maintain 
their diamond cubic lattice structure (Figure 4.1f). 
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Figure 4.1 Characterization of 10-undecenoic acid passivated Si nanocrystals. (a) 
Photoluminescence emission (solid lines) and absorbance (dashed lines) 
spectra captured for samples dispersed in ethanol (black lines) or water (blue 
lines) indicate minimal shift in photoluminescence properties. Inset is a 
photo of Si nanocrystals dispersed in water on an ultraviolet lamp (365 nm), 
demonstrating emission in the visible range. TEM images of Si nanocrystals 
in (b) ethanol and (c) water. (d) TGA data for the 10-undecenoic acid 
capped Si nanocrystals. (e) FTIR data for Si nanocrystals dried out of 
ethanol or water shows the deprotonation of COOH. (f) XRD data for Si 
nanocrystals dried out of ethanol or water (reference pattern is PDF 027-
1402, with a=b=c=0.543088 nm). 
The colloidal stability of Si nanocrystals in water depends on the electrostatic 
repulsive forces between the nanocrystals exceeding the van der Waals attractive forces.
11
 
Figure 4.2 shows photographs of Si nanocrystals dispersed in water and then placed in 
water solutions adjusted to pH 2-12 using HCl or NaOH. At neutral pH (pH 7-8) the 
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nanocrystals appear to stay dispersed over three days. A slight change in color from red 
to orange suggests some oxidation of the nanocrystal surface, causing Si nanocrystal core 
size to shrink and therefore an increase in the bandgap. The zeta potential for Si 
nanocrystals in pH 7.4 water was -47.9 ± 0.6 mV. Zeta potentials with absolute values 
greater than 30 mV indicate stable dispersions.
25
 At low pH, the nanocrystals visibly 
aggregated. Carboxylic acid has a pKa of 4.8,
26
 indicating that as the pH drops below 4.8 
a higher proportion of the carboxylic acid groups are protonated. Protonated ligands do 
not contribute to electrostatic repulsion and thus the nanoparticles aggregate. The 
aggregates observed at low pH appeared fluorescent even after three days. At the high 
end of the pH spectrum, at pH 12 the nanocrystal PL degraded immediately, while at pH 
10 the PL degraded within one day. The high hydroxide ion content of those solutions 





Figure 4.2 Photographs of Si nanocrystals stored in water adjusted to pH 2 – pH 12 (as 
labeled on vials) over three days. 
The PL stability of Si nanocrystals in biological solutions was examined by 
incubating the nanocrystals in selected solutions for one week. In addition to water and 
buffer solutions, cell culture medium and all of its individual components were tested to 
determine if there were specific molecules that contribute to PL degradation.
20
 The 
sample PL emission was monitored on days 0, 1, 2, 4, and 7, and the results for select 
solutions are shown in Figure 4.3. Figure 4.3a shows that in water the Si nanocrystal PL 
intensity increased slightly for the first two days, after which it started to decline. The 
initial increase in intensity may be related to oxidation of the Si nanocrystal surface, 
which can passivate any remaining dangling Si surface bonds to form an oxide shell that 
improves quantum confinement and therefore brightness.
6,27
 Figures 4.3b and 4.3c shows 
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that in 0.1 M phosphate buffer and cell culture medium, the PL decreased throughout the 
seven days. Figure 4.4 shows the Si nanocrystal PL changes for all the biological 
solutions tested over the seven day period. Decreases in the PL intensity reflect loss of 
nanocrystal emission, while blue shifts in the peak emission wavelength suggest surface 
oxidation which results in shrinking of the crystalline core. For most of the solutions 
higher rates of PL loss corresponded to greater blue shifts in the emission wavelength. 
 
 
Figure 4.3 PL spectra of Si nanocrystals dispersed in (a) pH 7.4 water, (b) 0.1 M 
phosphate buffer, and (c) cell culture medium. In each figure, the spectra 
from days 0, 1, 2, 4, and 7 after adding Si nanocrystals into the solution are 
shown, with day 0 PL shown in black to day 7 PL shown in blue. Red 
spectra are PL measured for samples containing no Si nanocrystals and 
indicate solution fluorescence. Insets show normalized intensity over the 
same 7 day period (color coded as black for day 0 to blue for day 7). 
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Figure 4.4 Summary of changes in PL for Si nanocrystals dispersed in a variety of 
buffers and cell culture medium components for 7 days (error bars are 
standard deviation, n=3). PL decrease was measured by comparing PL 
intensity on day 7 to day 0. Positive values indicate a decrease in PL 
intensity. Peak wavelength was calculated as the average emission 
wavelength. A positive peak wavelength shift indicates a blue shift to lower 
wavelengths. 
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Figure 4.5 shows plots of PL decrease and wavelength shift as a function of 
solution concentration and pH. Trends are visible between the variables: for example, 
higher pH tends to result in a greater shift in emission wavelength. However, attempts to 
fit the data to linear or exponential functions resulted in very low fitting. This suggests 
that other factors such as chemical composition may play a role in PL degradation. Si 
nanocrystals incubated with L-cystine HCl exhibited a 44% loss in PL intensity, and 
cysteine has a terminal –SH group which can potentially interact with the silicon surface. 
Further, phosphate species have been shown to contribute to SiO2 dissolution,
28
 and here 
phosphate containing solutions resulted in PL degradation. 
 
 
Figure 4.5 Scatter plots showing PL intensity decrease (a-b) and peak emission 
wavelength (c- d) as a function of concentration or pH. 
Figure 4.6 shows XPS results for surface oxidation of Si nanocrystals. For Si 
nanocrystals dispersed in ethanol, the Si
0
 (99.2 eV and 99.7 eV for the 3/2 and 1/2 peaks, 
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respectively) peak contributions are apparent confirming sample crystallinity, while 
surface passivation is confirmed by the Si-C (102.0 eV) peak (Figure 6). Peaks 





 (100.9 eV), Si
3+
 (102.6 eV), and Si
4+
 (103.7 eV), likely as a result of 
some surface oxidation that occurs during the synthesis and as the Si nanocrystal sample 
is dried from solution in air. The oxidation in ethanol is consistent with previous reports.
8
 
The relative contribution from the oxidized states increased after the Si nanocrystals were 
transferred to water. For Si nanocrystals in cell culture medium, phosphate buffer, and 
sodium bicarbonate, XPS shows substantial oxidation of the nanocrystal surface, with 
almost no Si
0
 observed. All three of these solutions resulted in PL intensity decreases 
>60%, suggesting that surface oxidation contributes to a decrease in PL. However, for Si 
nanocrystals in the vitamin mix, the XPS measured oxidation levels are similar to those 
observed for Si nanocrystals in water even though PL intensity decreased by 41% over 






Figure 4.6 XPS Si 2p data for Si nanocrystals dispersed in ethanol, water, cell culture 
medium, phosphate buffer, vitamin mix, and sodium bicarbonate. Data 
(black diamonds) was fit (blue line) with the relative contributions (black 
lines) from oxidized Si states. 
 Figure 4.7 shows the results of measuring the physical degradation of Si 
nanocrystals by ICP. Si nanocrystals were incubated with test solutions and on days 1, 4, 
and 7 the samples were filtered through 30 kDa centrifugal filters.  The Si concentration 
of the filtrate (which excludes whole Si nanocrystals) was then measured to estimate the 
amount of Si that had been removed from the nanocrystals. As a reference, the maximum 
Si concentration for the preparation was 1.56 mg/L. The results show an increase of Si 
present in the filtrate from days 1-7 in all samples (Figure 4.7a). Taking the example of Si 
nanocrystals in water, which exhibited an 8.0% loss of PL over 7 days (Figure 4.4), the 
measured mass loss by ICP corresponds to 6.6% of total mass in the preparation. Si 
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nanocrystals in vitamin solution lost 41% PL intensity over 7 days, and close to 23% Si 
mass as measured by ICP. Figures 4.7b and 4.7c show plots relating the amount of Si 
mass loss measured by ICP to the PL degradation, and show positive correlations 
between the variables (linear fits of the data found R
2
 values of 0.68 for PL decrease 
versus ICP concentration and 0.41 for peak wavelength shift versus ICP concentration). 
The ICP results provide evidence for PL loss being attributed to physical loss of silicon 
from the nanocrystals. The results are also consistent with previous reports of fluorescent 
porous silicon particles, where the particles have been observed to degrade as PL is lost 





Figure 4.7 (a) Results of ICP analysis of Si concentration in the filtrate from Si 
nanocrystals dispersed in various solutions. For each solution, the plots 
represent measurements taken on days 1, 4, and 7 after adding Si 
nanocrystals. The maximum possible Si concentration for the preparation 
was 1.56 mg/L. Comparison of the (b) PL intensity decrease and (c) the 
emission wavelength shift to the filtrate Si concentration on day 7.  
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While the previous results demonstrate Si nanocrystal PL degradation rate at 
room temperature, most in vivo and in vitro studies take place at physiological conditions. 
Figure 4.8 shows the PL loss at 25 °C and 37 °C over a one day period. The samples 
incubated at physiological temperature degraded more significantly in all solutions. The 
increased PL loss at higher temperature can likely be attributed to higher rates of surface 
oxidation and nanoparticle degradation. 
 
 
Figure 4.8 Summary of changes in PL for Si nanocrystals dispersed in solutions at 
either 25 °C (blue bars) or 37 °C (orange bars) over 24 hours. 
The interactions of Si nanocrystals and proteins in solution were characterized 
using DLS (Table 4.1). Particles in biological fluids are known to be coated by a protein 
corona, which can increase nanoparticle size and how the particles interact with cells.
14,17
 
Si nanocrystals were incubated for 3 hours at 37 °C either in water or with a molar excess 
of the proteins bovine serum albumin (BSA) or lysozyme. The colloidal dispersion sizes 
were measured using dynamic light scattering and the resulting correlation functions 
were fit to estimate particle sizes.
24
 Si nanocrystals in pH 7.4 water were found to have a 
hydrodynamic diameter of 15.0 nm, which is larger than the expected size of the 
nanocrystals with ligands attached (around 5 nm), and may be related to the interactions 
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between the ligands and the surrounding water affecting the hydrodynamic diameter 
measured by DLS, or may indicate that there is some degree of aggregation between 
particles in water. Incubation with BSA resulted in an increase in size for the Si 
nanocrystals to 23.3 nm (a significant population of smaller particles were also present in 
the dispersion and can be attributed to free BSA molecules). Lysozyme, which was found 
to have a positive zeta potential, resulted in aggregation with Si nanocrystals and particle 
sizes around 621.7 nm. In a complex fluid such as cell culture medium where there are a 
variety of charged species, it is likely that the nanocrystal surface becomes coated with 
biomolecules and some aggregation at the nanoscale occurs due to electrostatic 
interactions. Unfortunately, measurement of particle size in a solution containing many 
different sizes is not possible using DLS, which is a technique best suited for dispersions 




Sample Particle Diameter Zeta Potential 
Si nanocrystals in water 15.0 ± 1.0 nm -47.9 ± 0.6 mV 
BSA 3.1 ± 0.1 nm -26.2 ± 1.0 mV 
Si nanocrystals + BSA 23.3 ± 1.2 nm * -43.5 ± 2.7 mV 
Lysozyme 1.7 ± 0.2 nm 12.3 ± 0.4 mV 
Si nanocrystals + lysozyme 621.7 ± 52.4 nm 19.1 ± 1.0 mV 
Table 4.1 Particle sizes as measured by DLS and zeta potentials. Values reported are 
mean ± standard deviation, for n=3 measurements. * A secondary 
population of particles with size 2.7 ± 0.1 nm was identified, and 
corresponds to free BSA molecules. 
 
4.3.2 Si Nanocrystal Uptake, Toxicity, and Inflammatory Response in Macrophage 
Cells 
Figure 4.9 demonstrates the results of 10-undecenoic acid capped Si nanocrystal 
uptake by J774 macrophage cells or CHO ovary cells. Previous work has identified that 
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the interactions between nanoparticles and cells are unique to the nanoparticle size and 
surface composition as well as cell type,
14–16
 with non-targeted nanoparticles typically 
being taken up by processes such as endocytosis.
3,29,30
 Si nanocrystals were transferred 
into water at a concentration of 2 mg/ml and then dilute 5-fold into cell culture medium 
for incubation with the cells. After incubation for 3 hours at either 4 °C or 37 °C, 
confocal microscopy confirmed that only J774 cells incubated with Si nanocrystals at 
physiological temperature showed Si nanocrystal emission in the cell cytoplasm (Figure 
4.9a). Emission measured from Si nanocrystals by flow cytometry (using a 670 long pass 
filter) further confirmed that only the macrophage cells incubated with Si nanocrystals at 
37 °C had taken up Si nanocrystals, as the mean fluorescence intensity (MFI) shifted to 
higher intensities (mean fluorescence intensity (MFI) results for J774 cells were: Si 
nanocrystals 37 °C = 741.5 ± 3.5; Water 37 °C = 112.5 ± 6.4; Si nanocrystals 4 °C = 
131.0 ± 5.6; Water 4 °C = 110.0 ± 6.9 (n=2); and for CHO cells were: Si nanocrystals 37 
°C = 62.7 ± 0.2; Water 37 °C = 50.0 ± 1.6; Si nanocrystals 4 °C = 47.1 ± 0.9; Water 4 °C 
= 46.0 ± 0.8 (n=3)). Taken together, these results suggest that Si nanocrystals are actively 
endocytosed from the surroundings and do not enter the cell by diffusion across the cell 
membrane. While CHO cells have been observed to take up silver nanoparticles,
31
 the 
lack of uptake of Si nanocrystals may be related to the particle size and surface 
characteristics, which may not interact with CHO cells in the same way as silver based 
particles. Macrophage cells help clear foreign debris from the body as part of the immune 
system, and thus active uptake of nanoparticles was an expected result consistent with 






Figure 4.9 Confocal images of (a) J774 and (b) CHO cells incubated with Si 
nanocrystals (SiNC) for 3 hours at either 4 °C or 37 °C. Excitation 
wavelength of 405 nm was used, and Si nanocrystal signal (false colored 
red) was captured at 670-740 nm while DAPI nucleus signal (false colored 
blue) was captured at 417-566 nm. Flow cytometry fluorescence intensity of 
(c) J774 and (d) CHO cells incubated with either Si nanocrystals or with just 
water, at either 4 °C or 37 °C, identified that only J774 cells incubated with 
Si nanocrystals at physiological temperature showed an increase in emission 
intensity. 
 Figure 4.10 shows the time and concentration dependent uptake of Si nanocrystals 
by macrophage cells. Over a 24 hour period, confocal microscopy (Figure 4.10a) 
identified that the increase in Si nanocrystal signal spread throughout the cell cytoplasm. 
The amount of uptake as measured by flow cytometry (Figure 4.10b) gradually increased 
up to 24 hours for samples incubated at 37 °C, corroborating the results seen in the 
confocal images. After 24 hours the emission did not increase further, suggesting that Si 
nanocrystal uptake and degradation had reached steady state. Considering that PL 
intensity decreased by almost 92% for Si nanocrystals dispersed in DMEM at 37 °C over 
24 hours (Figure 4.8a), the identification of Si nanocrystal emission from cells at 24 
hours suggests that the Si nanocrystal PL is stabilized inside of the cells. This could occur 
if the nanocrystals are contained in a low pH environment, where the nanocrystals 
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aggregate and PL stability is maintained. For example, in Figure 4.2 the low pH vials 
showed continued fluorescence for three days after the nanocrystals aggregated, and PL 
intensity was found to increase over one week when Si nanocrystals were dispersed in pH 
5 HEPES (Figure 4.4). Thus, the stability of the PL signal over several days may indicate 
that the Si nanocrystals are being trafficked into low pH regions of the cell, such as 
lysosomes. This result is also consistent with reports of porous silicon, which lost all 
photoluminescence within 6 hours after incubation at 37 °C in a buffer solution, however 
emission was captured for in vivo particles 24 hours after injection into a mouse.
6
 
 Figure 4.10c shows the results of concentration dependent emission measured 
from J774 macrophages. Si nanocrystals were prepared in water at concentrations from 
0.1-5 mg/ml before being added into the cell culture medium. As the loading 
concentration of Si nanocrystals was increased, the mean fluorescence intensity as 
measured by flow cytometry also increased in a non-linear manner and appeared to 
approach a maximum. Previous reports have noted that receptor mediated uptake by cells 
results in concentration dependent uptake that follow Michaelis-Menten like kinetics.
33–36
 
Here, the Si nanocrystal uptake could also be fit to a Michaelis-Menten model with 
relatively good fitting (R
2
=0.997, Vmax=961.01 and Km=0.941). The concentration 
dependent uptake indicates that surface receptors are involved in the uptake of Si 
nanocrystals, though the receptors may be interacting with the protein coronae 
surrounding the particles rather than the nanocrystals. 
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Figure 4.10 (a) Confocal images showing increase in Si nanocrystal (SiNC) signal 
throughout the cytoplasm of J774 cells after uptake over a 24 hour period. 
(b) Time dependent uptake of Si nanocrystals as measured by flow 
cytometry. (c) Concentration dependent uptake of Si nanocrystals as 
measured by flow cytometry. Error bars are standard deviation (n=3). 
 Endocytosis of nanoparticles can occur following multiple mechanisms including 
clathrin-mediated endocytosis, caveolin-mediated endocytosis, macropinocytosis, or an 
independent endocytosis mechanism.
37,38
 To determine the particular uptake pathway(s) 
for Si nanocrystals, J774 cells were treated with non-toxic levels of two drugs known to 
inhibit cellular processes necessary for distinct methods of endocytosis. Flow cytometry 
was used to determine the level of uptake of Si nanocrystals with each drug and was 
compared to control cells that were not treated with the drug. Incubation with 
cytochalasin D, a drug that blocks actin polymerization,
29
 resulted in a statistically 
significant reduction in Si nanocrystal uptake, though complete blockage was not 
observed (Figure 4.11a, P<0.05 between samples incubated with 0 mg/ml cytochalasin D 
and with 2, 4, or 10 mg/ml cytochalasin D). Incubation with nocodazole, which disrupts 
microtubules,
29
 did not reduce Si nanocrystal uptake (Figure 4.11a). Confocal images of 
cells treated with cytochalasin D (Figure 4.11b) or nocodazole (Figure 4.11c) at 10 µg/ml 
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identified that Si nanocrystal signal was not observed in the cytochalasin D sample, 
consistent with the decreased emission intensity measured by flow cytometry. Actin 
filaments are required for both clathrin-mediated and caveolin-mediated endocytosis, 
while microtubules are necessary for the transport of caveolin-rafts from the membrane 
into the cell.
39,40
 Disruption of microtubules does not appear to inhibit Si nanocrystal 
migration to the cell interior suggesting that uptake is primarily dependent on clathrin-
mediated endocytosis. Clathrin-mediated endocytosis results in particles being 
transported into endosomes and then lysosomes inside of cells, which is consistent with 
our findings that Si nanocrystal PL is visible for a long time (Figure 4.10), suggesting 
that they are in a low pH environment. 
 
 
Figure 4.11 (a) Uptake of Si nanocrystals (SiNC) in the presence of cytochalasin D 
(CytD) and nocodazole (Noco) blockers, as measured by flow cytometry 
(error bars are standard deviation n=3). * indicate P<0.05 between Si 
nanocrystals with no drug and sample with drug using unpaired Student’s t-
test. Data normalized to sample with no drug. Confocal images of cells 
treated with (b) CytD and (c) Noco at 10 µg/ml. 
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Figure 4.12 shows the results of toxicity testing for the Si nanocrystals in J774 
macrophage cells. Two assays were used to assess cell viability over 24 hours. First, a 
lactate dehydrogenase (LDH) enzyme assay was used, which measures the release of 
LDH enzyme upon damage to the plasma membrane. Second, a 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay was 
used to measure the metabolic activity of living cells. Si nanocrystal treated samples were 
compared to a no treatment and a Triton-X100 treated control. Both assays showed 
minimal cell toxicity as a result of Si nanocrystal uptake, with no discernible impact of Si 
nanocrystals compared to cells that were not exposed to the Si nanocrystals. 
 
 
Figure 4.12 Viability assays using LDH and MTS for cells incubated (orange bars) with 
Si nanocrystals or (blue bars) without Si nanocrystals. 
Figure 4.13 shows the results of testing to characterize the inflammatory response 
of Si nanocrystals in the macrophage cells. An inflammatory response can affect 
metabolic functions and increases gene expression of certain cytokines including tumor 
necrosis factor-α (TNF-α) and interleukin 1-β.
22,30
 To determine if an inflammatory 
response was taking place, the mRNA expression of TNF-α and IL-1β was measured 
using quantitative real time polymerase chain reaction (qPCR) for cells incubated with Si 
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nanocrystals, water, or lipopolysaccharide (LPS), a known stimulator of cytokine 
expression which acts as a positive control.
22
 As shown in Figure 4.13, the relative 
expression level of TNF-α or IL-1β is much greater in cells treated with LPS compared to 
water suggesting that an inflammatory response was triggered in the LPS treated cells. In 
contrast, J774 cells treated with Si nanocrystals have a nearly identical expression level 
of TNF-α and IL-1β to water treated cells. These results show that uptake of Si 
nanocrystals did not induce an inflammatory response in the macrophages. 
 
 
Figure 4.13 mRNA expression levels of inflammation markers TNF-α and IL-1β as 
measured by qPCR. Expression levels are reported as fold expression 
relative to cells treated with media containing only water. LPS was a 
positive control. Error bars are standard deviation (n=2). * indicate P<0.1 




Here, we have studied the feasibility of dispersing 10-undecenoic acid 2.8 nm Si 
nanocrystals in biological solutions and for imaging with live cells. We have 
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demonstrated that the nanocrystals lose PL intensity and exhibit a blue shift over time due 
to silicon oxidation and degradation. However PL emission was still detectable from 
macrophage cells by confocal microscopy after 24 hours, which may be related to the 
localization of the particles in low pH vesicles. Considering that many biomedical 
applications require several hours or even days for photoluminescent particles to 
accumulate in target tissue, the stability of Si nanocrystals compared to other quantum 
dots is promising for in vivo applications.
3
 We have also demonstrated that Si 
nanocrystals are taken up by macrophage cells through clathrin-mediated endocytosis 
even in the absence of surface conjugated targeting molecules. Future work can be done 
to explore how attaching biomolecules to the nanocrystal surfaces may change 
interactions with specific cell types. Further, since the Si nanocrystals can be prepared at 
larger sizes that emit at infrared wavelengths, which are ideal for deep tissue penetration 
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Chapter 5:  Aqueous Dispersibility and Photoluminescence of Near-
Infrared Emitting Si Nanocrystals 
5.1 INTRODUCTION 
Fluorescence imaging has become a common tool used to resolve biological 
structures and processes in real-time, non-invasively, and at a low cost, and as a result has 
found clinical application in a number of medical fields.
1–3
 Near infrared (NIR) emitting 
probes have drawn considerable interest for in vivo imaging because NIR wavelengths 
penetrate tissues at depths of a cm or more due to a minimum of photon absorption by 
biomolecules and cells.
1,2,4–8
 Additionally, photoluminescence (PL) in the NIR is well-
suited for imaging biological samples since it is possible to filter out cell 
autofluorescence which is present in blue-green wavelengths.
5
 Probes developed for NIR 
imaging include small molecules
5,7







 and porous 
silicon particles.
20,21
 Silicon (Si) based quantum dot fluorescence can be tuned by size 
across most of the visible range into NIR.
22
 Si quantum dots are biocompatible and can 
be used for in vitro and in vivo imaging.
22–25
 However, challenges remain for the use of Si 
nanocrystals in biological environments, such as the photoluminescence stability of the 
particles in aqueous solvents and surface oxidation. 
Previous reports have utilized surfactants or bulky polymers to disperse NIR 
emitting Si nanocrystals into aqueous environments,
23,25–27
 though these assemblies are 
an order of magnitude larger (50-150 nm) than the as-prepared Si nanocrystals, which can 
range in size from 2-15 nm. Because particle size and surface chemistry play crucial roles 
in cell uptake,
28
 it is of great interest to examine the use of particles < 50 nm for cell 
imaging work. Si nanocrystals can be directly capped with ligands containing terminal 
carboxylic acid or amine functional groups, allowing direct dispersion of the particles 
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into aqueous solvents, though previous reports did not result in stable, photoluminescent 
colloidal dispersions with size-dependent PL in red to NIR wavelengths.
29–32
 It was 
recently shown that NIR-emitting Si nanocrystals can be passivated using bifunctional 
alkenes with distal polar groups.
33
 While the smallest Si nanocrystals (around 3 nm) 
could be directly passivated with carboxylic acid terminated ligands, the larger Si 
nanocrystals ranging in size from 5.5 – 8.0 nm could be passivated with ethyl ester 
groups and were dispersible in a mixture of toluene and ethanol. Ester groups can be 
hydrolyzed into caryboxylic acids using an aqueous base, such as sodium hydroxide,
34
 
and these carboxylic acid groups can then enable the particles to be directly dispersed 
into water. While the Si nanocrystal surfaces are passivated to prevent surface oxidation, 
the presence of hydroxide ions can contribute to oxidation and degradation of the 
nanoparticle photoluminescence. Here, we characterize the hydrolysis of ethyl ester 
terminated Si nanocrystals with diameters of 4.7 nm and 6.3 nm. We also study the 
stability of the particles in water. Both the Si nanocrystal surface properties and 
photoluminescence characteristics were examined and revealed substantial surface 
oxidation as well as very low PL quantum yields after hydrolysis and then transfer into 
water. 
 
5.2 EXPERIMENTAL METHODS 
5.2.1 Materials 
Hydrogen silsesquoixane (HSQ, Fox®-16) was purchased from Dow Corning. 
Ethyl 10-undecenoate, sodium hydroxide (NaOH), and hydrofluoric acid (HF) were 
purchased from Sigma. Ethanol, hexanes, toluene, hydrochloric acid (HCl), and sodium 
chloride (NaCl) were purchased from Fisher. Rhodamine B was obtained from Acros. 
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Deionized water was obtained from a Millipore Synergy Ultrapure water system (18.2 
MΩ/cm). 
 
5.2.2 Si Nanocrystal Synthesis 
Si nanocrystals were synthesized according to a previously reported procedure.
33
 
HSQ was dried under vacuum and transferred to a quartz boat. The material was placed 
in a furnace and heat to either 1200 °C or 1250 °C for 1 hour under forming gas flow. 
After annealing the material, which resulted in Si nanocrystals embedded in an SiO2 
matrix, the product was downsized first by mortar and pestle and then by shaking for 9 
hours with borosilicate beads in a wrist-action shaker. The Si nanocrystals were liberated 
from the SiO2 matrix by stirring for 6 hours in the dark in a solution of 10 ml HF and 1 
ml HCl. The HF solution was washed away by precipitating the nanocrystals by 
centrifugation (8000 rpm for 5 min), resuspending the material in 10 ml ethanol, and 
repeating the wash 3 times in ethanol and then once more in chloroform. The hydrogen 
terminated Si nanocrystals were then dispersed in 10 ml of ethyl 10-undecenoate and 
transferred into a three neck flask on a Schlenk line. Three freeze-pump-thaw cycles were 
used to degas the sample. The nanocrystal dispersion was then left stirring overnight 
under N2 gas at room temperature (30 °C). The resulting solution, which contained 
partially passivated Si nanocrystals, was then transferred to a 20 ml vial with an 
additional 5 ml of ethanol and 5 ml of toluene. The vial was sealed with a septum and left 
on the bench top for at least one month, during which time the dispersion went from 
cloudy to transparent as the nanocrystals were passivated. 
The ethyl 10-undecenocate coated Si nanocrystals were then washed to remove 
unpassivated particles and excess capping ligands. The nanocrystal dispersion was 
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centrifuged at 8000 rpm for 5 min to precipitate out poorly passivated nanocrystals. The 
supernatant was transferred to a new centrifuge tube and hexane was added until the 
solution became turbid. The sample was then centrifuged, and the precipitated Si 
nanocrystals were collected and redispersed in a 1:1 v/v mix of ethanol:toluene. Washing 
was repeat 3 more times using hexane as the antisolvent and a mixture of toluene and 
ethanol as the solvent. The final washed Si nanocrystals were dispersed in 1:1 v/v 
ethanol:toluene solution. 
Si nanocrystals were hydrolyzed using sodium hydroxide. 1 ml of ethyl 10-
undecenoate Si nanocrystals in 1:1 v/v ethanol:toluene at a concentration of 10 mg/ml 
was mixed with 2 ml of deionized water adjusted to pH 8.5 using NaOH. The solution 
became turbid and phase separated. While stirring, ethanol was added drop-wise until the 
nanocrystal dispersion was no longer turbid. The solution was then transferred to a 100 
kDa centrifugal filter (Millipore) and centrifuged for 5 min at 1100 g to remove excess 
solvent, while Si nanocrystals remained above the filter. Ethanol was then added to the 
nanocrystal dispersion and the solution was centrifuged again. The ethanol wash was 
repeat 5 times to remove excess toluene and water, resulting in a clear dispersion of 
hydrolyzed Si nanocrystals in ethanol. 
The Si nanocrystals were transferred from ethanol to water (pH 8.5) using 100 
kDa centrifugal filters. 1 ml of the hydrolyzed Si nanocrystals in ethanol were dilute into 
5 ml of ethanol, and 5 ml of water was added. The solution was mixed with a pipette and 
then transferred to the centrifugal filter. After centrifugation (1000 g for 7 min), 5 more 
ml of water was added to the nanocrystals. This process was repeat 5 times to transfer the 
Si nanocrystals from ethanol to water. 
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5.2.3 Characterization 
Transmission electron microscopy (TEM) was conducted on an FEI Tecnai 
Biotwin operated at 80 kV and images were collected digitally. The Si nanocrystals were 
drop cast onto 200 mesh carbon-coated copper grids (Electron Microscopy Sciences) and 
dried overnight. Si nanocrystal sizes were estimated from TEM images (n=100). 
Thermal gravimetric analysis (TGA) was conducted on a Mettler Toledo 
TGA/DSC 1. Samples were dried into 70 µl alumina crucibles. The samples were heat 
under air flow from 25 °C to 800 °C at a rate of 10 °C per minute, and then held at 800 
°C for an additional 120 minutes. 
Fourier transform infrared spectroscopy (FTIR) was conducted on a Thermo 
Mattson Infinity Gold FTIR. Samples were drop cast onto undoped silicon wafers 
(Virginia Semiconductor) and dried overnight. The chamber was purged with N2 for 20 
minutes to remove residual CO2. Measurements were taken in transmission mode with 
1024 scans at a resolution of 4 cm
-1
. Background was calculated as the transmission 
through a bare Si wafer and subtracted from the samples. 
X-ray diffraction (XRD) was conducted on a Rigaku R-Axis Spider 
diffractometer. Cu Kα radiation (λ=0.15418 nm) was used, operated at 40 kV and 40 mA. 
Si nanocrystals were dried out of solution overnight and then loaded onto a nylon loop 
using mineral oil. The sample was scanned for 20 minutes while rotating at 10° per 
second. The two-dimensional diffraction data was integrated radially with 2DP Spider 
software (version 1.0, Rigaku Americas Corp.). Background was collected for the nylon 
loop with mineral oil and subtracted from the samples. 
X-ray photoelectron spectroscopy (XPS) was conducted on a Kratos Axis Ultra 
X-ray photoelectron spectrometer. A monochromatic Al Kα x-ray source was used 
operating at hν=1486.5, 150 W, 12 mA and 10 kV. Hybrid optics employing a 
 128 
simultaneous magnetic and electrostatic lens was used with a multi-channel plate coupled 
to a hemispherical photoelectron kinetic analyzer. The instrument was calibrated such 
that the instrument work function had a binding energy of 368.3 eV for the Ag 3d5/2 line 
for metallic silver. Spectra were charge-corrected by shifting the binding energy of 
carbon 1s to 284.8 eV. Si nanocrystals were drop cast onto indium tin oxide glass slides 
and secured to the experimental try with double sided copper tape and allowed to dry 
overnight. High resolution spectra were collected with 20 eV pass energy at 0.1 eV 
intervals, with 2000 ms integration time. Casa XPS software (version 2.3.18 PR 1.0) was 
used for peak deconvolution. 
Zeta potential was acquired with a Zetasizer Nano ZS (Malvern Instruments) at an 
angle of 173° and temperature of 25 °C. Sample sizes were measured in triplicate in 
disposable folded capillary zeta cells.  
Photoluminescence spectra were acquired for samples in glass cuvettes with 1 cm 
pathlength. Absorbance was captured on a Varian Cary 50 Bio ultraviolet-visible 
spectrophotometer. Background (cuvettes containing only solvent) was subtracted from 
all absorbance plots. Photoluminescence emission (PL) and photoluminescence excitation 
(PLE) spectra were captured on either a Varian Cary Eclipse fluorescence spectrometer 
(for wavelengths below 850 nm) or on a Fluorolog3 Fluorimeter (for wavelengths above 
800 nm). PL spectra were captured upon excitation at 400 nm. For quantum yield 
measurements PL was excited at 350 nm and Rhodamine B was used as a standard 
(quantum yield of 0.49 in ethanol).
35
 Quantum yield was calculated according to the 
relation: QYSi=(QYref)(Aref/ASi)(Isi/Iref)(ηSi/ηref)
2
, where QY is the quantum yield, A is the 
absorbance at 350 nm, I is the PL intensity, η is the solvent refractive index, and the 
subscripts Si and ref refer to the Si nanocrystal samples and Rhodamine B reference, 
respectively. 
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5.3 RESULTS AND DISCUSSION 
5.3.1 Si Nanocrystal Hydrolysis and Transfer into Water 
Ethyl ester capped Si nanocrystals were prepared by thermal annealing of HSQ at 
either 1200 °C or 1250 °C and passivating with ethyl 10-undecenoate. Nanocrystals 
prepared at 1200 °C were 4.7 ± 0.9 nm in diameter and had a peak emission wavelength 
of 952 nm, while nanocrystals prepared at 1250 °C were 6.3 ± 1.1 nm in diameter and 
had a peak emission wavelength of 985 nm. The ester capped Si nanocrystals could be 
directly dispersed in a 1:1 v/v mixture of ethanol and toluene. After hydrolysis of the 
ester group on the capping ligands, the nanocrystals could be dispersed in ethanol. The 
nanocrystals were transferred to pH 8.5 water which deprotonates some of the carboxylic 
acid groups and results in electrostatic colloidal stability between the anionic 
nanocrystals (Figure 5.1). 
 
 
Figure 5.1 Illustration of Si nanocrystal passivation, hydrolysis, and transfer to water. 
The photograph shows a vial containing 6.3 nm Si nanocrystals dispersed in 
water. 
After transfer into water, the Si nanocrystal dispersions appeared optically clear, 
suggesting that the nanocrystals were well dispersed. The zeta potential of the 6.3 nm Si 
nanocrystals in pH 8.5 water was -37.7 mV. Colloidal dispersions with zeta potential 
absolute values greater than 30 mV are considered stable and unlikely to aggregate. Thus, 
the pH 8.5 water was high enough to deprotonate a sufficient percentage of ligand 
carboxylic acid groups to confer electrostatic repulsion between the nanoparticles. 
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Figure 5.2 shows TEM images of the nanocrystals at each stage in the process, 
and after one week in water. The images show that the nanocrystals maintain their 
integrity after hydrolysis of the ester group on the capping ligands as well as after 
dispersion in water. However, after one week in water the 4.7 nm nanocrystals were no 
longer visible under TEM, and only amorphous material was observed on the TEM grid. 
For the 6.3 nm nanocrystals, after one week in water nanocrystals were observed 
embedded in large, irregularly shaped material. 
 
 
Figure 5.2 Transmission electron microscopy images of Si nanocrystals capped with 
ethyl 10-undecnocate with diameters of (a) 4.7 nm or (b) 6.3 nm. After one 
week in water the 6.3 nm nanocrystals (yellow arrows) appeared embedded 
in larger, amorphous material. 
Si is prone to oxidation, however, alkene ligand passivation is an effective way to 
prevent oxidative degradation of Si nanocrystals. The ligand coverage on the Si 
nanocrystals was determined by thermal gravimetric analysis (TGA) performed under air 
flow. The TGA data in Figure 5.3 show a mass loss event between 250-400 °C, which 
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can be attributed to removal of the ligands. At higher temperatures, the mass of the 
sample begins to increase again as Si transforms into SiO2 in the air atmosphere. The 
TGA results indicate that the 4.7 nm Si nanocrystals are 51% by mass Si (the remaining 
mass is ligand), which corresponds to a ligand density of 4.9 ligands/nm
2
. In comparison, 
the 6.3 nm Si nanocrystals are 62% by mass Si, which corresponds to a ligand density of 
4.3 ligands/nm
2
. These results are comparable to surface coverage reported with alkene 
ligands (3-6 ligands/nm
2





Figure 5.3 TGA results for ethyl 10-undecenoic acid Si nanocrystals performed in air 
atmosphere. 
FTIR spectra, XPS and XRD characterization of 6.3 nm Si nanocrystals after 
hydrolysis and transfer into water is presented in Figure 5.4. FTIR spectra (Figure 5.4a) 
show that while CH3 stretching is present before hydrolysis, after hydrolysis and transfer 
to water this stretch disappears. This indicates that the ester groups are hydrolyzed into 
carboxylic acids. In all spectra Si-H stretching is observed, indicating incomplete 
passivation of the Si nanocrystal surface. The Si-O stretching at 1100 cm
-1
 is also present 
in all three spectra, and indicates surface oxidation. Since all samples were dried out of 
solution overnight, it is possible that some of the oxidation observed was the result of 
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sample preparation. XRD spectra (Figure 5.4b) demonstrate that the Si nanocrystals 
maintain their diamond cubic lattice. The crystal size can be estimated from the XRD 
peak widths using the Scherrer equation.
36
 The calculated sizes were: 5.8 ± 0.4 nm before 
hydrolysis, 5.1 ± 0.6 nm after hydrolysis, and 5.6 ± 0.2 nm after transfer into water (n=3 
for 3 peaks used in analysis of each XRD pattern). These sizes indicate the crystalline 
cores remain at nearly constant size through hydrolysis and water transfer. Surface 
oxidation was characterized using XPS (Figure 5.4c). Before hydrolysis, the crystalline 
Si
0
 peaks are observed. There is also contribution from Si-C (indicating surface 









). After hydrolysis and transfer into water, the surface becomes more oxidized. 
After one week in water, there was no Si
0
 identified and the sample appeared to be 
completely oxidized. Though there may be some crystalline material remaining (see TEM 
of 6.3 nm Si nanocrystals after one week in water, Figure 5.2b), oxidation of the outer Si 
nanocrystal surface may obscure the interior crystalline material. The substantial Si 
oxidation was anticipated for these samples, since pH 8.5 water (adjusted with NaOH) 
was used for hydrolysis and to store the Si nanocrystal dispersion, and hydroxide ions 





Figure 5.4 Characterization results of 6.3 nm Si nanocrystal hydrolysis and transfer into 
water. (a) FTIR spectra show the hydrolysis of ethyl 10-undecenoate ligands 
into carboxylic acids. (b) XRD patterns for Si nanocrystals throughout the 
process show no change to the crystal structure. The reference pattern is for 
diamond cubic silicon (PDF 027-1402, with a=b=c=0.543088 nm). (c) XPS 
spectra for Si nanocrystals. Raw data (black diamonds) was fit (blue line) by 
summing Si peak contributions (black lines). 
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5.3.2 Photoluminescence of NIR Emitting Si Nanocrystals 
 The photoluminescence stability of the NIR emitting Si nanocrystals was 
measured. Figure 5.5 shows the normalized PL and absorbance spectra for the Si 
nanocrystals. The peak emission wavelength before hydrolysis was 952 nm for the 4.7 
nm Si nanocrystals and 985 nm for the 6.3 nm Si nanocrystals dispersed in 1:1 v/v 
ethanol:toluene, which is consistent with the PL emission observed for alkene coated Si 
nanocrystals synthesized from HSQ at the same temperatures.
22
 The PL emission peak 
wavelength did not change after hydrolyzing the ester and dispersing the nanocrystals in 
ethanol; however, it did shift 20 nm towards the blue after dispersing in pH 8.5 water (to 
934 nm and 967 nm for the 4.7 nm and 6.3 nm Si nanocrystals, respectively). The PL 
blue-shift suggests that as the nanocrystal surfaces oxidize, the crystalline Si core shrinks 






Figure 5.5 Normalized absorbance and PL emission spectra for (a) 4.7 nm and (b) 6.3 
nm Si nanocrystals, showing changes in spectra after hydrolysis of ethyl 10-
undecenoate and then transfer into water. Si nanocrystals were dispersed in 
1:1 v/v ethanol:toluene before hydrolysis, in ethanol after hydrolysis, and in 
pH 8.5 water after water transfer. Grey dashed lines indicate peak PL 
wavelength before hydrolysis (952 nm for the 4.7 nm Si nanocrystals and 
985 nm for the 6.3 nm Si nanocrystals). 
Si nanocrystal PL was further characterized by estimating the quantum yield. 
Quantum yield (QY) measurements of NIR emitters are challenging because of a lack of 
adequate infrared reference standards.
39
 Here, Rhodamine B was used as a standard, 
although the dye does not have significant spectral overlap with the NIR Si nanocrystals, 
and thus the values calculated are an estimate of quantum yield magnitude. Figure 5.6 
shows the PL quantum yields for 4.7 nm and 6.3 nm Si nanocrystals measured before 
hydrolysis, after hydrolysis, and after transfer into water. The QY for both samples were 
very low (< 1.0%) in comparison to alkene capped Si nanocrystals in the same size range 
which exhibit quantum yields of 30-45%.
40
 In this case, the ethyl 10-undecenoate capped 
nanocrystals were considerably more oxidized than nanocrystals of the same size 
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passivated with alkenes, which may contribute to the low QY.
40
 Lower PL QY has 
previously been observed for carboxylic acid terminated Si nanocrystals in comparison to 
alkene capped nanocrystals,
33
 and thus the low QY may be attributed to the ligands used 
and surface oxidation. The QY was further reduced for both samples after hydrolyzing 
the ester and transferring into water.
29
 Almost no emission was captured from the NIR 
emitting Si nanocrystals after one day in water. 
 
 
Figure 5.6 PL emission quantum yields of 4.7 nm and 6.3 nm Si nanocrystal samples. 
Si nanocrystals were dispersed in 1:1 v/v ethanol:toluene before hydrolysis, 
in ethanol after hydrolysis, and in pH 8.5 water after water transfer. 
 
5.4 CONCLUSION 
The aqueous dispersibility of NIR emitting Si nanocrystals has been 
demonstrated. However, the photoluminescence quantum yields for the Si nanocrystals, 
particularly after transfer into water, were extremely low and thus these particles would 
likely not be useful for bioimaging. For these Si nanocrystals to be sufficiently bright for 
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bioimaging applications, improvements to the quantum yield through the use of different 
ligands, polymer shells, or surfactants will be required.
29
 Adding polymer shells onto the 
Si nanocrystals would not only deter surface oxidation, but can also support colloidal 
stability.
41
 Additionally, while the Si nanocrystals emit in the NIR, here we used 
excitation in the visible range (400 nm). In order to take full advantage of NIR 
wavelengths for in vivo imaging it would be ideal for NIR excitation to be used as well. 
NIR excitation has been explored using up-converting nanoparticles, as well as through 
the use of multi-photon excitation of semiconductor quantum dots.
11,21,42
 Si nanocrystals 
have already been demonstrated to have two photon absorption,
43
 and thus two photon 
excitation can enable the use of NIR excitation and emission. There is opportunity to 
continue developing NIR emitting Si nanocrystals for bioimaging applications, however 
improvements to the photoluminescence stability must be accomplished for these 
particles to be bright enough for in vivo imaging. 
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Chapter 6:  Spectral and Temporal Multiplexing for Colocalization of 
Silicon Nanocrystals in Mouse Macrophage Cells 
6.1 INTRODUCTION 
The field of bioimaging with fluorescent probes has grown tremendously for 
applications in research and medicine due to the ability to quickly examine biomolecules 
and tissue with minimal equipment.
1–5
 Silicon (Si) based nanoparticles are biocompatible 
and exhibit bright, size-tunable photoluminescence (PL) in the visible to infrared 
wavelengths and have been demonstrated for in vitro and in vivo bioimaging 
applications.
6–16
 However, challenges remain with using Si nanocrystals for bioimaging. 
First, while the Si nanocrystals exhibit size dependent emission, the emission spectrum is 
broad, often with full width at half maximum (FWHM) on the order of 150-200 nm.
14,17
 
Compared to other semiconductor quantum dots which have narrow emission spectra,
18
 
the broad emission spectrum of Si nanocrystals makes it difficult to spectrally multiplex 
simultaneously with multiple fluorescent probes without conducting multiple scans of the 
sample, which can result in fluorophore photobleaching.
1
 The development of temporal 
multiplexing has offered new opportunities for simultaneously imaging multiple probes 
with spectral overlap.
1,19
 In fluorescence lifetime imaging microscopy (FLIM), the 
fluorescence decay is monitored at each pixel using time-correlated single photon 
counting (TCSPC), enabling fluorophores with similar emission color to be distinguished 
and mapped independently according to their PL lifetime.
19
 FLIM has been used to 
simultaneously image several fluorophores using both spectral and temporal separation.
20
 
For quantum dots, which typically have longer PL lifetimes (10’s-100’s of ns) than 
fluorescent dyes (< 10 ns),
18
 TCSPC has been used either as a mechanism for gating PL 
between short lived and long lived emission (for example, to remove short-lived cell 
autofluorescence),
21–24




 Si based nanoparticles have significantly longer decay times 
on the order of 10’s of microseconds
13,17,35
 and can be used as probes for lifetime gating 




The other remaining challenge for bioimaging with Si nanocrystals is that since Si 
is an indirect bandgap semiconductor with a wide apparent Stokes shift, excitation is 
typically accomplished with blue wavelengths. However, red to infrared wavelengths are 
optimal for bioimaging applications because light at these wavelengths can penetrate 
deep into tissue and biomolecule autofluorescence is minimized.
38,39
 Multiphoton 
microscopy can allow for imaging using longer wavelengths. Instead of a single photon 
exciting a molecule or quantum dot from the ground state to the excited state, in multi-
photon microscopy two or more photons are absorbed at once.
40,41
 Since the photons must 
be absorbed near-simultaneously the probability of two-photon absorption depends 
quadratically on the incident light intensity and requires a high flux of excitation photons 
from a pulsed laser source.
1,41
 The requirement for high power density provides the added 
benefit of confining excitation to a small focal volume, which allows for three 
dimensional spatial resolution not possible with single photon excitation. Additionally, 
because selection rules for two-photon absorption processes in molecular dyes are 
different than single-photon selection rules, dyes that require separate one-photon 
excitation wavelengths may be excited with the same two-photon excitation 
wavelengths.
41
 Si nanoparticles have two-photon absorption cross-sections comparable to 




Here, we demonstrate the use of FLIM with two-photon excitation of Si 
nanocrystal quantum dots and fluorescent dyes to image fixed cells with a single scan. 
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Spectral separation is used to resolve the locations of blue vs red emitters and temporal 
separation to resolve the locations of fast vs slow emitters. The spectral and temporal 
multiplexing was applied to study the uptake mechanism of 10-undecenoic acid coated Si 
nanocrystals in mouse macrophage cells. 
 
6.2 EXPERIMENTAL METHODS 
6.2.1 Materials 
Hydrogen silsesquoixane (HSQ, Fox®-16) was purchased from Dow Corning. 
10-Undecenoic acid, sodium hydroxide (NaOH), hydrofluoric acid (HF), and Dulbecco’s 
Modified Eagle Medium (DMEM) were purchased from Sigma. Ethanol, hexanes, 
toluene, and hydrochloric acid (HCl) were purchased from Fisher. Rhodamine B was 
purchased from Acros. Fetal bovine serum (FBS), penicillin-streptomycin, and sodium 
pyruvate were purchased from Life Technologies. Dextran (10k)-Cascade Blue was 
purchased from Invitrogen. CellMask Deep Red was purchased from Thermo Fisher 
Scientific. eFluor 660 conjugated to CD107a (LAMP-1) was purchased from 
eBioscience. Fluoromount-G and DAPI-Fluoromount-G were purchased from 
SouthernBiotech. A Millipore Synergy Ultrapure water system operated at 18.2 MΩ/cm 
was used for deionized water. 
 
6.2.2 Si Nanocrystal Synthesis and Transfer into Water 
Silicon (Si) nanocrystals passivated with 10-undecenoic acid were prepared per a 
previous protocol.
44
 Solvent was removed from HSQ and the resulting material was 
annealed in a tube furnace set to 1100 °C for one hour under forming gas flow. The 
annealed material (Si nanocrystals embedded in an SiO2 matrix) was ground by mortar 
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and pestle and downsized by 9 hours of shaking with borosilicate beads in a wrist action 
shaker, and then etched while stirring in a solution of 10 ml hydrofluoric acid and 1 ml 
HCl in the dark for 3 hours. The acids were removed by centrifuging the nanoparticle 
dispersion (8000 rpm, 5 min) and removing the supernatant. The precipitate was then 
redispersed in ethanol and centrifuged again. The washing process was repeat for a total 
of three washes in ethanol and one wash in chloroform. Finally, the nanocrystals were 
dispersed in 15 ml of 10-undecenoic acid. The dispersion was degassed using three 
freeze-pump-thaw cycles with liquid nitrogen, and finally left to stir overnight at 35 °C 
under nitrogen gas flow. The Si nanocrystals were then transferred to a vial with 5 ml of 
ethanol and the vial was sealed with a septum. The vial was allowed to sit on the 
benchtop for one month as the dispersion turned from cloudy to clear as the passivation 
yield increased. The resulting passivated Si nanocrystals were washed with centrifugation 
using ethanol as the solvent and hexane as the antisolvent. The prepared Si nanocrystals 
were stored in ethanol until use. 
Si nanocrystals were transferred from ethanol to water for cell uptake 
experiments. The transfer process requires gradual dilution of Si nanocrystals into pH 7.4 
water (pH adjusted with NaOH) to deprotonate the distal carboxylic acid groups. The 
deprotonated carboxyl groups can then electrostatically stabilize the colloidal dispersion. 
The water transfer was accomplished by adding 5 ml of 5 mg/ml 10-undecenoic acid 
coated Si nanocrystals in ethanol to a 30 kDa centrifugal filter (EMD Millipore). 2 ml of 
pH 7.4 water was added and a pipette was used to mix the dispersion. The filter was then 
centrifuged at 1000 g for 5 min, and the solution that passed through the filter was 
discarded. An additional 5 ml of water was again added to the dispersion and the 
filtration process was repeated. A total of five rinses into water were used to completely 
transfer the nanocrystals into water. 
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6.2.3 Cell Culture and Incubation with Si Nanocrystals 
J774A.1 cells (ATCC) were grown in a humidified 37 ˚C incubator with an 
atmosphere of 5% CO2 in cell culture medium containing DMEM supplemented with 
10% fetal bovine serum, 100 U/mL penicillin-streptomycin, and 1 mM sodium pyruvate. 





days before the assay. Culture medium was replaced with SiNC and/or 1mg/ml Dextran 
10K Cascade Blue and incubated for 30 minutes or 3 hours. The coverslips were then 
washed 4-5 times with PBS to remove extracellular SiNC. For membrane staining, 
coverslips were washed three times with PBS and stained with CellMask Deep Red at 
0.1X by inverting onto a 95ul droplet on parafilm for 10 min at 37 ˚C. Coverslips were 
washed three times with PBS before fixation with 4% formaldehyde for 10 min at 37 ˚C 
followed by three more washes with PBS. For intracellular staining, coverslips were 
permeabilized with 1% TritonX100 for 10min at 37 ˚C, washed three times with PBS, 
and blocked with 1%FBS in PBS before 1˚ antibody staining with 1:100 dilution of 
monoclonal CD107a (LAMP-1) antibody conjugated to eFluor 660 by inverting onto a 
95ul droplet on parafilm for 30 minutes at room temp. The coverslips were finally 
washed three times with 1% FBS in PBS and mounted on glass slides with Fluoromount-
G or DAPI Fluoromount-G. Slides were imaged within 1 hour after preparation. 
 
6.2.4 Characterization and Imaging 
Transmission electron microscopy (TEM) was conducted on an FEI Tecnai 
Biotwin TEM operated at 80 kV. Si nanocrystal samples were dropcast on 200 mesh 
carbon-coated copper grids (Electron Microscopy Science). Si nanocrystal size was 
estimated from the TEM images by measuring 100 particles.  
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Photoluminescence (PL) emission spectra were collected on a Varian Cary 
Eclipse fluorescence spectrometer. 
Confocal images using one-photon excitation were captured on a Zeiss LSM 710 
Confocal. DAPI was excited at 405 nm and emission was captured from 417-566 nm. Si 
nanocrystals were excited at 405 nm and emission was captured from 660-740 nm. 
The two photon response of Si nanocrystals was characterized by varying the 
input Ti:sapphire laser power and measuring the emission intensity. 40 µl of Si 
nanocrystals (1 mg/ml) were dispersed in water. Emitted photons were filtered with a 
609/181 nm bandpass filter and recorded by a photomultiplier tube (PMT). Photon counts 
were monitored by a digital photon counting board (DPC-230 Becker & Hickl GmbH) at 
increasing laser powers; each measurement was taken in triplicate (error bars represent 
standard deviation). Background emission was measured using 40 µl of water and the 
logarithm of the background-subtracted signal values is plotted as a function of 
logarithmic excitation power. 
The PL decay of Si nanocrystals upon two photon excitation was measured with 
TCSPC using a temporally-gated Ti:sapphire oscillator as the excitation laser. Due to the 
long fluorescence lifetime of SiNCs (10s of µs), the temporal separation between laser 
pulses in a Ti:sapphire oscillator (76 MHz, 13 ns) is not sufficient to sample the full 
decay. To overcome this challenge, an electro-optic modulator was used to generate a 
short gate of pulsed excitation light with user-controlled inter-gate intervals as previously 
described.
45
 Briefly, a 20-µs gate of excitation pulses was used at a modulation rate of 5 
kHz, which resulted in a 200-µs window of measurable fluorescence decay. This window 
is approximately 2-3 times longer than the SiNC lifetime and is sufficient for sampling 
the full decay. Emission was filtered with a 609/181 nm bandpass filter. 
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TCSPC data was processed using Matlab R2017a and ImageJ 1.48v. The JaCOP 




6.3 RESULTS AND DISCUSSION 
6.3.1 Time Gated Imaging Setup 
Figure 6.1a shows an illustration of the microscope used to acquire TCSPC data. 
A femtosecond titanium: sapphire laser tuned to 800 nm (Mira 900, Coherent) was 
scanned across the sample to excite the fluorescent samples, and the emission was 
captured simultaneously by two GaAsP photomultiplier tubes (PMT) (H7422PA-40, 
Hamamatsu) with 457/50 nm (“blue PMT”) and 675/67 nm (“red PMT”) bandpass filters 
in a non-descanned detection scheme. The output current from each PMT was amplified 
using a preamplifier (HFAC-26, Becker & Hickl GmnH) and routed to the photon 
counting board (SPC-150, Becker & Hickl GmbH) by a four-channel router (HRT-41, 
Becker & Hickl GmbH). Fluorescence lifetimes were recorded for an array of 250 x 250 
pixels (square area of 58 µm x 58 µm) with 20 ps time resolution and a pixel dwell time 
of 5 ms. The point spread function of the microscope was characterized by imaging 100-
nm fluorescent beads, and the image resolution was 0.35 µm in the plane of the substrate 
and 1.37 µm perpendicular to the substrate. A timing delay between the laser trigger 
pulse and fluorescent emission resulted in a shifted lifetime curve with electrical noise at 
the late time points. The curve was processed and shifted, and the electrical noise was 
excluded. 
Lifetime gating within the red PMT was performed as depicted in Figure 6.1b: at 
each pixel, 13 ns of PL data were captured and separated into two temporal regions, “R1” 
and “R2.” R1 started at the apex of the photoluminescence (PL) decay curve, and R2 
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started 9.5 ns seconds later, with each region lasting for 2 ns. Both short-lived dye 
emission and long-lived Si nanocrystal emission contribute to R1, whereas only the long-
lived Si nanocrystal emission is observed in R2. The PL intensity within each time period 
was summed to give the intensity in the region. Thus, the intensity measured in R2 can be 
attributed to Si nanocrystals, while a subtraction of intensity at R1 minus intensity at R2 
results in the intensity attributed to the short lived red emitting fluorescent dye (R1-R2). 
 
 
Figure 6.1 (a) Schematic depiction of TCSPC microscope setup, showing data capture 
from two PMTs to enable simultaneous capture of emission from spectrally 
distinct probes. HWP: half-wave plate, BD: beam dump, PBS: polarizing 
beam splitter, SM: scanning mirrors, DM: dichroic mirror. (b) Depiction of 
lifetime gating, showing the regions “R1” (0-2 ns after the PL peak) and 
“R2” (9.5-11.5 ns after the peak). The difference between the two sums (R1-
R2) corresponds to the contribution from the short-lived emitting dye, while 
R2 corresponds to the contribution from the long-lived Si nanocrystals. 
Si nanocrystals with diameter 2.7 ± 0.6 nm (n=100, as measured by TEM) were 
prepared and passivated with 10-undecenoic acid as the capping ligand.
44
 The resulting 
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nanocrystals could be dispersed in ethanol or transferred into pH 7.4 water. In water, the 
distal carboxylic acid group on the ligands deprotonates and imparts electrostatic stability 
on the colloidal dispersion. Figure 6.2a shows the emission from 10-undecenoic acid Si 
nanocrystals. The peak emission wavelength was 698 nm, and the measured full width at 
half maximum of the emission curve was 159 nm. 
Figure 6.2b shows the time-dependent PL of the Si nanocrystals as measured with 
TCSPC using a temporally-gated Ti:sapphire oscillator as the excitation laser. The data 

















   Equation 6.1 
 
with values of A1=0.40, τ1=60.54 µs, A2=0.34, τ2=16.30 µs, A3=0.32, τ3=2.87 µs 
(R
2




Figure 6.2c shows the PL emission intensity as a function of excitation laser 
power for 10-undecenoic acid capped 2.7 nm Si nanocrystals dispersed in water. Two 
photon absorption is expected to show a quadratic dependence between the excitation 




 A linear fit of the log-log data confirmed a 
slope of 1.95 (R
2
=0.994), indicating two-photon absorption for Si nanocrystals dispersed 
in water. Two-photon absorption by Si nanocrystals has been reported in a number of 






Figure 6.2 (a) PL spectrum for 10-undecenoic acid capped Si nanocrystals excited at 
320 nm. Inset shows a vial of 10-undecenoic acid capped Si nanocrystals 
dispersed in water on a 365 nm ultraviolet lamp. (b) Time-resolved PL 
emission of Si nanocrystals dispersed in water exhibiting microsecond 
fluorescence decay lifetime; the data are fit to Equation 6.1 (red line). (c) Si 
nanocrystal PL intensity measured at increasing excitation laser powers. A 
linear fit (red line) to the log-log plot had a slope close to 2, confirming two-
photon absorption. 
 
6.3.2 Cell Imaging with Si Nanocrystals, CellMask Deep Red, and DAPI 
For cell uptake testing, 0.4 ml of Si nanocrystals (2 mg/ml dispersed in water) was 
added to 1.6 ml of cell culture medium and incubated with J774 mouse macrophage cells 
at 37 °C for 30 min or 3 hr. Prior to fixing the cells for imaging, a buffer was used to 
rinse the cells in order to remove non-internalized materials. Macrophage cells, which are 
part of the body’s immune response, employ endocytosis (primarily phagocytosis) to 
actively internalize nanomaterials.
47–51
 Figure 6.3 shows confocal microscopy images 
using one photon excitation at 405 nm demonstrating that after the 3 hr incubation Si 
nanocrystals were located throughout the cell interior, but not in the nucleus. In contrast, 
incubation at 4 °C did not result in Si nanocrystal uptake. These results suggest that the Si 
nanocrystals are taken up by an active endocytosis pathway and are transported to 





Figure 6.3 One-photon confocal microscopy images of J774 cells after 3 hours of 
incubation with 10-undecenoic acid capped Si nanocrystals. DAPI emission 
is false colored blue and Si nanocrystal emission is false colored red. 
For two-photon multiplexed cell imaging, macrophage cells were incubated with 
Si nanocrystals and stained with dyes that selectively locate in the cell membrane and cell 
nucleus: CellMask Deep Red (a membrane stain) and 4',6-diamidino-2-phenylindole 
(DAPI, a nucleus stain). Figure 6.4a illustrates the emission wavelengths of the dyes and 
Si nanocrystals. Si nanocrystal emission overlaps with CellMask Deep Red (emission 
maximum 666 nm), but the PL lifetimes of the two probes are significantly different, 
which enables the use of lifetime gating to separate the signals. DAPI emits in blue 
wavelengths (emission maximum 461 nm), and thus can be separated from the Si 
nanocrystal and CellMask Deep Red emission using the blue optical filter. The gating 
parameters for the probes were as follows: (i) CellMask Deep Red emission was defined 
as the difference between the short lived emission (R1) and long lived emission (R2) in 
the red PMT, (ii) Si nanocrystal emission was defined as the long-lived emission (R2) in 
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the red PMT, and (iii) DAPI emission was defined as the short lived emission (R1) in the 
blue PMT. 
 Control experiments were conducted by imaging cells stained with no dye, or 
with only CellMask Deep Red, DAPI, or Si nanocrystals. Figures 6.4b-6.4c demonstrate 
the relative contribution from each of the control samples to time correlated PL. Figure 
6.4c shows that the Si nanocrystal signal is nearly constant on the 13 ns timescale, while 
cell autofluorescence and the fluorescent dyes exhibit PL decay within the first few 
nanoseconds. The PL lifetimes for CellMask Deep Red and DAPI were calculated by 
fitting the PL decays to single exponential functions, and were found to be 1.83 ns and 
1.41 ns, respectively. Figure 6.4d shows the relative peak intensities obtained for each 
control sample when analyzed using the gating parameters. For example, the intensity of 
(R1-R2) in the red PMT was highest for CellMask Deep Red by at least an order of 
magnitude compared to the other control samples. Similarly, within the red PMT region 
R2, the Si nanocrystals exhibited the highest intensities, while in the blue PMT the DAPI 
signal was most intense. In each case, the photoluminescent probe with the highest 
intensity was at least one order of magnitude more intense than all the other emitters. 
These results indicate that there is minimal contribution from other dyes or cell 
autofluorescence using the gating parameters defined above. 
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Figure 6.4 (a) Si nanocrystal emission (orange line) shown in relation to peak DAPI 
emission (blue dotted line) and CellMask Deep Red (red dotted line), with 
shaded regions showing positions of the blue and red PMT emission filters. 
For control experiments containing either no probes or just one of the 
probes, the PL intensity over time for each image was summed in (b) the 
blue PMT and (c) the red PMT. Samples contained either no probes (cells 
only, black dots), Si nanocrystals only (red dots), DAPI only (blue dots), or 
CellMask Deep Red only (green dots). (c) The gating parameters selected 
were used to analyze images taken of the control samples, and the maximum 
intensity within each of the defined gating regions was normalized to the 
highest intensity probe. 
Figure 6.5 shows the results of time gated two photon imaging of for cells 
incubated with Si nanocrystals, DAPI, and CellMask Deep Red simultaneously. Data 
were captured for three optical sections that were 4 µm apart, providing images at the top, 
middle, and bottom of the cells. Figure 6.5a shows the time correlated PL curves for the 
red and blue PMTs as sums across all pixels. The PL intensity in the region R2 (9.5-11.5 
ns) in the red PMT corresponds to the long-lived Si nanocrystal emission, and 
demonstrates that PL emission from the nanocrystals is distinct from the dye PL.  
Figure 6.5b shows the intensity maps of the time gated data for each probe. The 
images are displayed with a 99.99% maximum pixel intensity threshold, and images for 
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each probe were individually scaled to display the full range of pixel intensities. Overlaid 
images of the signals from Si nanocrystals, CellMask Deep Red, and DAPI demonstrate 
the spatial separation of the signals throughout the cells (Figure 6.5c). CellMask Deep 
Red dye is concentrated at the outer edges of the cells, DAPI is located in the nucleus, 
and the Si nanocrystals are spread throughout the cell interior. There are regions in the 
cell where Si nanocrystals appear to have accumulated, most likely in vesicles such as 
endosomes or lysosomes.
47,48,50–52
 The optical sections showing the top, middle, and 
bottom of the cells confirm that the nanocrystals are dispersed in all three dimensions 
within the cell interior. By comparing the ratio of Si nanocrystal intensity to DAPI 
intensity at 30 min and 3 hr in the middle plane, it was estimated that the Si nanocrystal 
signal doubled, suggesting that Si nanocrystal uptake increased during that time period. 
The observation of Si nanocrystal emission spread throughout the cell interiors at both 
the 30 min and 3 hr time points are consistent with the expected kinetics of macrophage 






Figure 6.5 (a) PL decay curves captured by the red and blue PMTs and integrated over 
all pixels show the fast and slow lifetime components of the fluorescent 
dyes and the Si nanocrystals. A brief gap in the lifetime data was an artifact 
of the collection system. (b) Intensity maps for each probe were constructed 
using the summed PL intensity in regions R1 and R2 at each pixel. (c) 
Overlaid images of the cells with emission from Si nanocrystals (false 
colored red), CellMask Deep Red dye (false colored green), and DAPI dye 
(false colored blue), show that the nanocrystals appear throughout the 
interior of the cell cytoplasm. The optical sections showing the top, middle, 
and bottom of the cells were taken 4 µm apart. 
 
6.3.3 Localization of Si Nanocrystals in Macrophage Cells 
To further demonstrate the utility of lifetime gated imaging with dyes and 
nanocrystals, we investigated the colocalization of Si nanocrystals with other 
fluorophores. Dextran (10,000 MW)-Cascade Blue was co-incubated with the Si 
nanocrystals. Dextran molecules are expected to follow an endocytosis pathway in 




 Since lysosomes are often the ultimate destination for materials carried into 
cells via endocytosis,
47,53
 lysosome tagging anti-CD107a (lysosomal-associated-
membrane protein 1, LAMP-1) conjugated with EFluor 660 fluorescent dye was used. In 
these experiments, data processing was performed using the same time gating windows 
as with the DAPI and CellMask Deep Red experiments, with Cascade Blue emitting in 
the blue PMT range (emission maximum 420 nm) and EFluor 660 emitting in the red 
PMT range (emission maximum 668 nm). Figure 6.6 shows the overlaid images taken of 
the cells at 30 min and 3 hr at three planes 4 µm apart. Compared to the samples stained 
with DAPI and CellMask Deep Red (Figure 6.5), the images with the dextran and 
lysosome dyes exhibit significant overlap between the probes: for example, yellow color 
where the red and green false colored images overlap, indicating colocalization of Si 






Figure 6.6 Lifetime-gated images showing overlaid Si nanocrystals (false colored red), 
lysosomes (false colored green), and dextran (false colored blue). The cells 
were incubated with the Si nanocrystals for either (a) 30 minutes or (b) 3 
hours, and the optical sections were taken 4 µm apart to show the top, 
middle, and bottom of the cells. Cells selected for colocalization analysis are 
outlined with white dashed boxes. Insets show intensity scatter plots of the 
selected cells comparing the (top) green-lysosome and red-Si nanocrystal 
pixel intensities, and the (bottom) blue-dextran and red-Si nanocrystal pixel 
intensities, with linear data indicating colocalization. 
To assess the correlation between overlapping probe emission, pixel intensity 
scatter plots were constructed to show the relative photoluminescence of each emitter at 
each pixel. A linear relationship between pixel intensities is expected if there is 
colocalization between probes.
46
 Scatter plots shown in Figure 6.6 provide evidence for 
partial colocalization of Si nanocrystals with the dextran and lysosomes. 
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Table 6.1 shows the Pearson’s coefficients calculated for single cells in each of 
the images to quantify the colocalization of Si nanocrystals with either dextran or 
lysosomes.
46
 For Pearson’s coefficients, -1 indicates inverse correlation, 0 indicates no 
correlation, and 1 indicates perfect correlation. For dextran and Si nanocrystals the 
colocalization was most evident at the top and middle of the cells, with a slight decrease 
in colocalization at 3 hr compared to at 30 min. These results suggest that while Si 
nanocrystals and dextran may be initially internalized using similar endocytotic 
pathways, over time the particles may be processed differently inside the cells. This may 
be due to factors such as differences in size or surface charge between the dextran and Si 
nanocrystals, and the specific type of endocytosis (for example, clathrin-dependent or 
caveolin-dependent endocytosis).
47,54
 In contrast, the Si nanocrystals show increased 
colocalization with lysosomes at the 3 hr time point compared to at 30 min. In 
endocytosis nanomaterials are internalized through an energy dependent process and 
transferred through vesicles (such as endosomes) to lysosomes,
47
 and thus the 
colocalization statistics combined with the temperature dependent Si nanocrystal uptake 
(Figure 6.3) suggest the 2.7 nm Si nanocrystals are taken up by endocytosis. Additional 
analysis of the images using a method proposed by Van Steensel et al.
55
 confirmed partial 








Dextran : Si Nanocrystals  
Top 0.871 0.759 
Middle 0.869 0.797 
Bottom 0.664 0.317 
Lysosome : Si Nanocrystals  
Top 0.39 0.796 
Middle 0.853 0.927 
Bottom 0.653 0.766 
Table 6.1 Pearson’s coefficients for PL colocalization calculated between Si 
nanocrystals and dextran or lysosomes. 
As a comparison, the colocalization of Si nanocrystals with DAPI and CellMask 
Deep Red was also assessed. Table 6.2 shows that there was considerably less 
colocalization between these dyes and the Si nanocrystals. 
 




DAPI : Si Nanocrystal 
Top -0.072 0.1 
Middle 0.084 0.133 
Bottom 0.106 0.36 
Cell Mask Deep Red: Si Nanocrystal  
Top 0.166 0.713 
Middle 0.4 0.672 
Bottom 0.62 0.773 
Table 6.2 Pearson’s coefficients for PL colocalization calculated between Si 
nanocrystals and DAPI or CellMask Deep Red. 
The colocalization results shown here demonstrate that J774 macrophage cells 
take up Si nanocrystals by endocytosis. Within endocytosis, processes such as 
phagocytosis, pinocytosis, caveolae-dependent endocytosis, or clathrin-mediated 
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endocytosis may be contributing to the uptake of Si nanocrystals, depending on factors 
such as particle size, charge, and how proteins in the cell culture medium adhere to the 
nanoparticle surfaces and communicate with cell surface receptors.
47,56
 The movement of 
Si nanocrystals into lysosomes not only confirms their intracellular fate, but can also 
guide future nanocrystal design. Since lysosomes have a low pH that can degrade 
nanocrystals and lead to PL loss, it may be desirous to avoid accumulation of Si 
nanocrystals in lysosomes. Methods to avoid lysosomes include, for example, designing 
the fluorescent probes to be preferentially taken up by a caveolae-dependent pathway, 





We have demonstrated the use of two-photon time gated confocal imaging with Si 
nanocrystals to study nanoparticle uptake in cells. Not only was it possible to image 
multiple fluorophores with Si nanocrystals using a single 800 nm excitation source, but 
the resulting emission could be captured simultaneously by multiple PMTs, enabling a 
single scan of the sample without risk of photobleaching effects. The resulting images 
could be analyzed using colocalization statistics to determine that the Si nanocrystals 
move into macrophage cell lysosomes. 
 
6.5 REFERENCES 
(1)  Handbook of Biological Confocal Microscopy; Pawley, J. B., Ed.; 3rd ed.; 
Springer US: Boston, MA, 2006. 
(2)  Terai, T.; Nagano, T. Fluorescent Probes for Bioimaging Applications. Curr. 
Opin. Chem. Biol. 2008, 12, 515–521. 
(3)  Hilderbrand, S. A.; Weissleder, R. Near-Infrared Fluorescence: Application to in 
Vivo Molecular Imaging. Curr. Opin. Chem. Biol. 2010, 14, 71–79. 
 162 
(4)  Chan, J.; Dodani, S. C.; Chang, C. J. Reaction-Based Small-Molecule Fluorescent 
Probes for Chemoselective Bioimaging. Nat. Chem. 2012, 4, 973–984. 
(5)  Yao, J.; Yang, M.; Duan, Y. Chemistry, Biology, and Medicine of Fluorescent 
Nanomaterials and Related Systems: New Insights into Biosensing, Bioimaging, 
Genomics, Diagnostics, and Therapy. Chem. Rev. 2014, 114, 6130–6178. 
(6)  Li, Z. F.; Ruckenstein, E. Water-Soluble Poly(Acrylic Acid) Grafted Luminescent 
Silicon Nanoparticles and Their Use as Fluorescent Biological Staining Labels. 
Nano Lett. 2004, 4, 1463–1467. 
(7)  Warner, J. H.; Hoshino, A.; Yamamoto, K.; Tilley, R. D. Water-Soluble 
Photoluminescent Silicon Quantum Dots. Angew. Chem. 2005, 117, 4626–4630. 
(8)  O’Farrell, N.; Houlton, A.; Horrocks, B. R. Silicon Nanoparticles: Applications in 
Cell Biology and Medicine. Int. J. Nanomedicine 2006, 1, 451–472. 
(9)  Erogbogbo, F.; Yong, K.-T.; Roy, I.; Xu, G.; Prasad, P. N.; Swihart, M. T. 
Biocompatible Luminescent Silicon Quantum Dots for Imaging of Cancer Cells. 
ACS Nano 2008, 2, 873–878. 
(10)  Park, J.-H.; Gu, L.; Maltzahn, G. von; Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. 
Biodegradable Luminescent Porous Silicon Nanoparticles for in Vivo 
Applications. Nat. Mater. 2009, 8, 331–336. 
(11)  Erogbogbo, F.; Yong, K.-T.; Roy, I.; Hu, R.; Law, W.-C.; Zhao, W.; Ding, H.; 
Wu, F.; Kumar, R.; Swihart, M. T.; Prasad, P. N. In Vivo Targeted Cancer 
Imaging, Sentinel Lymph Node Mapping and Multi-Channel Imaging with 
Biocompatible Silicon Nanocrystals. ACS Nano 2010, 5, 413–423. 
(12)  Tu, C.; Ma, X.; Pantazis, P.; Kauzlarich, S. M.; Louie, A. Y. Paramagnetic, 
Silicon Quantum Dots for Magnetic Resonance and Two-Photon Imaging of 
Macrophages. J. Am. Chem. Soc. 2010, 132, 2016–2023. 
(13)  Henderson, E. J.; Shuhendler, A. J.; Prasad, P.; Baumann, V.; Maier-Flaig, F.; 
Faulkner, D. O.; Lemmer, U.; Wu, X. Y.; Ozin, G. A. Colloidally Stable Silicon 
Nanocrystals with Near-Infrared Photoluminescence for Biological Fluorescence 
Imaging. Small 2011, 7, 2507–2516. 
(14)  Hessel, C. M.; Reid, D.; Panthani, M. G.; Rasch, M. R.; Goodfellow, B. W.; Wei, 
J.; Fujii, H.; Akhavan, V.; Korgel, B. A. Synthesis of Ligand-Stabilized Silicon 
Nanocrystals with Size-Dependent Photoluminescence Spanning Visible to Near-
Infrared Wavelengths. Chem. Mater. 2012, 24, 393–401. 
(15)  Bhattacharjee, S.; Rietjens, I. M. C. M.; Singh, M. P.; Atkins, T. M.; Purkait, T. 
K.; Xu, Z.; Regli, S.; Shukaliak, A.; Clark, R. J.; Mitchell, B. S.; Alink, G. M.; 
Marcelis, A. T. M.; Fink, M. J.; Veinot, J. G. C.; Kauzlarich, S. M.; Zuilhof, H. 
Cytotoxicity of Surface-Functionalized Silicon and Germanium Nanoparticles: 
The Dominant Role of Surface Charges. Nanoscale 2013, 5, 4870–4883. 
 163 
(16)  Gu, L.; Hall, D. J.; Qin, Z.; Anglin, E.; Joo, J.; Mooney, D. J.; Howell, S. B.; 
Sailor, M. J. In Vivo Time-Gated Fluorescence Imaging with Biodegradable 
Luminescent Porous Silicon Nanoparticles. Nat. Commun. 2013, 4. 
(17)  Yu, Y.; Fan, G.; Fermi, A.; Mazzaro, R.; Morandi, V.; Ceroni, P.; Smilgies, D.-
M.; Korgel, B. A. Size-Dependent Photoluminescence Efficiency of Silicon 
Nanocrystal Quantum Dots. J. Phys. Chem. C 2017, 121, 23240–23248. 
(18)  Resch-Genger, U.; Grabolle, M.; Cavaliere-Jaricot, S.; Nitschke, R.; Nann, T. 
Quantum Dots versus Organic Dyes as Fluorescent Labels. Nat. Methods 2008, 5, 
763–775. 
(19)  Berezin, M. Y.; Achilefu, S. Fluorescence Lifetime Measurements and Biological 
Imaging. Chem. Rev. 2010, 110, 2641–2684. 
(20)  Niehörster, T.; Löschberger, A.; Gregor, I.; Krämer, B.; Rahn, H.; Patting, M.; 
Koberling, F.; Enderlein, J.; Sauer, M. Multi-Target Spectrally Resolved 
Fluorescence Lifetime Imaging Microscopy. Nat. Methods 2016, 13, 257–262. 
(21)  Dahan, M.; Laurence, T.; Pinaud, F.; Chemla, D. S.; Alivisatos, A. P.; Sauer, M.; 
Weiss, S. Time-Gated Biological Imaging by Use of Colloidal Quantum Dots. 
Opt. Lett. 2001, 26, 825–827. 
(22)  Giraud, G.; Schulze, H.; Bachmann, T. T.; Campbell, C. J.; Mount, A. R.; Ghazal, 
P.; Khondoker, M. R.; Ross, A. J.; Ember, S. W. J.; Ciani, I.; Tlili, C.; Walton, A. 
J.; Terry, J. G.; Crain, J. Fluorescence Lifetime Imaging of Quantum Dot Labeled 
DNA Microarrays. Int. J. Mol. Sci. 2009, 10, 1930–1941. 
(23)  Mandal, G.; Darragh, M.; Andrew Wang, Y.; D. Heyes, C. Cadmium-Free 
Quantum Dots as Time-Gated Bioimaging Probes in Highly-Autofluorescent 
Human Breast Cancer Cells. Chem. Commun. 2013, 49, 624–626. 
(24)  Bouccara, S.; Fragola, A.; Giovanelli, E.; Sitbon, G.; Lequeux, N.; Pons, T.; 
Loriette, V. Time-Gated Cell Imaging Using Long Lifetime near-Infrared-
Emitting Quantum Dots for Autofluorescence Rejection. J. Biomed. Opt. 2014, 
19, 051208. 
(25)  Grecco, H. e.; Lidke, K. a.; Heintzmann, R.; Lidke, D. s.; Spagnuolo, C.; 
Martinez, O. e.; Jares-Erijman, E. a.; Jovin, T. m. Ensemble and Single Particle 
Photophysical Properties (Two-Photon Excitation, Anisotropy, FRET, Lifetime, 
Spectral Conversion) of Commercial Quantum Dots in Solution and in Live Cells. 
Microsc. Res. Tech. 2004, 65, 169–179. 
(26)  Conroy, J.; Byrne, S. J.; Gun’ko, Y. K.; Rakovich, Y. P.; Donegan, J. F.; Davies, 
A.; Kelleher, D.; Volkov, Y. CdTe Nanoparticles Display Tropism to Core 
Histones and Histone-Rich Cell Organelles. Small 2008, 4, 2006–2015. 
 164 
(27)  Ruedas-Rama, M. J.; Orte, A.; Hall, E. A. H.; Alvarez-Pez, J. M.; Talavera, E. M. 
Quantum Dot Photoluminescence Lifetime-Based PH Nanosensor. Chem. 
Commun. 2011, 47, 2898–2900. 
(28)  Tang, R.; Lee, H.; Achilefu, S. Induction of PH Sensitivity on the Fluorescence 
Lifetime of Quantum Dots by NIR Fluorescent Dyes. J. Am. Chem. Soc. 2012, 
134, 4545–4548. 
(29)  Sutter, J. U.; Birch, D. J. S.; Rolinski, O. J. CdSe/ZnS Core/Shell Quantum Dots 
as Luminescence Lifetime Sensors for Cu 2+. Meas. Sci. Technol. 2012, 23, 
055103. 
(30)  Orte, A.; Alvarez-Pez, J. M.; Ruedas-Rama, M. J. Fluorescence Lifetime Imaging 
Microscopy for the Detection of Intracellular PH with Quantum Dot Nanosensors. 
ACS Nano 2013, 7, 6387–6395. 
(31)  Carlini, L.; Nadeau, J. L. Uptake and Processing of Semiconductor Quantum Dots 
in Living Cells Studied by Fluorescence Lifetime Imaging Microscopy (FLIM). 
Chem. Commun. 2013, 49, 1714–1716. 
(32)  Lu, Y.; Zhao, J.; Zhang, R.; Liu, Y.; Liu, D.; Goldys, E. M.; Yang, X.; Xi, P.; 
Sunna, A.; Lu, J.; Shi, Y.; Leif, R. C.; Huo, Y.; Shen, J.; Piper, J. A.; Robinson, J. 
P.; Jin, D. Tunable Lifetime Multiplexing Using Luminescent Nanocrystals. Nat. 
Photonics 2014, 8, 32–36. 
(33)  Damalakiene, L.; Karabanovas, V.; Bagdonas, S.; Rotomskis, R. Fluorescence-
Lifetime Imaging Microscopy for Visualization of Quantum Dots’ Endocytic 
Pathway. Int. J. Mol. Sci. 2016, 17, 473. 
(34)  Bangalore Rajeeva, B.; Lin, L.; Perillo, E. P.; Peng, X.; Yu, W. W.; Dunn, A. K.; 
Zheng, Y. High-Resolution Bubble Printing of Quantum Dots. ACS Appl. Mater. 
Interfaces 2017, 9, 16725–16733. 
(35)  Sinelnikov, R.; Dasog, M.; Beamish, J.; Meldrum, A.; Veinot, J. G. C. Revisiting 
an Ongoing Debate: What Role Do Surface Groups Play in Silicon Nanocrystal 
Photoluminescence? ACS Photonics 2017, 4, 1920–1929. 
(36)  Joo, J.; Liu, X.; Kotamraju, V. R.; Ruoslahti, E.; Nam, Y.; Sailor, M. J. Gated 
Luminescence Imaging of Silicon Nanoparticles. ACS Nano 2015, 9, 6233–6241. 
(37)  Tu, C.-C.; Awasthi, K.; Chen, K.-P.; Lin, C.-H.; Hamada, M.; Ohta, N.; Li, Y.-K. 
Time-Gated Imaging on Live Cancer Cells Using Silicon Quantum Dot 
Nanoparticles with Long-Lived Fluorescence. ACS Photonics 2017, 4, 1306–
1315. 
(38)  Bashkatov, A. N.; Genina, E. A.; Kochubey, V. I.; Tuchin, V. V. Optical 
Properties of Human Skin, Subcutaneous and Mucous Tissues in the Wavelength 
Range from 400 to 2000 Nm. J. Phys. Appl. Phys. 2005, 38, 2543. 
 165 
(39)  Kobayashi, H.; Ogawa, M.; Alford, R.; Choyke, P. L.; Urano, Y. New Strategies 
for Fluorescent Probe Design in Medical Diagnostic Imaging. Chem. Rev. 2010, 
110, 2620–2640. 
(40)  Denk, W.; Strickler, J. H.; Webb, W. W. Two-Photon Laser Scanning 
Fluorescence Microscopy. Science 1990, 248, 73–76. 
(41)  Zipfel, W. R.; Williams, R. M.; Webb, W. W. Nonlinear Magic: Multiphoton 
Microscopy in the Biosciences. Nat. Biotechnol. 2003, 21, 1369–1377. 
(42)  He, G. S.; Zheng, Q.; Yong, K.-T.; Erogbogbo, F.; Swihart, M. T.; Prasad, P. N. 
Two- and Three-Photon Absorption and Frequency Upconverted Emission of 
Silicon Quantum Dots. Nano Lett. 2008, 8, 2688–2692. 
(43)  Kim, D.; Kang, J.; Wang, T.; Ryu, H. G.; Zuidema, J. M.; Joo, J.; Kim, M.; Huh, 
Y.; Jung, J.; Ahn, K. H.; Kim, K. H., Sailor, M. J. Two-Photon In Vivo Imaging 
with Porous Silicon Nanoparticles. Adv. Mater. 2017, 1703309. 
(44)  Yu, Y.; Hessel, C. M.; Bogart, T. D.; Panthani, M. G.; Rasch, M. R.; Korgel, B. 
A. Room Temperature Hydrosilylation of Silicon Nanocrystals with Bifunctional 
Terminal Alkenes. Langmuir 2013, 29, 1533–1540. 
(45)  Kazmi, S. M. S.; Salvaggio, A. J.; Estrada, A. D.; Hemati, M. A.; Shaydyuk, N. 
K.; Roussakis, E.; Jones, T. A.; Vinogradov, S. A.; Dunn, A. K. Three-
Dimensional Mapping of Oxygen Tension in Cortical Arterioles before and after 
Occlusion. Biomed. Opt. Express 2013, 4, 1061–1073. 
(46)  Bolte, S.; Cordelières, F. P. A Guided Tour into Subcellular Colocalization 
Analysis in Light Microscopy. J. Microsc. 2006, 224, 213–232. 
(47)  Zhao, F.; Zhao, Y.; Liu, Y.; Chang, X.; Chen, C.; Zhao, Y. Cellular Uptake, 
Intracellular Trafficking, and Cytotoxicity of Nanomaterials. Small 2011, 7, 
1322–1337. 
(48)  Kim, S.; Choi, I.-H. Phagocytosis and Endocytosis of Silver Nanoparticles Induce 
Interleukin-8 Production in Human Macrophages. Yonsei Med. J. 2012, 53, 654–
657. 
(49)  Fernando, L. P.; Kandel, P. K.; Yu, J.; McNeill, J.; Ackroyd, P. C.; Christensen, 
K. A. Mechanism of Cellular Uptake of Highly Fluorescent Conjugated Polymer 
Nanoparticles. Biomacromolecules 2010, 11, 2675–2682. 
(50)  Macrophages; Kloc, M., Ed.; Springer International Publishing: Cham, 2017; 
Vol. 62. 
(51)  Lee, K. D.; Nir, S.; Papahadjopoulos, D. Quantitative Analysis of Liposome-Cell 
Interactions in Vitro: Rate Constants of Binding and Endocytosis with Suspension 
and Adherent J774 Cells and Human Monocytes. Biochemistry (Mosc.) 1993, 32, 
889–899. 
 166 
(52)  Fluorescence Microscopy of Living Cells in Culture, Part A: Fluorescent 
Analogs, Labeling Cells and Basic Microscopy; Wang, Y. L.; Taylor, D. L., Eds.; 
Academic Press, 1989; Vol. 29. 
(53)  Schmid, S. L.; Fuchs, R.; Male, P.; Mellman, I. Two Distinct Subpopulations of 
Endosomes Involved in Membrane Recycling and Transport to Lysosomes. Cell 
1988, 52, 73–83. 
(54)  dos Santos, T.; Varela, J.; Lynch, I.; Salvati, A.; Dawson, K. A. Effects of 
Transport Inhibitors on the Cellular Uptake of Carboxylated Polystyrene 
Nanoparticles in Different Cell Lines. PLoS ONE 2011, 6. 
(55)  van Steensel, B.; van Binnendijk, E. P.; Hornsby, C. D.; van der Voort, H. T.; 
Krozowski, Z. S.; de Kloet, E. R.; van Driel, R. Partial Colocalization of 
Glucocorticoid and Mineralocorticoid Receptors in Discrete Compartments in 
Nuclei of Rat Hippocampus Neurons. J. Cell Sci. 1996, 109, 787–792. 
(56)  Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Baldelli 
Bombelli, F.; Dawson, K. A. Physical−Chemical Aspects of Protein Corona: 
Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles. J. Am. 
Chem. Soc. 2011, 133, 2525–2534. 
(57)  Shin, J.-S.; Abraham, S. N. Caveolae--Not Just Craters in the Cellular Landscape. 
Science 2001, 293, 1447–1448. 
  
 167 
Chapter 7:  Bioconjugation of Si Nanocrystals 
7.1 INTRODUCTION 
Si nanocrystals are fluorescent probes that may be useful for in vivo and in vitro 
bioimaging applications.
1
 Fluorescent probes used in imaging applications can be used to 
tag specific types of cells or biomolecules by accumulating at the target site.
2,3
 Attaching 
biomolecules, such as proteins, antibodies, or antibody fragments, to the surface of 
nanoparticles is one way to achieve active targeting. Quantum dots can be engineered to 
have surfaces that act as platforms for bioconjugation, and have been used to demonstrate 
targeted bioimaging in various cell types.
2,4–7
 Si nanocrystals (2.8 nm diameter, 700 nm 
emission wavelength) can be synthesized with hydrophilic ligands that have a distal 
carboxylic acid group,
8
 which can allow for bioconjugation to biomolecules with primary 
amines using carbodiimide crosslinker chemistry.
9
 
However, challenges exist with the bioconjugation of Si nanocrystals to 
biomolecules. First, Si surfaces are prone to surface oxidation which can affect 
fluorescence stability of samples. Previous reports of bioconjugation using Si 
nanocrystals have reported that the fluorescence after conjugation to streptavidin and 
DNA appears at blue wavelengths,
10,11
 which are not ideal for bioimaging applications 
and likely indicate degradation of the Si nanocrystal surface.
12
 The second challenge is 
around confirmation of the successful conjugation to the surface. While Si nanocrystals 
have been reportedly conjugated to molecules such as lysine or folate,
13
 clear evidence of 
the conjugation is difficult to obtain, and most reports rely on successful uptake by cells 
as indication of conjugation. For example while Fourier transform infrared spectroscopy 
(FTIR) may be useful for observing the formation of amide bonds, if a biomolecule also 
contains amide bonds (and many do) then FTIR results would be inconclusive. Here, we 
present the results of bioconjugating 2.8 nm, highly fluorescent Si nanocrystals to an 
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amine-PEGn-biotin molecule. Biotin is a commonly used biomolecule in chemistry for 
tagging proteins as well as for amplification assays and there are numerous probes for its 
detection.
14–16
 The results indicate a low conjugation efficiency, though the Si 
nanocrystals maintain their bright fluorescence. 
 
7.2 EXPERIMENTAL METHODS 
7.2.1 Materials 
 Hydrogen silsesquoixane (HSQ, Fox®-16) was purchased from Dow Corning. 
10-Undecenoic acid, sodium hydroxide (NaOH), and hydrofluoric acid (HF) were 
purchased from Sigma. Ethanol, hexanes, toluene, hydrochloric acid (HCl), 2-(N-
morpholino)ethanesulfonic acid (MES),  1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC), N-hydroxysulfosuccinimide (sulfo-NHS), 2-mercaptoethanol, 
amine-PEGn-biotin, biotin quantitation kit, and streptavidin magnetic beads were 
purchased from Fisher. Rhodamine B was purchased from Acros. A Millipore Synergy 
Ultrapure water system operated at 18.2 MΩ/cm was used for deionized water. 
 
7.2.2 Silicon Nanocrystal Synthesis 
Silicon (Si) nanocrystals passivated with 10-undecenoic acid were prepared per a 
previous protocol.
8
 Solvent was removed from HSQ and the material was annealed under 
forming gas flow in a tube furnace for one hour at 1100 °C. The material was then 
ground by mortar and pestle and downsized by shaking with borosilicate beads for 9 
hours. The powder was then etched in 10 ml HF and 1 ml HCl in the dark for one hour. 
The hydrogen terminated nanocrystals were removed from the acids by centrifugation, 
and then washed twice in ethanol and once in chloroform. The particles were resuspended 
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in 10 ml 10-undecenoic acid and transferred to a Schleck line. The dispersion was put 
through three freeze-pump-thaw cycles to remove oxygen, and then left stirring overnight 
under nitrogen flow. The Si nanocrystals were then transferred to a septum-sealed vial 
with 5 ml of ethanol to ensure complete passivation of the nanocrystal surface. The 
resulting passivated Si nanocrystals were washed with centrifugation using ethanol as the 
solvent and hexane as the antisolvent, and then stored in ethanol until use. Nanocrystals 
were transferred into pH 7.4 water (pH adjusted with NaOH) by repeated dilution through 
a 30 kDa centrifugal filter (Millipore). 
 
7.2.3 Bioconjugation 
Si nanocrystals were conjugated with amine-PEGn-biotin (n= 2 or 11) using 
carbodiimide chemistry with EDC and sulfo-NHS.
9
 The Si nanocrystals (0.5 mg/ml) were 
stirred at 400 rpm as freshly prepared EDC (5 mg/ml) and sulfo-NHS (5 mg/ml) in water 
were added drop-wise. The solution was allowed to stir for 10 minutes at room 
temperature. In some preparations, an inactivation step was used. The inactivation step 
included adding either 9.3 µl of 2-mercaptoethanol or washing the Si nanocrystals with a 
centrifugal filter. Then, the amine-PEGn-biotin molecule (10 mg/ml in water) was added 
to the stirring solution with 2 ml of 0.01 M MES buffer at pH 7, and the solution was 
stirred for another 1 hour. The final product was washed 5 times through a 30 kDa 
centrifuge column into 0.01 M MES buffer at pH 7. Five washes was selected since 
measurements of free biotin in solution dropped over the first three washes, and so two 





An FEI Tecnai Biotwin operated at 80 kV was used to collect transmission 
electron microscopy (TEM) images. The Si nanocrystals were drop cast onto 200 mesh 
carbon-coated copper grids (Electron Microscopy Sciences). 
A Zetasizer Nano ZS (Malvern Instruments) was used to acquire dynamic light 
scattering (DLS). DLS data was acquired for samples in 40 µl disposable cuvettes using 
an angle of 173°. Sizes were calculated by fitting each measurement to the correlation 
coefficient data from the Zetasizer software (Malvern Instruments).
17
 All measurements 
were taken in triplicate at 25 °C. 
Photoluminescence spectra were acquired for samples in 1 cm pathlength glass 
cuvettes. Absorbance was measured on a Varian Cary 50 Bio ultraviolet-visible 
spectrophotometer. Photoluminescence emission (PL) spectra were captured on either a 
Varian Cary Eclipse fluorescence spectrometer. PL spectra were captured upon excitation 
at 320 nm. For quantum yield measurements PL was excited at 350 nm and Rhodamine B 
was used as a standard (quantum yield of 0.49 in ethanol).
18
 Quantum yield was 
calculated according to the relation: QYSi=(QYref) (Aref/ASi)(Isi/Iref)(ηSi/ηref)
2
, where QY is 
the quantum yield, A is the absorbance at 350 nm, I is the PL intensity, η is the solvent 
refractive index, and the subscripts Si and ref refer to the Si nanocrystal samples and 
Rhodamine B reference, respectively. 
Biotin quantification was conducted by measuring absorbance at 500 nm in a 
solution containing  4'-hydroxyazobenzene-2-carboxylic acid (HABA) with avidin. In the 
presence of biotin, HABA dissociates from avidin due to the high affinity between biotin 
and avidin. The extinction coefficient of HABA bound to avidin (34,000/Mcm) can be 
used to calculate the amount of biotin in solution by measuring the absorbance before and 
after adding a biotin containing sample to the HABA-avidin mix. The HABA-avidin 
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concentration can be calculated according to C=A/(εl), where A is the absorbance at 500 
nm, ε is the molar extinction coefficient, and l is the pathlength. 
Magnetic beads coated with streptavidin were used to separate the biotin-capped 
Si nanocrystals according to the manufacturer’s instructions. The beads were washed by 
collection with a magnet and removing supernatant twice before resuspending them in 
0.01 M MES pH 7 buffer. The beads were added to Si nanocrystals prepared with biotin 
and mixed by inverting the vial, and was then allowed to sit on the benchtop for 2 hours. 
A magnet was used to separate the beads from the solution. 
 
7.3 RESULTS AND DISCUSSION 
7.3.1 Bioconjugation 
Figure 7.1 illustrates the steps used in bioconjugation of amine-PEGn-biotin to Si 
nanocrystals. Si nanocrystals capped with 10-undecenoic acid were prepared according to 
a previously reported method.
8
 The first step of bioconjugation is the activation of the 
carboxylic acid group. EDC and sulfo-NHS can react with the carboxylic acid groups to 
form semi-stable amine-reactive sulfo-NHS esters. During the activation step, low pH 
(around 5) is typically used, as lower pH results in more efficient formation of the semi-
stable esters.
9,19
 Since Si nanocrystals can aggregate in low pH conditions, here we limit 
the time for the activation step to 10 minutes and keep the solution spinning rapidly. It is 
necessary to add the EDC and sulfo-NHS slowly (drop-wise) to the solution to prevent 
aggregation of the nanoparticles. After activation, the reaction can proceed to the 
conjugation step. However, in cases where the target biomolecule contains both carboxyl 
and amine groups (for example, in antibodies), it is necessary to first inactivate any 
excess EDC or sulfo-NHS. This can be done by either (i) physically washing away the 
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EDC and sulfo-NHS, for example by centrifugal filtration, or (ii) inactivating the EDC 
reaction by quenching with 2-mercaptoethanol. Finally, the conjugation step is typically 
performed at a pH where the biomolecule is stable (commonly around 7) by adding the 
amine-terminated biomolecule of interest. Two different polyethylene glycol lengths 




Figure 7.1 Illustration of the bioconjugation of biotin to Si nanocrystals. 
Table 7.1 outlines the conditions used for the samples presented here. In all cases, 
EDC and sulfo-NHS were used, however different inactivation conditions were 
attempted. The molar ratio of Si nanocrystal carboxyl groups to EDC, sulfo-NHS, and 
biotin, was selected to optimize the bioconjugation while avoiding aggregation of the 
nanocrystals. The calculations were based on an estimate that there are approximately 
200 carboxylic acid groups per 2.8 nm Si nanocrystal, which was based on previous 
thermal gravimetric analysis data for 10-undecenoic acid capped Si nanocrystals.
8
 In all 
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preparations the samples were washed by centrifugal filtration five times after the 
conjugation reaction to remove free biotin and crosslinking agents. 
 
Sample Activation Inactivation Conjugation 
A Si nanocrystals (14 
µmol carboxylic acid 
groups) + EDC (14 
µmol) + sulfo-NHS 
(14 µmol) in water 
None amine-PEGn-biotin 
(21 µmol) in 0.01 M 
MES buffer, pH 7 
B Si nanocrystals (14 
µmol carboxylic acid 
groups) + EDC (14 
µmol) + sulfo-NHS 
(14 µmol) in water 
2-mercaptoethanol amine-PEGn-biotin 
(21 µmol) in 0.01 M 
MES buffer, pH 7 
C Si nanocrystals (14 
µmol carboxylic acid 
groups) + EDC (14 
µmol) + sulfo-NHS 
(14 µmol) in water 
Wash three times 
through a 30 kDa 
filter into 0.01 M 
MES buffer, pH 7 
amine-PEGn-biotin 
(21 µmol) in 0.01 M 
MES buffer, pH 7 
D Si nanocrystals (14 
µmol carboxylic acid 
groups) + EDC (14 
µmol) + sulfo-NHS 
(14 µmol) in ethanol 
Wash three times 
through a 30 kDa 
filter into 0.01 M 
MES buffer, pH 7 
amine-PEGn-biotin 
(21 µmol) in 0.01 M 
MES buffer, pH 7 
Table 7.1 Summary of conditions tested for bioconjugation of Si nanocrystals to 
amine-PEG11-Biotin. 
Figure 7.2 shows TEM images of the samples A-D after preparation, indicating 
that the Si nanocrystal integrity was maintained. Insets show that the dispersions remain 
brightly fluorescent after bioconjugation. The quantum yields of the dispersions were 
measured relative to Rhodamine B to verify that the nanocrystals maintained brightness. 
The results, presented in Figure 7.2, indicate that there was a drop in the quantum yield 
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after bioconjugation (before conjugation, Si nanocrystals dispersed in water had a 
quantum yield of 10.7%), however the quantum yields still remained bright (4.6%-5.2%). 
 
 
Figure 7.2 TEM images of Si nanocrystals after conjugation to amine-PEG11-biotin, 
and pictures of the vials on 365 nm ultraviolet lamp. (a-d) correspond to 
samples A-D as outlined in Table 7.1. 
 
7.3.2 Measurement of Bioconjugation Efficiency 
Table 7.2 shows the results of using the HABA-avidin assay to determine the 
amount of biotin in the solution after five washes. The HABA-avidin assay measures the 
change in absorbance as a result of biotin binding to avidin and displacing the HABA 
molecules. The results show that there was some Si nanocrystal conjugated biotin 
measured, though it was significantly less than the amount of biotin added (biotin was 
added at a ratio of 300 biotin molecules per Si nanocrystal at the start of the reaction). 
These very low results suggest that conjugation was not efficient for the nanocrystals. 
Also, the results indicate that the error in the assay is on the same order of magnitude as 
the measured biotin concentrations (-0.29 biotin/Si nanocrystal measured for sample 
without any biotin present). Thus, the assay results suggest some bioconjugation, 
however do not provide sufficient confidence on the number of molecules per Si 
nanocrystal. The assay did indicate that there was more bioconjugation for the biotin 
molecules with longer polyethylene glycol (PEG) chains. This can suggest that steric 
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hinderance at the nanocrystal surface may prevent the formation of amid bonds for short 
chain molecules. The results also show that using preparation conditions D, which 
include washing away excess EDC and sulfo-NHS, did not have an adverse effect on the 
bioconjugation efficiency. This indicates that for future experiments using molecules 
such as antibodies, EDC and sulfo-NHS can be removed by washing through centrifugal 
filters to prevent crosslinking of the antibodies. 
 




A 0.07 0.36 
B 0.10 0.18 
C -0.19 0.21 
D 0.17 0.54 
Si nanocrystals in water 
(no bioconjugation) 
-0.29 
Table 7.2 Results of the HABA-avidin assay to measure biotin on Si nanocrystals. 
Figure 7.3 shows particle diameters as measured by DLS after biotin conjugation. 
The results show that compared to Si nanocrystals that were not conjugated, there was a 
slight increase in size for the bioconjugated samples A and C (from around 17 nm in 
water to 25-28 nm after conjugation). For sample B, the DLS sizes measured were very 
large (160-180 nm), and suggest that there was significant aggregation in those 
preparations. Since sample B contained the 2-mercaptoethanol, it is possible that the 
inactivation agent interacted with the charged nanoparticles to induce aggregation. 
Sample D also showed larger than expected sizes (40-45 nm) and may indicate limited 




Figure 7.3 Dynamic light scattering data for bioconjugated samples. Measurements 
were taken in triplicate (error bars are standard deviation, n=3) at 25 °C. 
Biotinylation is frequently used in biology experiments as a way to tag and 
separate biomolecules, and thus there are a number of methods available to physically 
separate biotinylated materials from non-conjugated particles. Attempts to use avidin 
columns, which retain biotin conjugated products, did not work for the Si nanocrystal 
dispersions, as non-conjugated Si nanocrystals could not pass through the column (likely 
due to aggregation of the nanocrystals with the agarose beads). Figure 7.4a shows the 
results of using magnetic beads coated with streptavidin to separate conjugated Si 
nanocrystals from non-conjugated Si nanocrystals. The magnetic beads were added to Si 
nanocrystals that either had not been conjugated or that had been conjugated according to 
the process for sample D with amine-PEG11-biotin. The results showed that while the 
magnetic beads were able to separate out of solution, there was very little change in 
fluorescence in the nanocrystal dispersions. Measurements of the photoluminescence 
(PL) intensity for samples that had been separated with the magnetic beads were used to 
estimate amount of bioconjugated nanocrystals (Figures 7.4b and 7.4c). For Si 
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nanocrystals without biotin, there was a 6% decrease in PL intensity after using the 
magnetic separation beads. This slight drop may be a result of some Si nanocrystals 
becoming aggregated with the magnetic beads even without biotin attached. In 
comparison, for biotin conjugated Si nanocrystals there was a 16% drop in PL intensity 
(the absorbance of the samples dropped by 4% for Si nanocrystals alone and 14% for 
bioconjugated Si nanocrystals, suggesting that the PL emission intensity changes are 
valid estimates for Si nanocrystal concentration changes). This suggests that up to 16% of 
the Si nanocrystals may have been conjugated to the biotin molecules. Comparing this 
value to the 0.54 biotin molecules per Si nanocrystal compared above, this indicates that 
those Si nanocrystals may have actually had a coverage density of 3.3 biotin molecules 





Figure 7.4 (a) Photographs of nanocrystal dispersions before and after magnetic bead 
separation. Left two vials contain Si nanocrystals not conjugated to biotin. 
Right two vials contain Si nanocrystals conjugated to biotin. Middle two 
vials have streptavidin magnetic beads added. PL intensity of samples 
containing Si nanocrystals (SiNC) (b) or Si nanocrystals conjugated to 
biotin (c), measured before and after separation with magnetic beads. 
 
7.4 CONCLUSION 
 The conjugation of an amine-terminated biotin molecule to Si nanocrystals was 
demonstrated. We found that the conjugation rates are low, however, and indicate very 
low reaction efficiency. For practical application of bioconjugated probes, it would be 
ideal to have at least one, if not more, conjugated molecules per particle,
3,7
 and thus the 
results presented here would need to be improved before attempting to use these targeted 
probes for imaging applications. The fact that all of the conjugated Si nanocrystal 
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samples retained their bright fluorescence, however, indicates that EDC and sulfo-NHS 
assisted conjugation can be compatible with Si nanocrystals passivated with 10-
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Chapter 8:  Conclusions and Future Directions 
8.1 CONCLUSIONS 
Si nanocrystals offer the possibility to conduct fluorescence imaging with 
biocompatible particles that have size-dependent, bright emission. Methods to produce Si 
nanocrystals have improved such that pure nanocrystals can be reproducibly synthesized 
at controlled sizes by the thermal annealing of hydrogen silsesquioxane.
1,2
 However, the 
ability to use Si nanocrystals for practical applications requires that the particles can be 
dispersed into biological environments while maintaining their photoluminescence, and 
that the particles be bright and stable enough for imaging over several hours or days. The 
aqueous dispersibility and photoluminescence stability of Si nanocrystals has been 
explored. The results indicate that Si nanocrystals which emit in visible to near infrared 
wavelengths are non-toxic and are bright and stable for in vitro imaging.   
 
8.1.1 Si Nanocrystal-Surfactant Assemblies 
Si nanocrystals were incorporated into assemblies composed of lipids and 
quatsomes, resulting in stable dispersion in aqueous solvents. When assembled with 
liposomes, it was estimated that up to half of the Si nanocrystals available for assembly 
could be dispersed with the lipids. The quantum yields for the liposome-Si nanocrystal 
assemblies were 3.2%, and up to 60% of the sample photoluminescence remained after 
three weeks. The quatsome assemblies resulted in even higher photoluminescence 
stability: the quantum yield for these assemblies was 6.6%, and bright dispersions were 
visible for twelve weeks after preparation. Furthermore, the quatsomes maintained stable 
dispersions after repeated dilution. In both the liposome and quatsome assemblies, the Si 
nanocrystals incorporated into the dispersions as aggregates coated with a monolayer of 
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surfactant molecules. The surfactant dispersed Si nanocrystal assemblies thus provide a 
platform for delivering hydrophobic Si nanocrystals into biological environments. 
 
8.1.2 Hydrophilic Ligand Passivated Si Nanocrystals 
Si nanocrystals passivated with hydrophilic ligands could be dispersed directly 
into water. Small nanocrystals of approximately 3 nm capped with 10-undecenoic acid 
which emit at 700 nm could be transferred into water and photoluminescence was stable 
for at least one week, with a quantum yield of 9.1% in water. Larger nanocrystals capped 
with ethyl 10-undecenoate that emit at 900-1000 nm could be transferred into water by 
first hydrolyzing the ligand ester groups and then transferring the particles into water. 
However, these larger nanocrystals exhibited very low quantum yield (<0.1% in water). 
All of the Si nanocrystals dispersed in water or biological solutions exhibited surface 
oxidation. 
 
8.1.3 Cell Uptake of Si Nanocrystals and Toxicity 
Si nanocrystals dispersed in liposome assemblies or directly dispersed into water 
were taken up by mouse macrophage cells at biological temperatures by endocytosis. For 
the 10-undecenoic acid capped Si nanocrystals, uptake was found to be by clathrin-
mediated endocytosis and the nanocrystals were trafficked into cell lysosomes. The 
clathrin-mediated uptake into lysosomes resulted in photoluminescence emission from 
the Si nanocrystals for up to three days, suggesting that the low pH environment 
contributes to stabilizing the Si nanocrystals against degradation. Experiments with other 
cell lines did not show significant uptake of the nanocrystals, which was expected since 
the liposomes and 10-undecenoic acid capped Si nanocrystals were not conjugated to any 
 183 
targeting molecules. Toxicity assays performed on the cells showed that the Si 
nanocrystals did not result in any toxicity, and the hydrophilic nanocrystals did not 
induce an inflammatory response in macrophage cells. 
 
8.1.4 Imaging 
Si nanocrystals that emit at 700 nm could be imaged using one-photon confocal or 
two-photon microscopy following incubation with mouse macrophage cells, indicating 
that the nanocrystal emission was sufficiently bright enough for commercially available 
imaging equipment to detect. The Si nanocrystal emission could be observed for up to 24 
hours using confocal microscopy. Lifetime gated imaging was also possible using the Si 
nanocrystals, and demonstrated that temporal multiplexing can help solve the challenges 
associated with the broad emission spectra characteristic of Si nanocrystals. 
 
8.1.5 Bioconjugation 
The bioconjugation of an amine-PEGn-biotin molecule to 10-undecenoic acid 
capped Si nanocrystals was performed by carbodiimide chemistry without any adverse 
effects to the nanocrystal photoluminescence. However, the conjugation efficiency was 
low, with <1 biotin molecule per Si nanocrystal, indicating that the methods used require 




8.2 FUTURE DIRECTIONS 
8.2.1 Active Targeting through Bioconjugated Molecules 
Nanoparticles make excellent platforms for bioimaging because their surface 
chemistries can be engineered with various shells, ligands, and adsorbed molecules. The 
coating of nanoparticle surfaces with biomolecules is an important technique that allows 
for the targeted accumulation of fluorescent probes or control of the particle fate inside of 
cells. Liposomes have been studied with various targeting ligands,
3
 and thus using tagged 
liposomes loaded with Si nanocrystals can provide a straightforward approach to enable 
targeted delivery of Si nanocrystal probes. For hydrophilic Si nanocrystals, while 





 most attempts have resulted in blue emitting Si nanocrystals, where emission 
is not as useful for bioimaging applications. The carboxylic acid terminal groups on 10-
undecenoic acid capped Si nanocrystals provide a convenient platform for direct 
conjugation to molecules with primary amines through carbodiimide chemistry,
6
 and a 
previous work has demonstrated that Si nanocrystals can be conjugated with lysine or 
folate.
7
 Here, we found very low conjugation efficiency for Si nanocrystals with amine-
PEGn-biotin molecules, and thus further work will be needed to improve those results. 
The bioconjugation of Si nanocrystals to antibodies or antibody fragments would be an 
interesting system to explore, since these molecules can be used to tag cells directly or 
through the use of primary and secondary antibodies. The conjugation with antibodies 
must be carefully controlled, however, since the conjugation reaction can result in 





8.2.2 Near Infrared Imaging 
The biological imaging window in the near infrared (NIR) continues to drive the 
development of new fluorescent probes.
8
 Si nanocrystals capped with distal ester groups 
resulted in very weak fluorescence which was almost negligible after transfer into an 
aqueous environment. Thus, in order for Si nanocrystals produced by annealing hydrogen 
silsesquioxane to be useful for NIR imaging applications, the quantum yield of these 
probes must be improved. This can be accomplished either by (i) encapsulating 
hydrophobic, alkene terminated Si nanocrystals which already display bright 
photoluminescence
9
 into surfactant assemblies, or (ii) applying surface coatings such as 
polymers which can coat the surfaces of Si nanocrystals. 
Multi-photon excitation is also important for NIR imaging applications, since 
excitation sources in the infrared can be used. Here, Si nanocrystal emission was able to 
be captured after two-photon excitation at 800 nm. Further work can also be conducted to 
look at the possibility of using three-photon excitation with Si nanocrystals, which can 
use even longer wavelength lasers and allow multiplexing with different organic dyes. 
 
8.2.3 In Vivo Imaging 
The work in this dissertation has demonstrated in vitro imaging using Si 
nanocrystals, however there are many in vivo fluorescence imaging applications that can 
benefit from the use of biocompatible particles. Full scale animal imaging has been 
conducted using porous silicon particles and nanocrystals.
10,11
 Based on the in vitro 
results obtained with Si nanocrystals, it is likely that by first ensuring that the 
nanocrystals can accumulate in the target region, for example by using bioconjugated 
targeting molecules, the nanocrystal emission could be bright enough to image through 
tissue. The ability for nanoparticles to reach target tissue depends not only on tissue 
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characteristics, but also on nanoparticle size, shape, and surface chemistry.
12
 Porous 
silicon nanoparticles have been found to biodegrade in vivo,
10
 and here the 10-undecenoic 
acid capped Si nanocrystals degraded in aqueous solvents. However, studies on Si 
nanocrystals in mice found that the particles did not degrade as expected within three 
months,
13
 suggesting that the crystalline material takes far longer to degrade than porous 
silicon. Thus, studies on the fate of Si nanocrystals as they degrade and are cleared from 
living specimens would be necessary before these particles can be used for in vivo 
applications. 
 
8.2.4 Therapy with Si Nanocrystals 
In addition to uses in bioimaging, Si nanocrystals can also find therapeutic 
applications. For example, photodynamic therapy (PDT) makes uses of singlet oxygen 
generated upon excitation of fluorescent probes to cause photodamage to local cells.
14
 
PDT is most efficient when fluorescent probes have long lifetimes, and thus Si 
nanoparticles have been investigated as PDT photosensitizers.
15
 However, challenges 
remain with the use of Si nanocrystals for PDT since the ligand shell which protects the 
nanocrystals from oxidation can prevent the efficient formation and transfer of singlet 
oxygen from the nanocrystal to the target cells. By engineering the nanocrystals to allow 
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